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  V 
Foreword 
We are pleased to present this Risk Assessment Report which is the result of in-depth work 
carried out by experts in one Member State, working in co-operation with their counterparts in 
the other Member States, the Commission Services, Industry and public interest groups. 
The Risk Assessment was carried out in accordance with Council Regulation (EEC) 793/931 on 
the evaluation and control of the risks of “existing” substances. “Existing” substances are 
chemical substances in use within the European Community before September 1981 and listed in 
the European Inventory of Existing Commercial Chemical Substances. Regulation 793/93 
provides a systematic framework for the evaluation of the risks to human health and the 
environment of these substances if they are produced or imported into the Community in 
volumes above 10 tonnes per year. 
There are four overall stages in the Regulation for reducing the risks: data collection, priority 
setting, risk assessment and risk reduction. Data provided by Industry are used by Member States 
and the Commission services to determine the priority of the substances which need to be 
assessed. For each substance on a priority list, a Member State volunteers to act as “Rapporteur”, 
undertaking the in-depth Risk Assessment and recommending a strategy to limit the risks of 
exposure to the substance, if necessary. 
The methods for carrying out an in-depth Risk Assessment at Community level are laid down in 
Commission Regulation (EC) 1488/942, which is supported by a technical guidance document3. 
Normally, the “Rapporteur” and individual companies producing, importing and/or using the 
chemicals work closely together to develop a draft Risk Assessment Report, which is then 
presented at a Meeting of Member State technical experts for endorsement. The Risk Assessment 
Report is then peer-reviewed by the Scientific Committee on Health and Environmental Risks 
(SCHER) which gives its opinion to the European Commission on the quality of the risk 
assessment. 
If a Risk Assessment Report concludes that measures to reduce the risks of exposure to the 
substances are needed, beyond any measures which may already be in place, the next step in the 
process is for the “Rapporteur” to develop a proposal for a strategy to limit those risks. 
The Risk Assessment Report is also presented to the Organisation for Economic Co-operation 
and Development as a contribution to the Chapter 19, Agenda 21 goals for evaluating chemicals, 
agreed at the United Nations Conference on Environment and Development, held in Rio de 
Janeiro in 1992. 
This Risk Assessment improves our knowledge about the risks to human health and the 
environment from exposure to chemicals. We hope you will agree that the results of this in-depth 
study and intensive co-operation will make a worthwhile contribution to the Community 
objective of reducing the overall risks from exposure to chemicals
                                                 
1 O.J. No L 084, 05/04/1993 p.0001 – 0075 
2 O.J. No L 161, 29/06/1994 p. 0003 – 0011 
3 Technical Guidance Document, Part I – V, ISBN 92-827-801 [1234] 
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0  OVERALL RESULTS OF THE RISK ASSESSMENT 
CAS No: 103-11-7 
EINECS No: 203-080-7 
IUPAC Name: 2-ethylhexyl acrylate 
Environment 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
2-ethylhexyl acrylate represents, based on the present data configuration, no risk to the 
environment.  
There is therefore at present no need for further testing or gathering of exposure information. 
Human Health 
Human Health (toxicity) 
Consumers 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Workers 
Conclusion (iii) There is a need for limiting the risks; risk reduction measures which are 
already being applied shall be taken into account. 
The risk assessment reveals concern with regard to local effects after repeated inhalation for the 
formulation of preparations (Scenario 2). 
Skin sensitisation gives rise to concern for dermal exposure during production and 
polymerisation (Scenario 1), the formulation of preparations (Scenario 2) and the use of 
formulations containing monomeric 2-EHA in the building trade (Scenario 3) 
Humans exposed via the environment 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Human Health (risks from physico-chemical properties) 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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1 GENERAL SUBSTANCE INFORMATION 
1.1 IDENTIFICATION OF THE SUBSTANCE 
CAS No: 103-11-7 
EINECS No: 203-080-7 
IUPAC Name: 2-ethylhexyl acrylate 
Synonyms: Acrylic acid 2-ethylhexyl ester, 2-Ethylhexylprop-2-enoate, 2-Propenoic 
acid 2-ethylhexylester 
Empirical formula: C11H20O2 
Molecular weight: 184.28 g/mol 
Structural formula: 
O
O  
1.2 PURITY/IMPURITIES, ADDITIVES 
Commercial 2-Ethylhexylacrylate has a purity of > 99%. 
The following impurities are possible: 
2-Ethylhexylacetate 
2-Ethylhexylpropionate 
2-Ethylhexanol 
2-Methylstyrol 
Styrol 
n-Butylmethacrylate 
n-Butylacrylate 
Methylmethacrylate 
Ethylacrylate 
Methacrylate 
2-Ethyl-4-methylpentylacrylate 
2-Ethylhexylbutyrate 
2-Ethylhexylcrotonate 
2-Ethylhexylether 
2-Ethylhexene 
n-Hexylacetate 
p-Methoxyphenol 
2-Ethylhexyl 3-acryloxypropionate 
2-Ethylhexyl 3-(2-ethylhexoxy) propionate 
Acrylic acid 
Water 
EU RISK ASSESSMENT – 2-ETHYLHEXYL ACRYLATE  FINAL REPORT, 2005 
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Table 1.1    Physico-chemical properties 
Parameter Value Reference 
Physical state liquid at 20°C  
Melting point -90°C Gerhartz, 1987 
Boiling point 216°C at 1,013 hPa 
134°C at 80 hPa 
Stull, 1947 
 
Relative Density 0.887  at 20°C Gerhartz, 1987 
Vapour Pressure 533.3 hPa at 192.2°C 
133 Pa at 50°C 
17.1 Pa at 20°C 
12 Pa at 20°C 
Stull, 1947 
 
 
BASF AG, 1995b 
Surface Tension 69.2 mN/m at 20°C BASF AG, 1995a 
Water Solubility 9.6 mg/l at 25°C BASF AG, 1996 
Partition Coefficient 
(logPow-value) 
3.67 
4.6 
3.9 
4.09 
Fujisawa and Masuhara,  1981 
BASF AG, 1988 
BASF AG, 1988 
BAuA, 1997 
Flash Point 82°C Chemsafe, 1994 
Auto Flammability 245°C (DIN 51 794) Chemsafe, 1994 
Flammability non flammable Chemsafe, 1994 
Explosive Properties not explosive no test conducted because of structural reasons 
Oxidising properties no oxidising properties no test conducted because of structural reasons 
Remarks: 
boiling point: both data are literature values; 216°C is the boiling temperature  
  under normal pressure and 134°C is the boiling temperature under 
  reduced pressure at 80 hPa 
vapour pressure: the values at 50°C and 192.2°C are literature values; the vapour  
  pressure at 20°C was extrapolated from these data 
  the value of 12 Pa was used for environment section of the risk 
  assessment 
surface tension: experimental value, using OECD guideline 115 (ring method); the 
  concentration of the used test solution was approximately 90 mg/l 
water solubility: valid experimental value based on column elution analysis 
partition coefficient: 3.67 is a literature value on the basis of a HPLC-method 
  4.6 is an experimental value, using the OECD guideline 107 (shake 
  flask method) 
3.9 is an experimental value and has been used for the calculations in 
the environmental section of the risk assessment 
  CHAPTER 1. GENERAL SUBSTANCE INFORMATION 
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4.09 was calculated by the computer programme KOWWIN for 
Microsoft Windows 3.1 of the company Syracuse Research 
Corporation 
All four values have been assessed as correctly conducted; although 
the logPow of 4.6 is assumed to be a runaway 
1.3 CLASSIFICATION 
Classification and labelling according to the 29th ATP of directive 67/548/EEC1: 
Classification 
R 37/38 Irritating to respiratory system and to skin. 
R 43 May cause sensitisation by skin contact. 
According to the data presented below and the criteria of Directive 67/548/EEC, 2-ethylhexyl 
acrylate has not to be classified as dangerous to the environment. 
Concentration limits: c ≥ 20%  R37/38-43 
  1 % ≤ c < 20% R 43 
Labelling 
S: (2-) 36/37-46 
                                                 
1 Commission Directive 2004/73/EC of 29 April 2004, adapting to technical progress for the 29th time Council 
Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the 
classification, packaging and labelling of dangerous substances, OJ L 216,  16.06.04, p.34. 
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2 GENERAL INFORMATION ON EXPOSURE 
2-Ethylhexyl acrylate is produced from 2-ethyl hexanol and acrylic acid by catalytic 
dehydratisation in a continuous process. The spent lye of the aqueous work-up is treated in a 
waste water treatment plant. 
6 companies are known to produce or import 2-ethylhexyl acrylate within the European Union. 
In 1999 the total EU production volume was 70,000 tonnes/annum, the import volume was 
approximately 30,000 tonnes/annum and 10,000 tonnes/annum were exported. 
From the actual figures available for 1999, a total amount of 90,000 tonnes/annum is estimated 
to be available on the European market, 32,000 tonnes of that are used as an internal 
intermediate and 58,000 tonnes are sold to external processing sites. Recent information obtained 
from industry confirmed that no significant changes of the tonnages have to be expected for 2000 
and 2001. 
2.1 USE 
2-Ethylhexyl acrylate is used as a monomer in the chemical industry for the production of 
polymers and copolymers, which are mainly processed further to aqueous polymer dispersions. 
The polymers and polymer dispersions are used in adhesives and as binders for paints. Other 
applications include coatings raw materials and uses in the plastics and textiles industries. 
In addition, 2-ethylhexyl acrylate is used as a monomer in construction-industry chemicals (e.g. 
floor coatings, road-marking substances) in concentrations between 0.1-21%. 
A quantitative breakdown of the use pattern is available for Western Europe for the year 1988 
(BUA Report No 88).  
Assuming no significant changes in the use pattern, with a total amount of approximately 
90,000 tonnes of 2-ethylhexyl acrylate available on the European market in 1999, the following 
application amounts are estimated: 
Table 2.1    Quantitative breakdown of the use pattern of 2-ethylhexyl acrylate  
Type of use Approximate % in this application Estimated amount in this application 
adhesives raw materials 60% 54,000 tonne/annum 
binders for paints 25% 22,500 tonne/annum 
coatings raw materials 5% 4,500 tonne/annum 
plastics industries 5% 4,500 tonne/annum 
textiles industries 5% 4,500 tonne/annum 
A summary of the content of 2-ethylhexyl acrylate in different products as actually presented in 
the Danish Product Register (no production in Denmark): 
  CHAPTER 1. GENERAL SUBSTANCE INFORMATION 
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Table 2.2    Danish Product Register data recorded in March 2002  
Content of 2-ethylhexyl acrylate in the product Number of products Quantity [tonnes/annum] 
0-2% 410 < 1 
2-20% 10 2 
20-50% 6 13 
total 426 16 
The main application areas recorded are adhesives, binding agents, construction materials, 
surface treatment, paints, lacquers and varnishes, reprographic agents, corrosion inhibitors and 
fillers. 
From the Norwegian Product Register it can be seen that the number of products but not the 
quantities of 2-ethylhexyl acrylate contained in the products had significantly increased since 
1993.  
Table 2.3    Norwegian Product Register data recorded from 1993 until 2000  
 1993 1994 1995 1996 1997 1998 1999 2000 
number of products 77 112 221 298 308 257 233 456 
quantity [t/a] 286 536 546 350 493 304 354 171 
A summary of the actual content of 2-ethylhexyl acrylate in different products is presented in the 
Norwegian Product Register from 15 February 2002: 
Table 2.4    Norwegian Product Register data recorded in February 2002  
Content of 2-ethylhexyl acrylate in the 
product 
Number of products Quantity [tonnes/annym] 
0-1% 565 0.5 
1-10% 1 - 
10-80% 7 45 
80-100% 2 126 
total 575 171 
125 tonnes of the total amount are attributed to raw materials, 10 tonnes to binders for paints and 
paints and 6 tons to other binders. 
In the Swedish Product Register, a total of 26 products containing a total quantity of 
544-621 tonnes of 2-ethylhexyl acrylate were identified in 1993. Seven of those products (related 
to three functions) were available to consumers. The highest amounts of the substance are 
applied in the constructing industries, the plastics industries, the paint industries and as 
intermediates. 
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3 ENVIRONMENT 
3.1 ENVIRONMENTAL EXPOSURE 
3.1.1 General discussion 
3.1.1.1 Release into the environment 
Releases of 2-ethylhexyl acrylate into the environment are expected to occur mainly during 
production and processing with waste water and exhaust gases. 
Further releases are expected through residual monomeric acrylate-contents in the polymeric 
products.  
According to the producer, the aqueous polymer dispersions, as the main products, contain less 
than 200 mg monomeric 2-ethylhexyl acrylate per kg. In addition to this, a residual monomeric 
content of up to 800 ppm of 2-ethylhexyl acrylate in polymer dispersions is reported, but it was 
confirmed by the main producer that this value is not relevant for the current situation in Europe. 
Therefore, 200 ppm is considered to represent a realistic worst case and is used in the further 
assessment. 
Through storage of the polymeric products the residual monomers may partly polymerise and 
quantification of the releases into the environment from polymeric products can be performed 
only roughly. 
3.1.1.2 Degradation 
Hydrolysis 
There are no data available about hydrolysis of 2-ethylhexyl acrylate. However, acrylic acid 
esters are known to hydrolyse very slowly. For example, for ethyl acrylate a half life of 
approximately 3.5 ears at pH 7 and 25°C is reported (Mabey and Mill, 1978). Due to sterical 
reasons the half life of 2-ethylhexyl- acrylate is expected to be significantly longer. The 
HydroWin program (SRC) estimates a half life of 17 years at pH 7. Therefore, hydrolysis is not 
considered a relevant degradation pathway under environmental conditions.  
Biodegradation 
In a MITI-I test (OECD 301C) employing sludge from different sewage treatment plants, rivers, 
bays and a lake as inoculum biodegradation of 51% (on the upward trend) after 14 days was 
obtained. Biodegradation was measured as BOD (CITI 1992).  
In a manometric respirometry test conducted according to OECD guideline 301 F biodegradation 
(related to BOD) of 2-ethylhexyl acrylate of 70% after 15 days and 75% after 28 days was found 
(BASF 1991a). The 10-day window criterion was fulfilled. As inoculum domestic activated 
sludge was used. 
CHAPTER 3. ENVIRONMENT 
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In a modified OECD screening test (OECD 301 E) using filtered effluent from a domestic 
sewage treatment plant as inoculum biodegradation of 2-ethylhexyl acrylate of 93% after 7 days 
and 99% after 14 days (measured as DOC) was observed (Amann/Steinhäuser 1986). 
Price et al. (1974) tested the biodegradation of 2-ethylhexyl acrylate both in fresh and salt water. 
In the freshwater test settled domestic wastewater was used as inoculum (3 ml/bottle). The 
concentration of the test substance was 3, 7 or 10 mg/l. After 20 days a BOD/TOD ratio of 30% 
was achieved. The same test was then repeated with acclimated inoculum. An equal-volume 
mixture of 2 biologically treated petrochemical effluents, settled domestic wastewater, Kanawha 
river water (this river receives the waste effluent from numerous industrial and domestic sources) 
and soil in BOD dilution water was acclimated to 2-ethylhexyl acrylate for 45-60 days. With this 
acclimated inoculum a BOD/TOD ratio of 40% after 20 days was achieved. The saltwater test 
conducted in artificial seawater was performed in the same manner as the freshwater test with 
exception of the seed source. The seed used in the seawater test was developed in seawater taken 
from Lavaka Bay. This seed source was maintained by adding small amounts of settled raw 
waste water about every 3 to 4 days as a source of substrate, seed bacteria and growth factors. 
After 20 days a BOD/TOD ratio of 35% was achieved. 
Regarding the available test results 2-ethylhexyl acrylate can be classified as readily 
biodegradable. Although the data reported by Price et al. (1974) do not point towards ready 
biodegradation the results from the standardised screening tests confirm the classification as 
readily biodegradable. 
According to the available test results, a biodegradation rate in sewage treatment plants of 1 h-1 is 
assumed. Results from biodegradation simulation tests in surface water and soil are not available 
and have to be estimated based on the above described tests and the partition behaviour of 
2-ethylhexyl acrylate (EC, 1995).  
In Appendix A1, the respective calculations are presented.  
Table 3.1    Biodegradation rate constants  
Compartment / medium Biodegradation rate 
activated sludge (STP) KSTP = 1 h-1 
surface water Ksw = 0.047 d-1 
sediment Ksed = 0.002 d-1 
soil Ksoil = 0.023 d-1 
Photo oxidation 
In the atmosphere, 2-ethylhexyl acrylate will react with the photochemically produced hydroxyl 
radicals and with ozone.  
Based upon atmospheric concentrations of 5 . 105 ⋅ OH/cm3 and 7 ⋅ 1011 O3/cm3, the 
atmospheric half-life of 2-ethylhexyl acrylate has been estimated to be about 19 hours (Atkinson, 
1987). 
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3.1.1.3 Distribution 
The Henry's law constant is estimated from the water solubility of 9.6 g/m3 and the vapour 
pressure of 12 Pa. The value of H = 230 Pa.m3/mol at 20-25°C indicates, that volatilisation from 
surface water is rapid. 
The adsorption and desorption behaviour of 2-ethylhexyl acrylate was not investigated. 
According to the EU Technical Guidance Document (Chapter 4), from the experimentally 
determined logPow of 3.9 a Koc of 9, 14 l/kg is calculated.  
From this value, the partition coefficients in the different compartments can be estimated using 
default organic carbon contents in the different compartments.  
In Appendix A1, the calculations are presented. 
Table 3.2    Partition coefficients  
Compartment Partition coefficient 
soil-water Kp_soil = 18 l/kg 
sediment - water Kp_sed = 91 l/kg 
suspended matter - water Kp_susp = 91 l/kg 
Using the fugacity model of Mackay (level 1), the theoretical distribution at equilibrium can be 
estimated. About 97% of the total amount of 2-ethylhexyl acrylate is expected to be distributed 
to the atmosphere and about 1% is allocated to surface water. Less than 1% is expected to end up 
in each soil and sediment. 
Based on the physical chemical properties of 2-ethylhexyl acrylate, the atmosphere is the main 
target compartment for distribution and only small amounts remain in the hydrosphere. 
Elimination in the sewage treatment plants 
Based on the above cited physical chemical properties (log H = 2.36 ; log Pow = 3.9 ), as well as 
the biodegradation rate of 1 h-1 in STP, the elimination through biodegradation and distribution 
can be estimated with the model SIMPLETREAT: 
Table 3.3    Elimination and distribution in STPs  
% to air 29.8 
% to water 7.0 
% to sludge 7.5 
% degraded 55.8 
% removal 93.0 
From measurements of the influent and effluent concentration in an industrial sewage treatment 
plant, a similar elimination-rate can be estimated. Using the detection limit as effluent 
concentration because no 2-ethylhexyl acrylate was detected in the effluent and the 90 percentile 
of the measured influent concentrations, an elimination-rate of 90% is calculated (BASF, 2000). 
For further calculations, the removal rate estimated with the SIMPLETREAT model is used. 
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3.1.1.4 Accumulation 
There are no experimental results on bioaccumulation available. The log Pow of 3.9 indicates a 
moderate potential for bioaccumulation though. 
According to the Technical Guidance Documents (EC 1995), the BCF for fish can be estimated 
from the log Pow using the method developed by Veith et al. (1979). For 2-ethylhexyl acrylate a 
BCF of 4,12 l/kgwet fish is calculated.  
The estimated Koc-value of 9,14 l/kg also indicates moderate potential for geoaccumulation. It is 
not expected, that considerable amounts of 2-ethylhexyl acrylate released to soil may leach with 
rain water to the groundwater. 
3.1.2 Aquatic compartment 
For the estimation of the local PECs, a total production volume of 70,000 tonnes/annum is 
assumed. With an import volume of approximately 30,000 tonnes/annum and approximately. 
10,000 tonnes/annum that are exported a total amount of about 90,000 tonnes/annum is estimated 
to be available on the European market. 
3.1.2.1 Estimation of PEClocal/Generic approach: production and processing 
In the Technical Guidance Documents (EC 1995), a generic (i.e. non site-specific) exposure 
scenario (“emission scenario document”) for the release into surface water of intermediates 
during production and processing is proposed. The following scenario reflects a worst case 
situation: 
The total production quantity in the EU of 70,000 tonnes/annum and the total internal processing 
volume of 32,000 tonnes/annum is used for the generic calculation. For production an emission 
factor of 0.3% is proposed and for processing a generic release estimate of 0.001% for wet 
polymerisation process is used resulting in a worst case estimation of a PEClocal of 9.5 µg/l (for 
calculations see Appendix 2). 
3.1.2.2 Estimation of PEClocal / Site-specific approach: production and 
processing 
Using the available specific data for the production and processing sites, more precise PEC-
estimations can be performed.  
Table 3.4    Site specific release estimation  
Company Clocal water [µg/l] Release [tonnes/annum] Specific data 
A 0.13 2.56 flow rate of receiving river, flow rate of STP; actual 
release estimated on the basis of effluent measurements; 
B 0.005 0.007 processing volume, no further specific data; 
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From the confidential data provided to the rapporteur it is known that for site A a reliable PEC 
estimation based on site specific information was performed that is representative for production 
and internal processing in Europe.  
Site B represents a realistic worst case situation for wet polymerisation of 2-ethylhexyl acrylate 
at external processing sites. The approximate number of external sites and the size of the biggest 
external sites are known to the rapporteur. From this a processing volume of 
10,000 tonnes/annum is assumed and a default release estimate has been performed 
(see Appendix 3). 
3.1.2.3 Estimation of PEClocal/Generic approach: use 
a) Formulation of aqueous polymer dispersions 
The release of monomeric 2-ethylhexyl acrylate is possible during formulation of adhesives, 
paints and other polymeric products. Especially for adhesives, generalising assumptions are 
difficult to make and there is no “emission scenario document” available at the moment for the 
mentioned applications. 
Due to the lack of specific data it is assumed, that from the total amount of 90,000 tonnes 
2-ethylhexyl acrylate aqueous polymer dispersions are obtained and formulated. The emissions 
are estimated with the “worst case” emission tables presented in Appendix I of the Technical 
Guidance Documents.  
Based on information from industry it is assumed that from 90,000 tonnes/annum 2-ethylhexyl 
acrylate approximately 210,000 tonnes of aqueous based polymers are obtained containing 
200 ppm (42 tonnes/annum) residual monomeric 2-ethylhexyl acrylate.  
A generic exposure assessment for the formulation-stage is performed assuming a fraction of 
main source of 0.4 (Table B 2.3) and a release factor of 0.3% (Table A 2.1). From the calculation 
elaborated in Appendix 4 as a result a Clocal water of 0.6 µg/l is obtained for formulation. 
This estimation is considered a worst case scenario. But as there are no information available 
indicating that the formulation of 2-ethylhexyl acrylate based polymer dispersions is wide 
disperse throughout Europe it is judged appropriate to use the TGD defaults. 
b) Processing/use of water based adhesives and paints 
Sufficient information for a reliable estimation of the releases of monomeric 2-ethylhexyl 
acrylate from the processing and use of adhesives raw materials is not available. 
Aqueous polymer dispersions are understood to be the main product type for both, adhesives and 
paints. Therefore, in a first approach it is suggested, that the releases during processing and use 
can be estimated for both application areas accordingly.  
Assuming that from approximately 76,500 tonnes 2-ethylhexyl acrylate (54,000 tonnes for 
adhesives and 22,500 tonnes for paints, see Section 2) approximately. 178,500 tonnes of water-
based dispersions containing 200 ppm residual monomers are obtained, approximately 
35.7 tonnes of monomeric 2-ethylhexyl acrylate are annually handled. 
The estimation is performed using the A/B-tables for paints (IC 14, UC 10) proposed in Annex 1 
of the Technical Guidance Documents. In Table A 3.15/A 4.5 a fraction of emission of 0.5% is 
CHAPTER 3. ENVIRONMENT 
 15 
proposed and Table B 3.13/B 4.5 provides a fraction of main source of 0.05. The respective 
calculations elaborated in Appendix 5 result in a Clocal water of 0.1 µg/l. 
The releases of 2-ethylhexyl acrylate into the aquatic environment through the private use of 
adhesives and paints are not relevant on a local scale due to the smaller amounts used. 
c) Paper recycling  
As 2-ethylhexyl acrylate-based polymers are used for coatings, paints and printing inks the 
residual monomers may be released during the paper recycling process.  
According to the use pattern presented in Section 2, in a first approach it is assumed that 10% of 
the total amount available on the European market is processed to aqueous polymer dispersions 
used in the paper industry. An annual tonnage of 21,000 tonnes of those dispersions are assumed 
containing 200 ppm (4.2 tonnes) residual monomeric 2-ethylhexyl acrylate.  
A PEC-estimation according to the “emission scenario document” proposed in the Technical 
Guidance Documents (EC, 1995) leads to a Clocal water of 0.5 µg/l (see Appendix 6). 
3.1.2.4 Monitoring data 
No relevant data on measured aquatic concentrations are available. 
3.1.2.5 Sediment 
Neither monitoring data on concentrations of 2-ethylhexyl acrylate in sediment nor experimental 
results with benthic organisms are available. A quantitative risk assessment using the equilibrium 
partitioning method proposed in the TGD seems not necessary for this substance as no 
information beyond those available for the water compartment can be obtained.  
3.1.3 Atmosphere 
3.1.3.1 Estimation of PEClocal at production and processing 
No emission scenario document for the release into the atmosphere of intermediates during 
production and processing is available at the moment. The emissions can therefore be estimated 
with the emission tables presented in Appendix I of the Technical Guidance Documents.  
However, specific data are available for the main production site from 1989, so that the PEC-
calculation can be performed with these data. For external processing a default calculation is 
performed assuming a processing volume of 10,000 tonnes/annum and a fraction of emission of 
0.1% (Table A 3.10). In a generic scenario for the formulation of aqueous polymer dispersions a 
fraction of emission of 0.5% (Table A 2.1) and a fraction of main source of 0.4 (Table B 2.3) are 
applied.  
The calculations are presented in Appendices A7.1, A7.2 and A7.3 and the results are 
summarised in Table 3.5. 
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Table 3.5    Atmospheric release estimation  
Scenario Release[tonnes/annu
m] 
PEClocal (air) 
[μg/m3] 
DEPtotal ann 
[μg.m-2.d-1] 
production site, specific 
data 
0.18 (direct) 
10.9 (via STP) 
8.3 9.1 
external processor, 
default 
10 (direct) 
0.03 (via STP) 
7.6 8.2 
formulation of polymer 
dispersions 
0.08 (direct) 
0.1 (via STP) 
0.1 0.2 
Releases to the atmosphere during the use of the aqueous based polymeric products made from 
2-ethylhexyl acrylate are significantly lower than the scenarios considered above. 
3.1.4 Terrestrial compartment 
The release of 2-ethylhexyl acrylate to soil is expected to occur through atmospheric deposition 
after local release to the atmosphere at the production and processing sites. The input through 
sludge application on agricultural soil is considered to be of minor relevance, because industrial 
sludge is incinerated and from the use pattern of the substance (predominantly polymeric 
material is handled containing only small amounts of residual monomers), considerable amounts 
of 2-ethylhexyl acrylate in municipal sewage sludge are not expected. 
With the annual deposition rates calculated above, equilibrium soil concentrations in the vicinity 
of the plants are calculated according to the EU Technical Guidance Document (EC, 1995). The 
detailed calculation is presented in Appendices A8.1, A8.2 and A8.3: 
Table 3.6    Local exposure of the soil compartment  
 Exposure of the ecosystem Exposure of grassland Exposure of agricult. soil 
site A: 
bulk soil and porewater 
concentration 
PEClocal = 0.85 µg/kg ww 
PEClocal pw =  0.05 µg/l 
PEClocal = 1.34 µg/kg ww 
PEClocal pw =  0.08 µg/l 
PEClocal  = 0.85 µg/kg ww 
PEClocal pw =   0.05 µg/l 
processing site: 
bulk soil and porewater 
concentration 
PEClocal = 0.77 µg/kg ww 
PEClocal pw =  0.05 µg/l 
PEClocal = 1.21 µg/kg ww 
PEClocal pw =  0.07 µg/l 
PEClocal  = 0.77 µg/kg ww 
PEClocal pw =   0.05 µg/l 
formulation site: 
bulk soil and porewater 
concentration 
PEClocal = 0.014 µg/kg ww 
PEClocal pw =  0.0009 µg/l 
PEClocal = 0.022 µg/kg ww 
PEClocal pw =  0.0014 µg/l 
PEClocal  = 0.014 µg/kg ww 
PEClocal pw =   0.0009 µg/l 
3.1.5 Non compartment specific exposure relevant to the food chain 
3.1.5.1 Secondary poisoning 
For 2-ethylhexyl acrylate a moderate bioaccumulation potential is expected. Therefore, an 
exposure assessment for secondary poisoning is required. Using the calculated BCF for fish (see 
Section 3.1.1) of 4,12 l/kgwet fish for the calculation and assuming that 50% of the diet comes from 
a source using the highest local concentration in surface water and 50% using PECregional, the 
following PECoral, fish can be estimated: 
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PECoral fish = 0.5 . (0.6 µg/l . 4,12 l/kg + 0.006 µg/l . 4,12 l/kg) = 125 µg/kgwet fish  
3.1.6 Regional concentrations 
For the estimation of the regional background concentrations, all releases, from diffuse as well as 
point sources should be taken into account. From the total release volume it is recommended to 
use 90% in the continental model and 10% in the defined EU-standard regional model. However, 
for 2-ethylhexyl acrylate it is known that the main fraction of production and internal processing 
and a considerable amount of external processing takes place within one region in Europe. Only 
approximately 48,000 tonnes/annum are available for external processing elsewhere in Europe. 
Therefore, for modelling purpose it is assumed that site A and site B are located in the same 
region and that an external processing volume of 48,000 tonnes/annum is allocated to the 
continent. 
Point source releases to the aquatic compartment: 
Based on the actual release data provided by the producers (see Section 3.1.2.2.) and the default 
releases estimated for the external processing sites (0.001% emission for wet polymerisation, 7% 
directed to surface water after elimination in STP), the total release amounts are summarised in 
the Table 3.7. The releases through the industrial use of products manufactured from 
2-ethylhexyl acrylate are taken into account below (diffuse releases). 
Table 3.7    Point sources releases to hydrosphere  
Regional releases [tonnes/annum] Continental releases [tonnes/annum] Point source 
To surface water To STP To surface water To STP 
site A 2.56 36.6 - - 
site B 0.007 0.1 - - 
other processing sites - - 0.03 0.48 
Point source releases to air: 
Using the same approach as described above for the aquatic compartment the releases to air from 
production (specific data) and external processing (default releases, 0.1% direct releases and 
29.8% of the releases via STP) are estimated: 
Table 3.8    Point sources releases to atmosphere  
Rregional releases [tonnes/annum] Continental releases [tonnes/annum] Point source 
Direct Via STP Direct Via STP 
site A 0.18 10.9 - - 
site B 10 0.03 - - 
other processing sites - - 48 0.14 
Point source releases to soil: 
No direct releases to soil from point sources were identified. 
Diffuse releases: 
Diffuse releases occur from residual 2-ethylhexyl acrylate in the polymeric products. 
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As the main product-type app. 210,000 tonnes/annum aqueous polymer dispersions are obtained 
containing about 200 ppm (42 tonnes/annum) residual monomeric 2-ethylhexyl acrylate.  
As an initial worst case approach, it is assumed that 50% of the monomers (21 tonnes/annum) 
may leach into the hydrosphere during the whole life-cycle of the products. Diffuse releases via 
municipal STPs from professional and private use of the products are thought to be already 
included in this assumption, 30% of these releases are assumed to be directly to surface water, 
70% via STP. 10% of the monomers (4.2 tonnes/annum) are assumed to be evaporated to the 
atmosphere during the whole life-cycle of the products. Through storage of the polymeric 
products the residual monomers may partly polymerise and quantification of the releases can 
only be regarded as a rough estimate. 
Table 3.9    Diffuse releases  
Diffuse releases Regional releases [tonnes/annum] Continental releases [tonnes/annum] 
Directly to surface water 0.63 5.67 
To STP 1.47 13.23 
To air 0.42 3.78 
The regional and continental PECs were calculated according to EUSES (see Appendix A 9). In 
Table 3.10 an overview is given of all the releases considered as input for the model calculation.  
Table 3.10  Total releases considered on regional and continental scale  
Releases Regional releases [tonnes/annum] Continental releases [tonnes/annum] 
Directly to surface water 0.63 5.67 
To STP 38.17 13.71 
Directly to air 10.6 51.78 
The results of the calculations are compiled below : 
PECregionalaquatic = 5.8 ⋅ 10-3 µg/l 
PECregionalsoil = 8.1 ⋅ 10-5 µg /kg ww 
PECregionalair = 7.9 ⋅ 10-4 µg /m3 
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3.2 EFFECTS ASSESSMENT: HAZARD IDENTIFICATION AND DOSE 
(CONCENTRATION)-RESPONSE (EFFECT) ASSESSMENT  
3.2.1 Aquatic compartment (incl. sediment) 
3.2.1.1 Toxicity test results 
3.2.1.1.1 Fish 
Juhnke and Lüdemann (1978) examined the effects of 2-ethylhexyl acrylate in fish in a 
short-term study. As test organism Leuciscus idus was used. The aim of the study was to 
compare the reproducibility of the standard test method DIN 38 412 L 15 that was new at that 
time. Fish were exposed in a static system for 48 hours. Apart from the shorter exposure time the 
method is comparable to the OECD Guideline 203. A 48-hour LC50-value of 23 mg/l was found. 
The corresponding LC0 and LC100 value was 9 mg/l and 45 mg/l. All values are nominal 
concentrations. As the effect concentrations exceed the water solubility of 9.6 mg/l for 
2-ethylhexyl acrylate and as the possible decrease in test concentration by volatilisation of the 
substance was not considered, the test is regarded as invalid. 
In a semi-static test BASF (1999) studied the acute toxicity of 2-ethylhexyl acrylate in the 
rainbow trout Oncorhynchus mykiss. The test was performed according to OECD Guideline 203 
“Fish acute toxicity test” including the updated version of July 1992. Fish were exposed for 
96 hours with daily replacement of the test water. Six test concentrations ranging nominally from 
0.681 mg/l to 4.64 mg/l were used. The following effect values related to the analytically 
detected concentrations (mean values of the detected concentrations after 1, 24, 48 and 96 hours) 
are reported: 
Table 3.11  Acute toxicity in rainbow trout  
Effect  concentration Effect Nominal concentration 
96-hour LC50 = 1.8 mg/l* mortality 2.15 mg/l  < 96-hour LC50 < 3.16 mg/l 
96-hour NOEC = 1.49 mg/l mortality 2.15 mg/l 
* Calculated as geometric mean from 1.49 mg/l < 96-hour LC50 < 2.19 mg/l 
3.2.1.1.2 Invertebrates 
In a short-term test with Daphnia magna conducted according to EEC guideline a 48-hour EC50 
of 17 mg/l was found. The EC50-value after 24 hours was 50 mg/l. Tween 80 was used as 
solubiliser (BASF 1989). The given effects values are related to nominal concentrations that 
significantly exceed the water solubility of 9.6 mg/l for 2-ethylhexyl acrylate. The possible 
decrease in test concentration by volatilisation of the substance was not considered and the test is 
regarded as invalid. 
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In addition, other static tests are available on Daphnia magna (Bringmann/Kühn 1982) and on 
the brine shrimp Artemia salina (Price et al. 1974) where only nominal concentrations are 
reported that are invalid and not suitable for risk assessment purpose. 
BASF (2001) studied the effects of short-term exposure of Daphnia magna to 2-ethylhexyl 
acrylate according to OECD Guideline 202. The test was performed in a static and closed system 
in complete darkness. Darkness was chosen because of the instability of the pure substance 
against light (radical induced polymerisation). However, it is believed that this is not relevant for 
the aqueous solution and has not affected the test results. Six test concentrations ranging 
nominally from 3.13 mg/l to 100 mg/l were employed. The effect values were related to 
measured concentrations and are given below: 
Table 3.12  Acute toxicity in Daphnia magna  
Effects concentration Nominal concentration 
48-hour EC0 = 0.7 mg/l 25 mg/l 
48-hour EC50 = 1.3 mg/l 46.3 mg/l 
48-hour EC100 = 2.8 mg/l 100 mg/l 
3.2.1.1.3 Plants 
In a test conducted according to DIN 38 412 L 9 the toxicity of 2-ethylhexyl acrylate to the green 
algae Scenedesmus subspicatus was examined (BASF 1990). Cremophor RH 40 was used as 
solubiliser. Test parameter was the growth inhibition of the algae measured as 
chlorophyll-a-fluorescence. The following effect values related to growth rate (R) and biomass 
(B) were found: 
Table 3.13  Toxicity in algae (nominal concentrations only)  
Effects on growth rate Effects on biomass 
72-hour ERC10 = 30 mg/l 72-hour EBC10 = 23 mg/l 
72-hour ERC50 = 67 mg/l 72-hour EBC50 = 44 mg/l 
96-hour ERC10 = 40 mg/l 96-hour EBC10 = 24 mg/l 
96-hour ERC50 = 67 mg/l 96-hour EBC50 = 47 mg/l 
Again, the nominal concentrations exceed significantly the water solubility and the possible 
decrease in test concentration by volatilisation of the substance was not considered. The test is 
therefore regarded as invalid. 
In a 72-hour static test conducted according to EEC Directive 92/69/EEC and OECD Guideline 
201 the acute toxicity of 2-ethylhexyl acrylate to the green algae Desmodesmus subspicatus was 
examined (BASF 2002). The test was performed in a closed system in the nominal concentration 
range between 3.13 and 100 mg/l. Growth inhibition of the algae was measured as chlorophyll-a-
fluorescence. Effect data were related to the measured concentrations. 
Table 3.14  Toxicity in algae (measured and nominal  concentrations)  
Effects on growth rate Effects on biomass 
72-hour ERC10 = 0.8 mg/l  (nominal: 11.1 mg/l) 72-hour EBC10 = 0.55 mg/l  (nominal: 7.62 mg/l) 
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72-hour ERC50 = 1.71 mg/l  (nominal: 23.7 mg/l) 72-hour EBC50 = 1.17 mg/l  (nominal: 16.3 mg/l) 
72-hour ERC90 = 2.91 mg/l  (nominal: 40.4 mg/l) 72-hour EBC90 = 2.38 mg/l  (nominal: 33.1 mg/l) 
In a growth inhibition test conducted with Scenedesmus quadricauda Bringmann and Kühn 
(1977, 1978) obtained an 8-day-TGK-value of > 1 mg/l. The TGK (toxic threshold 
concentration) corresponds to an EC3.  
With the blue-green algae Microcystis aeruginosa as test organism Bringmann and Kühn (1978) 
found in the growth inhibition test an 8-day-TGK of 0.06 mg/l. Also in this study the TGK was 
equivalent to an EC3 and was based on nominal concentrations.  
In both studies no analytical monitoring was performed and it has to be expected that the algae 
were not in the exponential growth phase during the whole test duration. Both studies are 
regarded as invalid. 
3.2.1.1.4 Microorganisms 
The toxicity of 2-ethylhexyl acrylate to different microorganisms was examined by Bringmann 
and co-workers using growth inhibition tests. The following test results were obtained: 
Table 3.15  Toxicity in microorganisms  
Pseudomonas putida 16-hour TGK(EC3) > 1 mg/l Bringmann/Kühn 1977 
Entosiphon sulcatum 48-hour TGK (EC5) > 10 mg/l Bringmann 1978 
Chilomonas paramaecium 48-hour TGK (EC5) = 2.3 mg/l Bringmann et al. 1980 
In a test with domestic activated sludge the inhibition of oxygen uptake was examined according 
to guideline OECD 209 (BASF 1991b). After 30 minutes oxygen uptake was inhibited by 7% at 
1,000 mg/l, the highest concentration tested. As no reference substance was tested and therefore, 
the sensitivity of the activated sludge is unknown, the test result should be used with care. 
In a test according to DIN 38 412 L 27 the inhibition of oxygen uptake for Pseudomonas putida 
exposed to 2-ethylhexyl acrylate for 30 minutes was studied (BASF 1991c). Tween 80 was used 
as solubiliser. At the highest tested concentration of 10,000 mg/l no inhibition of oxygen uptake 
was found. 
In addition to the data reported above, other test results are available, but due to missing 
information on test conditions they could not be checked on validity. 
For microorganisms only nominal concentrations are reported and the possible decrease in test 
concentrations by volatilisation of the substance was not considered. In most studies the reported 
effect concentrations exceed significantly the water solubility of 2-ethylhexyl acrylate. 
Therefore, only the results reported for the protozoan species Chilomonas paramaecium may be 
considered suitable for risk assessment purpose. 
3.2.1.1.5 Determination of PNECaqua 
Due to the moderate volatility and low water solubility (9.6 mg/l) of 2-etylhexyl acrylate only 
effect values based on analytically measured concentrations should be used for the derivation of 
the PNEC. Such results are available from three acute tests conducted under standardised 
EU RISK ASSESSMENT – 2-ETHYLHEXYL ACRYLATE  FINAL REPORT, 2005 
 
 22 
conditions. The relevant LC50-/EC50-values range from 1.3 mg/l (daphnids) to 1.8 mg/l (fish). 
The most sensitive species was Daphnia magna showing a 48-hour EC50 of 1.3 mg/l.  
Short-term tests with species from three trophic levels are available; therefore an assessment 
factor of 1,000 is applied to this value. 
Therefore: PNECaqua = 1.3 mg/l / 1,000 = 1.3 µg/l 
 
3.2.1.1.6 Determination of PNECmicroorganisms 
The most sensitive microorganism to 2-ethylhexyl acrylate was the protozoan Chilomonas 
paramaecium with a 48-hour TGK of 2.3 mg/l. Although this species does not influence the 
degradation processes itself, it is necessary for a proper function of a WWTP. For this kind of 
test result an assessment factor of 1 is proposed for the determination of PNECmicroorganism. 
Therefore: PNECmicroorganism = 2.3 mg/l / 1 = 2.3 mg/l 
3.2.1.1.7 Sediment 
There are no experimental results with benthic organisms available. The PNECsed can be 
provisionally calculated using the equilibrium partitioning method. However, a quantitative risk 
assessment is not deemed necessary for 2-ethylhexyl acrylate as no information beyond those 
available for the water compartment can be obtained and the substance is neither released nor 
distributed to sediments in significant amounts. 
3.2.2 Atmosphere 
Data on biotic or abiotic effects in the atmosphere are not available. Because of the short half-life 
of 2-ethylhexyl acrylate in the atmosphere (about 19 hours) adverse effects are not to be 
expected. 
3.2.3 Terrestrial compartment 
Data on effects to terrestrial organisms are not available.  
In an indicative risk assessment for the soil compartment, the aquatic PNEC will be used and 
compared to the concentration in soil pore water: 
PNECsoil =1.3 µg/l (soil pore water) 
3.2.4 Non compartment specific effects relevant to the food chain (secondary 
poisoning) 
Because 2-ethylhexyl acrylate has a log Kow > 3 there is an indication of bioaccumulation 
potential. To evaluate whether the substance may cause toxic effects if accumulated in higher 
organisms the classification on the basis of mammalian toxicity data can be used.  
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2-Ethylhexyl acrylate is not classified as Very Toxic or Toxic or Harmful and there are no 
adequate data from dietary toxicity tests which can be used for the determination of PNECoral. 
Therefore a quantitative assessment of secondary poisoning can not be performed but 
improvement of the data basis is not considered to be of high priority for 2-ethylhexyl acrylate. 
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3.3 RISK CHARACTERISATION 
3.3.1 Aquatic compartment (incl. sediment) 
3.3.1.1 Water 
3.3.1.1.1 Waste water treatment plants 
An evaluation of the inhibition to microorganisms in WWTPs would seem most relevant for 
those situations where 2-ethylhexyl acrylate containing waste water is released to domestic 
treatment plants. Excluding therefore the production sites which are known to have their own 
industrial treatment plant, the effluent concentration calculated for the formulation of aqueous 
polymer dispersions is used for the initial assessment. 
Therefore:  PECmicroorganisms = 6 µg/l 
With a PNECmicroorganisms of 2.3 mg/l, the PEC/PNEC ratio amounts to 0.003 and therefore a risk 
to microorganisms in WWTPs is not to be expected.  
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
3.3.1.1.2 Surface waters 
In Table 3.16 the comparison between PEC and PNEC (1.3 µg/l) for all relevant exposure 
scenarios are presented. 
Table 3.16  PEC/PNEC ratios for surface water  
Scenario Clocal +  PECregional = PEClocal  µg/l] PEC/PNEC 
production and processing: 
site A 
site B 
 
0.13 + 0.006 = 0.14   
0.005 + 0.006 = 0.01 
 
0.1 
0.008 
formulation of aqueous polymer dispersions 0.6 + 0.006 = 0.6 0.5 
processing/use of water based adhesives and paints 0.1 + 0.006 = 0.1 0.08 
paper recycling 0.5 + 0.006 = 0.5 0.4 
As for all exposure scenarios PEC/PNEC < 1, a risk for the aquatic compartment of the 
environment is not deduced for the present data configuration. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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3.3.1.1.3 Sediment 
Neither monitoring data on concentrations of 2-ethylhexyl acrylate in sediment nor experimental 
results with benthic organisms are available.  
A quantitative risk assessment based on the equilibrium partitioning method on the effects and 
the exposure side is not necessary as no information beyond those available for the water 
compartment can be obtained.  
From the results for the water phase it can be concluded that no further testing has to be 
recommended for the sediment compartment because 2-ethylhexyl acrylate is neither released 
nor distributed to sediments in significant amounts. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
3.3.2 Atmosphere 
Due to the short atmospheric lifetime (t1/2 = 19 hours), biotic or abiotic adverse effects upon the 
atmosphere are not expected from 2-ethylhexyl acrylate. 
Therefore, qualitatively, no risk is deduced for this compartment. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
3.3.3 Terrestrial compartment 
A site specific exposure scenario representing a worst case situation for production, processing 
and use of 2-ethylhexyl acrylate was used for a PEC calculation. Due to atmospheric deposition 
in the vicinity of this site, the concentration in the soil porewater is expected to be 
PEClocalporewater = 0.08 µg/l. The regional background concentration is considered to be 
negligible. An indicative risk assessment can be performed with the aquatic PNEC: 
PEC/PNEC = 0.08 / 1.3 = 0.06 
As PEC/PNEC < 1, a risk for the soil compartment is not identified. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
3.3.4 Non compartment specific effects relevant to the food chain (secondary 
poisoning) 
As 2-ethylhexyl acrylate does present indications of a bioaccumulation potential, a risk 
characterisation for secondary poisoning seems opportune.  
A PECoral, fish of 0.1 mg/kgwet fish had been calculated (see Section 3.1.5). However, no adequate data 
from dietary toxicity tests for the determination of a PNEC are available.  
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2-Ethylhexyl acrylate is not classified as Very Toxic or Toxic or Harmful. Therefore, 
qualitatively no risk is identified for secondary poisoning and improvement of the data basis 
seems not of high priority.  
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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4 HUMAN HEALTH 
4.1 HUMAN HEALTH (TOXICITY)  
4.1.1 Exposure assessment 
4.1.1.1.1 General discussion 
2-Ethylhexyl acrylate (2-EHA) is mainly used as a monomer in the chemical industry for the 
manufacture of polymeric chemicals, which are processed further to aqueous polymer 
dispersions (approximately 50% polymer). The polymers and polymer dispersions are used in 
different products e. g. in adhesives, in printing inks and as binders in paints 
(see Section 4.1.1.2). 
According to information provided by the manufacturers, aqueous polymer dispersions may 
contain residual monomer contents of 0.02% 2-EHA (BUA, 1991). In latex coatings, for 
instance, residual 2-EHA concentrations are generally 0.08% or less (BAMM, 1993). 
In addition, monomeric 2-EHA is an additive in preparations, which are applied in the building 
trade as floor coatings and road-marking materials. The concentration of monomeric 2-EHA 
amounts up to 21%. 
For workers the inhalative and dermal exposure routes are the most likely. 
According to the Swedish product register, 2-EHA is used e.g. in lubricants/greases. The 
consumer products are offered in wholesale and retail trade, e.g. in repair shops for cars and 
motor vehicles, as products for personal and household use (as per February 1995) and in 
agriculture. 
Consumers use e.g. dispersion paints or lubricants and greases which may contain 2-EHA as a 
residual monomer. Thus, the consumer may be exposed to 2-EHA via the inhalatory and dermal 
routes. 
4.1.1.2 Occupational exposure 
The exposure assessment generally aims at assessing exposure levels representing the reasonable 
worst case situation. The reasonable worst case is regarded as the level of exposure which is 
exceeded in a small percentage of cases over the whole spectrum of likely circumstances of use 
for a specific scenario.  
The assessment of inhalation exposure is mainly based on measured exposure levels from which, 
if possible, 90th or 95th percentiles are derived as representing reasonable worst case situations. 
For the purpose of exposure assessment only data measured later than 1990, if available, are 
taken. Scenarios are clustered as far as possible to make the description of exposure transparent.  
Beside inhalation exposure, dermal exposure is assessed for each scenario. Two terms can be 
used to describe dermal exposure:  
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Potential dermal exposure is an estimate of the amount of a substance landing on the outside of 
work wear and on the exposed skin. 
Actual dermal exposure is an estimate of the amount of a substance actually reaching the skin. 
There is an agreement between the EU-member states, within the framework of existing 
substances, to assess, as a rule, dermal exposure as exposure to hands and parts of the forearms. 
In this, the main difference between both terms, potential and actual, is the protection of hands 
and forearms by work wear and, more importantly, the protection by gloves. Within this 
exposure assessment, the exposure reducing effect achievable by gloves is only considered if 
information is provided, that for a certain scenario gloves are a widely accepted protective 
measure and that the gloves are fundamentally suitable for protection against the substance under 
consideration. As a measure for the latter, tests according to DIN EN 374 are taken as criteria. 
For most down stream uses it is commonly known, that gloves are not generally worn. In these 
cases, dermal exposure is assessed as actual dermal exposure for the unprotected worker. Since 
often quantitative information on dermal exposure is not available, the EASE model is used for 
assessing dermal exposure, at the most.  
Industrial activities using monomeric 2-EHA present opportunities for exposure. Exposure 
ranges depend on the particular operation and the risk reduction measures in use. Concerning 
dermal exposure, on account of the highly irritative effect of 2-EHA and preparations containing 
> 21% of the substance (see Section 4.1.3.2), workers avoid immediate dermal contact to a large 
extent by using PPE (here gloves) and by applying appropriate working techniques. 
There is only one occupational exposure limit for 2-EHA in Germany, amounting to about 
82 mg/m3 (10 ml/m3), which may not be exceeded even short-term (15-minute average) (TRGS 
900, 1996). 
The odour threshold levels for monomeric 2-EHA which are described in the literature amount to 
between 0.55 mg/m3 (0.07 ml/m3) and 1.4 mg/m3 (0.17 ml/m3) (Brauer, 1992). It cannot be 
judged if this odour threshold provides an indicator for situations where industrial hygiene and/or 
engineering controls may need to be implemented. 
The widespread industrial and skilled-trade applications of polymer dispersions containing 
residual 2-EHA monomer (< 0.08%) comprise uses in paints, lacquers, varnishes, moulding 
materials, impregnating agents and applications in adhesives and adhesive tapes. According to 
the Swedish product register 2-EHA is also used in lubricant/greases. In many cases, the 
polymeric dispersions are further processed to products, so that the concentration of the residual 
monomer decreases. However, the preparations are also directly used. Based on the low vapour 
pressure of the substance (12 Pa) and the low concentration of 2-EHA, the corresponding 
exposure scenario is expected to be of minor relevance for inhalation exposure. On account of 
the sensitising effect of the substance the scenario is described in view of dermal exposure.  
Relevant occupational exposure scenarios are to be expected in the following areas:  
• production of 2-EHA and polymerisation (Scenario 1),  
• formulation of preparations containing up to 21% 2-EHA (Scenario 2),  
• use of formulations containing monomeric 2-EHA in the building trade (Scenario 3), 
• use of dispersions with residual monomeric 2-EHA (< 0.08%) (Scenario 4). 
A decision on the importance of exposure scenarios is made in comparison with the “critical 
exposure level” derived on toxicological data. For 2-EHA, the critical exposure level amounts to 
CHAPTER 4. HUMAN HEALTH 
 29 
6.4 mg/m³. Within this occupational risk assessment, concern will be expressed for scenarios 
with exposure levels above this concentration. Therefore, exposure scenarios with anticipated 
exposure levels < 1 mg/m³, being considerably below this concentration, are regarded to be of 
minor relevance. These scenarios are therefore not described in detail and are not assessed 
quantitatively.  
4.1.1.2.1 Production of 2-EHA and polymerisation (Scenario 1) 
2-EHA is synthesised continuously in closed systems as a result of 2–ethyl hexanol and acrylic 
acid reacting in the boiling heat (acid-catalyzed esterification). Purification of the product is 
achieved via several stages of distillation (BUA, 1991). 
2-EHA is transported in rail tank cars, tank trucks, barges and drums. In-company transportation 
mainly takes place in a closed system. Exposure associated with transport of this chemical would 
result from loading, unloading and drumming operations. 
For the purpose of storage the substance is stabilised against spontaneous polymerisation using 
hydroquinone or hydroquinone monomethyl ether (BUA, 1991). 
The monomer is processed further to polymers in closed systems, mainly to approximately 50% 
aqueous polymer dispersions. Typical specifications of residual monomer content of 2-EHA in 
these polymers are between 0.02-0.08% (BAMM, 1993, BUA 1991). 
In the area of production and further processing of the substance exposure is possible during 
sampling, filling operations, reprocessing and cleaning, and maintenance works. Generally, it is 
to be assumed, that within the large-scale chemical industry high standards of control are 
practised even if the containment may be breached, e.g. during maintenance and the taking of 
process samples. Inhalation exposure in other areas is normally minimised by technical 
equipment (e.g. special designed filling stations, local exhaust ventilation). 
Inhalation Exposure Workplace measurements 
Table 4.1    2-EHA exposures (8-hour TWA) at workplaces during production and further processing (provided by 3 producers) 
Job category / activities Years of 
measurement 
Number of 
samples 1) 
Range of measurement 
data [mg/m3] 
95th percentile [mg/m3] 
8-hour time weighted average 
Production operations 1997 28 < 2.9 1.3 
Emulsion polymer plant 1993-1995 187 < 7.2 - 
     
Drumming / loading 1993-1995 20 0.75-4.5 - 
Maintenance 1997 20 < 7.6 2.8 
Maintenance 1993-1995 63 0.02-3.5  
EP collection / disposal 1997 14 < 2.5 2 
Quality assurance 1993-1995 9 < 0.-0.9 - 
All workplaces described 
below 
1995-2001 332 (27) < 0.0038-8.4 0.48 
Table 4.1 continued overleaf 
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Table 4.1 continued  2-EHA exposures (8-hour TWA) at workplaces during production and further processing (provided by 3 producers) 
Job category / activities Years of 
measurement 
Number of 
samples 1) 
Range of measurement 
data [mg/m3] 
95th percentile [mg/m3] 
Production (closed system) 1995-2000 97 (3) < 0.0084-8.4 0.54 
Subsequent users 
(closed system) 
1995-2000 173 (9) < 0.0038-2.45 0.077 
Laboratory 
(ventilation, exhaustion) 
1995-2000 47 (8) < 0.0076-2.22 0.3 
Pilot plants 
(ventilation, exhaustion, 
closed system) 
1995-2000 5 (2) < 0.0076-0.29 - 
Filling/Storage 
(ventilation, exhaustion) 
1995-2000 4 (2) 0.05-3.06 - 
Maintenance 
(ventilation, exhaustion) 
1995-2000 2 (2) 0.023-0.092 - 
Waste disposal 
(ventilation, exhaustion) 
1995-2000 4 (1) 0.038-0.36 - 
1) In brackets: number of plants 
For the purpose of determining 2-EHA in the air at the workplace, the substance is adsorbed to 
activated charcoal and then desorbed using carbon disulphide and determined gas-
chromatographically. The detection limit of the method amounts to 0.08 mg/m3 (0.01 ml/m3) 
(BASF, 1994). In most cases, no individual measurement results were provided by industry but 
pooled measurement data, in part only described as below a certain value (e.g. 1/10 of the OEL).  
Due to the measurement method and the measurement strategy which were employed, the 
currently available measurement results are regarded as valid. 
In the literature published personal monitoring data demonstrate, that on a routine basis, 
individuals involved in the production of 2-EHA are exposed to air concentrations that are 
generally lower than 8.3 mg/m3 (1.1 ml/m3) (BAMM, 1993). 
On the basis of the presented measurement results (see Table 4.1) it is not possible to calculate a 
90th percentile as the reasonable worst case representing all data collectives. The 95th percentiles 
provided for data collectives obtained 1995-2002 reveal that exposure levels have decreased. 
However, it is not known, whether the data from 1995-2000 is representative for all producers 
and users. Therefore, at present, the highest 95th percentile of 2.8 mg/m³ is taken as representing 
the reasonable worst case situation. 
No information on short term exposure is available.  
EASE estimation 
EASE estimation for the production and further processing of monomeric 2-EHA: 
• Input parameters:  T = 20°C, closed system, significant breaching, LEV present, vapour 
pressure 12 Pa 
• Exposure level:  4-8 mg/m3 (0.5-1 ml/m3) 
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Conclusion 
The reasonable worst case of 2.8 mg/m3 and the result of the estimation using the EASE model 
(4 - 8 mg/m3, 0.5 - 1 ml/m3) are in agreement, although the 95th percentile is slightly below the 
lower level of the assessed range. It has to be kept in mind, that the vapour pressure of 2-EHA is 
rather low. For the assessment of the risks of daily inhalation exposure 2.8 mg/m3 (8-hour TWA) 
should be taken. 
It is to be assumed that the substance is processed daily. Consequently, the duration and the 
frequency of exposure to 2-EHA are assumed to be daily and for the entire length of the shift. 
Measurement values on short term exposure are not available. The assessment of short term 
exposure using the EASE model has some limitations. The model leads to exposure level of 
4-8 mg/m³ for the time the activity under consideration is carried out, e.g. 1 hour. Based on the 
low vapour pressure of 2-EHA, the lower value seems to be reasonable. Since this level 
(4 mg/m³) is only slightly above the assessed 8-hour TWA, it does not provide useful 
information for the risk assessment.  
Dermal exposure 
When producing and further processing 2-EHA dermal exposure could occur during activities 
like drumming, sampling, cleaning, maintenance and repair work. For the unprotected worker, 
according to the EASE model, potential dermal exposure is assessed as follows: 
• Input parameters:  Non dispersive use, direct handling, intermittent 
• Exposure level: 0.1-1 mg/cm2/day. 
Considering an exposed area of 420 cm2 (palms of hands) the model yields an exposure level of 
42-420 mg/person/day.  
For assessing actual dermal exposure levels, it has to be considered that the substance is 
manufactured and further processed primarily in closed systems and that the use of PPE (here 
gloves and eye protection) during exposure relevant activities is highly accepted in the large-
scale chemical industry. Furthermore, on account of the highly irritative effect of pure 2-EHA as 
well as of preparations (> 21% 2-EHA) it is assumed that, as a rule, daily repeated immediate 
skin contact is avoided to a large extent by using personal protective equipment (here: gloves) 
and by applying appropriate working techniques. Therefore daily repeated actual dermal 
exposure is assessed as negligible. According to the discussion on the revision of the TGD 
(worker exposure) the experts concluded not to assess dermal exposure for the handling of 
corrosive or highly irritative formulations.  
Single dermal contacts may occasionally occur during activities like drumming, filling, cleaning 
and maintenance. For this scenario, potential dermal exposure is assessed applying the EASE 
model: 
• Input parameters: Direct handling, non dispersive use, incidental 
• Exposure level: 0-0.1 mg/cm2/day. 
Because workers avoid contact with highly irritative substances it is to be assumed that rather 
small skin areas are exposed. Considering an exposed area of 105 cm2 the exposure level 
amounts to 0-10.5 mg/person/day. This exposure level should be taken for assessing the risks of 
occasional but not daily dermal exposure. 
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In the case of occasional cleaning and maintenance of the plant (e.g. during “shut down” of the 
plant), larger skin areas than during usual daily work may be exposed and complex mixtures may 
be involved. If the highly irritative substance is handled, workers avoid immediate contact. This 
effect is not present if diluted solutions (concentration below 21% 2-EHA) are handled. An 
EASE estimation: 
• Input parameters: Non dispersive use, direct handling, intermittent 
• Level of exposure: 0.1-1 mg/cm²/day 
leads under consideration of a skin area of 1,300 cm² (both hands and parts of the forearms) and 
a concentration of 21% 2-EHA to exposure levels of 27-270 mg/person/day for occasional (not 
daily) exposure during cleaning and maintenance activities.  
Conclusions 
Taking into account the high irritative effect of 2-EHA, daily exposure is assessed as negligible. 
Nevertheless, occasional exposure of 0 – 10.5 mg/person/day is possible (not daily).  
In case of cleaning and maintenance activities (e.g. during shut down of a plant), higher dermal 
exposure of 27 - 270 mg/person/day are possible. It is to be assumed, that these exposure levels 
occur once a year for several days.  
Exposure to the eyes is largely avoided by using eye protection.  
4.1.1.2.2 Formulation of preparations containing up to 21% 2-EHA (Scenario 2) 
According to information provided by one producer formulations on monomer basis used in the 
building trade (such as, for example, floor coatings, road-marking substances) may contain 
2-EHA in concentrations up to 21%. 
Formulating works of 2-EHA may occur in large scale chemical companies as well as in small 
and medium-sized formulating companies. A research project of BAuA revealed that in small 
and medium-sized companies beneath high level of protection also lower levels are observed, 
e.g. workplaces are not equipped with ventilation systems and workers not wearing gloves 
although both measures are required (Voullaire, Kliemt, 1995). 
It is to be assumed, that floor coatings and road-marking agents are produced batch wise. In this, 
exposure relevant activities are performed not during the whole shift but for a limited duration. 
Inhalation exposure 
Workplace measurements 
No data on exposure levels of 2-EHA at the workplace are available. 
For the manufacture of formulations in the large scale chemical industry, exposure levels are 
regarded to be similar as those given for the production (see Table 4.1). Taking into account that 
exposure relevant activities are not performed during the whole shift (batch wise production), 
daily exposure is assumed to be lower. However, these results are not regarded to be 
representative for all formulators. 
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EASE estimation 
EASE estimation for the further processing of monomeric 2-EHA without local exhaust 
ventilation (LEV): 
• Input parameters:  T = 20°C, non dispersive use, direct handling, dilution 
 ventilation, vapour pressure 12 Pa 
• Exposure level: 77-154 mg/m3 (10-20 ml/m3). 
As described above it is assumed, that due to batch wise production exposure relevant activities 
are not performed during the whole shift. The duration and frequency of exposure are assumed to 
be daily and for 2 hours/day, thus reducing daily exposure to a shift average of 19-38.5 mg/m3. 
Conclusions 
Since measurement results are not available, exposure levels predicted according to the EASE 
model should be used for risk assessment. Due to the low vapour pressure of the pure substance 
(12 Pa at 20°C) the actual levels of exposure can be expected to be located at the lower limits of 
the predicted exposure ranges. 
Inhalation exposure of 77 mg/m³ (lower level of the assessed range) is assessed based on the 
EASE estimate. Taking into account a daily duration of 2 hours, the shift average is reduced to 
19 mg/m³. This level should be taken for assessing the risks related to workplaces not equipped 
with LEV. Investigations of BAuA revealed, that these workplaces are frequently observed in 
small and medium sized companies.  
The assessed exposure level is regarded to be an estimate for the reasonable worst case situation. 
Lower exposure levels are expected if workplaces are equipped with LEV. In this, for the 
collective of all formulators, the typical exposure level is assumed to be lower than the assessed 
level.  
Dermal exposure 
On account of the highly irritative effect of pure 2-EHA as well as of preparations 
(> 21% 2-EHA) it is assumed that, as a rule, daily repeated immediate skin contact is avoided to 
a large extent by using personal protective equipment (PPE, here: gloves) and by applying 
appropriate working techniques. It is assumed that worker avoid immediate dermal contact to a 
large extent even if besides the strongly irritating substance also irritating preparations are 
handled. Filling, drumming, cleaning and sampling are regarded to be relevant for exposure. 
Therefore daily repeated dermal exposure is assessed as negligible. According to the discussion 
on the revision of the TGD (worker exposure) the experts concluded not to assess dermal 
exposure for the handling of corrosive or highly irritative formulations. 
A research project of BAuA (Voullaire, Kliemt, 1995) revealed that in small and medium sized 
companies, if exposure relevant activities are performed, personal protective equipment is only 
seldom used. Therefore, for the further processing of 2-EHA in small and medium sized 
chemical enterprises it cannot be excluded that gloves are not regularly worn and that single 
dermal contacts may occasionally occur during activities like drumming, filling, cleaning and 
maintenance. The corresponding exposure is assessed by the EASE model: 
• Input parameters: Direct handling, non-dispersive use, incidental 
• Exposure level: 0-0.1 mg/cm2/day 
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Based on the highly irritative effect, it is to be assumed that rather small skin areas are exposed. 
Considering an exposed area of 105 cm2 the exposure level amounts to 0-10.5 mg/person/day. 
The higher level (10.5 mg/cm²/day) should be taken for assessing the risks of occasional but not 
daily dermal exposure.  
4.1.1.2.3 Use of formulations containing monomeric 2-EHA in the building trade 
(Scenario 3) 
2-EHA is a component of preparations used in the building trade, for example, coating agents for 
industrial flooring or road-marking agents. According to information provided by one 
manufacturer the monomer concentration amounts up to 21%. 
The preparations containing 2-EHA are filled into relevant containers on site, if necessary, mixed 
and applied by hand using a smoothing blade or other appropriate tools. It is to be assumed that a 
certain part of 2-EHA evaporates during the hardening phase. Similar information was provided 
by the Federal Monitoring Authorities in Germany. 
Information submitted with regard to the use of a 2-component floor-coating agent reveals that 
2-EHA is contained as a monomer in the liquid component in addition to methyl methacrylate. 
The preparation is used in the building trade for coating floors in buildings which are still at the 
shell stage. Technical protective measures are not employed. The wearing of respiratory 
protection and protective clothing are mentioned as personal protective equipment. The use of 
the coatings is determined by the order situation and is stated to be infrequent.  
Inhalative and dermal exposure of workers is possible during charging, mixing and coating work 
as well as during cleaning work. It is assumed that these works are performed during the whole 
shift, but not daily. In case of application of road marking agents works are performed outside. 
Inhalation exposure  
Workplace measurements 
No measurement results are available. 
Analogous data 
The formulations often contain beneath 2-EHA methyl methacrylate as a copolymer. The 
concentration of methyl methacrylate is similar to the concentration of ethyl hexylacrylate: up to 
20%. Therefore, exposure data of methyl methacrylate obtained during flooring works (cast 
coating, filling, sealing) are given (see RAR methyl methacrylate). Measurement values between 
200-800 mg/m³ (mean values, no TWA) were provided. In addition, 95th percentiles of 
1,045 mg/m³ (n = 78) for flooring works with ventilation systems being present and 625 mg/m³ 
for workplaces without ventilation systems were given. Using the value of 1,045 mg/m³ and 
taking into account the vapour pressures of the substances (3,870 Pa for methyl methacrylate and 
12 Pa for ethyl hexylacrylate) a rough estimation leads to an exposure level of 3 mg/m³ ethyl 
hexylacrylate (a linear relationship of vapour pressure of the pure substances and exposure levels 
is assumed). 
Results of measurements of methyl methacrylate for reduced times of exposure (< 1 hour) are 
clustered with other activities than floor coating (n = 50, 50th percentile: 195 mg/m³, 90th 
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percentile: 521, 95th percentile 683 mg/m³). It is stated that for the application of floor sealing 
agents, exposure levels were higher than the 50th percentile.  
Even if it is assumed that during flooring works the 95th percentile is a measure for the 
reasonable worst case situation of short term exposure, this level is not higher than the highest 
8-hour TWA. In this, assessing a short term value on this basis would not provide useful 
information.  
Model estimations 
The EASE estimation for the uses in the building trade (T = 20°C, wide dispersive use, direct 
handling, dilution ventilation, vapour pressure 12 Pa) leads to non-plausible exposure levels 
(765-1,071 mg/m3), since they are higher than the saturation concentration of 2-EHA. Therefore, 
the model estimates cannot be used for assessing exposure levels.  
Conclusions 
For assessing the risk of inhalation exposure in the building trade an exposure level based on 
measurement results of methyl methacrylate is taken. For flooring works, the risks of not daily 
inhalation exposure should be based on an exposure level of 3 mg/m³. For works performed 
outside (here road marking activities) exposure is assumed to be lower because the air ventilation 
rate is higher than in rooms.  
Short term exposure levels are not assessed. The available measurement results are below the 
shift average.  
Dermal exposure 
For the building trade it is to be assumed that protective gloves are not regularly worn. This 
assumption is also valid in case of handling preparations containing ≤ 21% 2 EHA, since these 
preparations are less irritative than the pure substance or concentrated preparations. Therefore 
dermal exposure is assessed according to the EASE model: 
• Input parameters:  Direct handling, wide dispersive use, intermittent 
• Exposure level:  1-5 mg/cm2/day. 
Considering a 2-EHA content of 21% and an exposed area of 840 cm2 (hands) an exposure level 
of 175-880 mg/person/day is obtained. The higher level (880 mg/person/day) should be taken for 
assessing the risks. Exposure is assumed to occur not daily.  
4.1.1.2.4 Use of dispersions with residual monomeric 2-EHA (Scenario 4) 
The widespread industrial and skilled-trade applications of polymer dispersions containing 
residual 2-EHA monomer (< 0.08%) comprise uses in paints, lacquers, varnishes, moulding 
materials, impregnating agents and applications in adhesives and adhesive tapes. 
It is to be assumed, that the amount of residual monomeric 2-EHA decreases during the further 
processing of the dispersions to products and by further reactions of the monomer, e.g. 
hydrolysis. At present, it is not possible to quantify the extent of this decrease. Inhalation 
exposure during the application of the preparations is assumed to be negligible even if spray 
applications are performed (low concentration, low vapour pressure). Taking into account the 
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sensitising effect of the substance, dermal exposure is regarded to be of importance in spite of 
the low concentrations. 
For an overall estimation of dermal exposure a 2-EHA concentration of 0.08% is assumed. 
Applying the EASE model with the following parameters: 
• Input parameters:   Direct handling, wide dispersive use, intermittent 
• Estimated level of exposure:  1-5 mg/cm²/day 
and considering an exposed area of 840 cm², dermal exposure levels of 1-3 mg/person/day are 
obtained. The higher level (3 mg/person/day) should be taken for assessing the risks. Exposure is 
assumed to occur not daily. 
4.1.1.2.5 Summary 
Based on the information available within the framework of this exposure assessment, ethylhexyl 
acrylate is mainly used as a monomer in the chemical industry for the manufacture of polymeric 
chemicals, which are processed further to aqueous polymer dispersions (approximately 50% 
polymer). The polymers and polymer dispersions are used in different products e. g. in 
adhesives, in printing inks and as binders in paints. In addition, monomeric 2-EHA is an additive 
in preparations, which are applied in the building trade as floor coatings and road-marking 
materials. The concentration of monomeric 2-EHA amounts up to 21%. 
Exposure scenarios regarding the handling of monomeric 2-EHA present opportunities for 
exposure. The low vapour pressure of 2-EHA (12 Pa) leads to limited inhalation exposure levels. 
If the pure substance or preparations containing > 21% 2-EHA are handled it is to be assumed, 
that workers protect themselves against the highly irritative effect of the substance by using 
protective equipment (here gloves) and by applying appropriate working techniques. 
Relevant occupational exposure scenarios are:  
• production of 2-EHA and polymerisation (Scenario 1),  
• formulation of preparations containing up to 21% 2-EHA (Scenarios 2),  
• use of formulations containing monomeric 2-EHA in the building trade (Scenario 3), 
• use of dispersions with residual monomeric 2-EHA (< 0.08%) (Scenario 4). 
The inhalative and dermal exposure levels (reasonable worst case) are given in Table 4.2 and 
Table 4.3. 
For the large-scale chemical industry, it is assumed that the production and further processing of 
2-EHA is mainly performed in closed systems. Exposure occurs during certain activities in the 
manufacturing and further processing of monomeric 2-EHA (Scenario 1, Table 4.2 and 
Table 4.3).  
Within the further processing industry and skilled-trade areas, lower levels of protection than in 
the large-scale chemical industry are to be assumed. Exposure occurs mainly during the 
manufacture of preparations containing up to 21% 2-EHA (Scenario 2, Table 4.2 and Table 4.3) 
and their uses in the building trade (floor coating, road marking) (Scenario 3, Table 4.2 and 
Table 4.3). 
The widespread industrial and skilled-trade applications of polymer dispersions containing 
residual 2-EHA monomer (< 0.08%) comprise uses in paints, lacquers, varnishes, moulding 
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materials, impregnating agents and applications in adhesives and adhesive tapes. On account of 
the low concentration of 2-EHA and the low vapour pressure (12 Pa); inhalation exposure is 
regarded to be negligible compared to the critical exposure level of 6.4 mg/m³ 
(see Section 4.1.1.1.2, rough estimation, < 1 mg/m³). In view of the sensitising effect of the 
substance, dermal exposure is assessed although the concentrations of monomeric 2-EHA are 
very low (Scenario 4, Table 4.3). 
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38 Table 4.2    Summary of inhalation exposure data of 2-ethylhexyl acrylate which are relevant for occupational risk assessment 
Inhalation exposure 
Area of production and 
use 
Form of 
exposure 
Activity Duration Frequency Shift average  
[mg/m3] 
Method Shortened 
exposure [mg/m3] 
Duration, 
Method 
Production and further processing as a chemical intermediate 
1) Production of 2-EHA 
and polymerisation 
vapour  
(liquid) 
filling, sampling, 
cleaning, repair,  
maintenance 
shift length daily 
 
2.8 95th percentile 
 
1) - 
Further processing of monomeric 2-EHA to formulations (< 21% 2-EHA) 
2) Formulation of 
preparations containing 
up to 21%  
2-EHA  
vapour  
(liquid) 
filling, sampling, 
cleaning, repair,  
maintenance 
 
2 hours/day 
(assumed) 
 
daily 
 
 
19 
 
EASE 
without LEV 
 
77 (2 hours) 
 
 
EASE 
Use of formulations  
3) Use of formulations 
containing monomeric 
2-EHA in the building 
trade (< 21% 2-EHA) 
vapour  
(liquid) 
floor coating, road 
marking 
shift length 
 
not daily 3 
 
analogous data 2) 1) - 
4) Use of dispersions with 
residual 2-EHA (< 
0.08%) 
vapour  
(liquid) 
different activities 
 
- - negligible 3) exp. judg. 
 
negligible exp. judg. 
 
1)  Short-term exposure levels are in the same range as the assessed shift average (see text)  
2)  Analogous data: methyl methacrylate is used, in part, in the same formulation 
3)  Exposure < 1 mg/m³ 
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Table 4.3    Summary of dermal exposure data of 2-ethylhexyl acrylate which are relevant for occupational risk assessment 
Dermal exposure 
Area of production and 
use 
Form of exposure Activity Contact level 
1) 
Frequency Level of exposure 
[mg/cm2/day] 
Exposed area  
[cm2] 
Shift average  
[mg/person/day] 
Method 
Production and further processing as a chemical intermediate 
1) Production of 2-EHA 
and polymerisation 
liquid€ filling, sampling, 
cleaning, repair,  
maintenance 
-- 
 
incidental 
daily 
 
not daily 
-- 
 
0.1 
-- 
 
105 
negligible 
 
10.5 2) 
exp. judg. 3) 
 
EASE 3, 4) 
Further processing of monomeric 2-EHA to formulations (< 21% 2-EHA) 
2) Formulation of 
preparations 
containing up to 21% 
2-EHA  
liquid 
 
filling, sampling, 
cleaning, repair,  
maintenance 
-- 
 
incidental 
daily 
 
not daily 
-- 
 
0.1 
-- 
 
105 
negligible  
 
10.5 
exp. judg. 3) 
 
EASE 3, 4)  
Use of formulations  
3) Use of formulations 
containing monomeric 
2-EHA in the building 
trade (< 21%) 
liquid floor coating, 
road marking 
intermittent 
 
not daily 1.05 840 
 
880  EASE 5) 
 
4) Use of dispersions 
with residual 2-EHA 
(< 0.08%) 
liquid different activities intermittent daily 0.004 840 
 
3  EASE 5) 
 
1) Contact level according to the EASE model 
2)  For cleaning and maintenance during shut down of a plant, exposure level of 27 – 270 should be taken (once a year, several days) 
3) Highly irritative substance 
4) Occasional exposure 
5)  Gloves are not regularly worn 
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4.1.1.3 Consumer exposure 
As mentioned in Section 4.1.1, the Swedish Product Register lists a total number of seven 
products available for consumers and containing 2-EHA, which are referred to three product 
categories/functions. The respective codes of the product types are 1) lubricants/greases, 2) 
Agricultures/forestry and 3) products offered in wholesale and retail trade, repair shops for motor 
vehicles, -cycles and other household goods.  
Because 2-EHA is also used in 4) paints and lacquers, as given in Section 4.1.1, it can be 
assumed that these products will reach the area of consumer use. 5) Because 2-EHA is used in 
the production of plastics, it can be expected that it is should appear as a residual monomer in 
plastic materials which may come into contact with food.  
Although 2-EHA is also present as a residual monomer in floor coatings, the notifier has 
declared that these coatings are used only for industrial floors.  
For consumer exposure, the following categories remain where knowledge of use is sufficient 
enough and paths of exposures are of interest for consumers. According to BAMM (1990; 1991; 
1993) the residual monomer content accounts for 0.08% of the polymer. 
Table 4.4    Summary of consumer product types 
 Type of category of use Path of exposure Residual monomer content in product 
1) Lubricants and greases dermal  0.08% 
2) Paints and lacquers inhalation 0.08% 
3) Plastics oral unknown 
Other uses have not been considered because of lack of information. 
Agricultural and forestry uses are mentioned under “indirect exposure” via the environment. 
Dermal exposure 
Lubricants and greases used in cars or other vehicles may be exposed dermally to consumer for 
short periods of time during bringing up the grease. From this point of view, dermal exposure 
can occur via the use of consumer products, the quantification, however, is not possible because 
of lack of data. For a worst case estimate of dermal exposure the following assumptions were 
made: the weight fraction of residual monomer in grease is assumed to be similar to paints 
(0.08%) of the content of the polymer which is 10%. The volume of grease contacting the hands 
is 8.4 cm³ (= 840 cm² [surface area] . 0.01 cm [thickness], TGD default, assumed density 1), 
then an amount of 0.672 mg/event of the residual monomer would lead to dermal contact 
(= 8.4 g . 10% . 0.08%). Assuming a body weight of 60 kg, the dermal exposure would result in 
11.2 µg/kg bw per event. 
For paints, the same scenario can be taken, however, taking a lower contact area set to 1 cm² for 
splashes of paints. Taking the weight fraction of the residual monomer in paints of 0.00048 
(see Table), the dermal exposure to paints would reveal 1.3 µg/kg bw/event. 
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Inhalation exposure 
For the estimation of the inhalatory exposure of the consumer, a computer simulation with the 
US-EPA model SCIES was used (comp. Technical Guidance Document p. 187-188) and using 
data given by BAMM for dispersion paints. All values together with SCIES default values are 
given in the table below. The amount of 2-EHApolymers in the paint is 60%, therefore the 
content of 2-EHA residual monomer is 0.048% (weight fraction of 2-EHA in paints 0.00012). 
Consumer exposure with 2-EHA (dispersion paints) 
Annual frequency of use   6 events/year 
Mass of product   13,600 grams 
Duration of use   4.9 hours 
Volume of room of use (zone 1 volume) 40 m³ 
Whole house volume   292 m³ 
House air exchange rate   0.2 room air exchange/hr 
User inhalation rate (during use)  1.3 m³ 
Non-user inhalation rate   1.1 m³ 
Molecular weight   184 g/mole 
Vapour pressure   0.09 torr 
Weight fraction   0.00048  residual monomer 
Body weight    60  kg 
The calculation reveals a peak room concentration during use of 22 mg/m³ (= 2.9 ppm), the 
average concentration is 16 mg/m³ (= 2.1 ppm). Measurements (BAMM) of 2-EHAresidual 
monomers after painting with paints containing 940 ppm (weight fraction 0.00094) and 
2,000 ppm (weight fraction 0.002) a room with restricted ventilation revealed room air peak 
concentrations of 2.5 ppm and 8 ppm, which is in accordance to the estimated values. 2-EHA 
was not detectable 25 hours after painting. 
For handicraftsmen, maximum air concentrations of < 1 ppm were measured during a monitoring 
programme by the notifier according to the TRG 402 which may be comparable to consumer use 
of paints.  
For risk characterisation, the value of 1 ppm (and 0.0075 mg/l) of 2-EHA residual monomer in 
indoor air should be taken as a worst case value for short-term exposure scenarios. Taking into 
account the time of application of paints and that 2-EHA was not measured 25 hours after 
painting, chronic (long-term) exposure by inhalation is not given. 
Oral exposure 
Exposure to articles coming into contact with food 
Plastic material that comes into contact with food is regulated by the EU directive 90/128/EEC, 
28th of February 1990, “Directive of materials and articles intended to come in contact with food 
stuff”. In this regulation, 2-EHA has not been finally evaluated. Exposure data due to limitations 
given by the directive are therefore not available. 
Due to other plastic material (e.g. MMA) the amounts of 2-EHA should be low and therefore be 
neglected. 
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4.1.1.4 Indirect exposure via the environment 
According to Appendix VII of Chapter 2 of the TGD, the indirect exposure to humans via the 
environment, i.e. through food, drinking water and air is estimated.  
Two local scenarios are calculated for comparison purpose. Site specific data for the main 
production site are used to represent worst case exposure of the soil and air compartment 
combined with a lower but realistic concentration in surface water. On the other hand, the 
scenario for the formulation of aqueous polymer dispersions is used representing the highest 
estimated concentration in surface water and comparably low exposure of the soil and air 
compartment. 
In addition, the average human intake due to the regional background concentrations is 
calculated.  
The input parameters are compiled in Table 4.5. The model calculations are presented in 
Appendix A10.1 and A10.2. 
Table 4.5    Local and regional scenarios for indirect exposure  
  Site specific, site A Formulation of polymer 
dispersions 
Regional 
Concentration in surface water PECwater_ann 1.2 ⋅ 10-4 mg /l 4.9 ⋅ 10-4 mg /l 5.8 ⋅ 10-6 mg /l 
Concentration in the atmosphere PECair_ann 8.3 ⋅ 10-3 mg /m3 7.7 ⋅ 10-5 mg /m3 7.9 ⋅ 10-7 mg /m3 
Concentration in grassland soil PECgrassland 1.3 ⋅ 10-3 mg /kg 2.2 ⋅ 10-5 mg /kg 6.8 ⋅ 10-5 mg /kg 
Concentration in grassland porewater  PECgrassland_pw 8.2 ⋅ 10-5 mg /l 1.4 ⋅ 10-6 mg /l 4.2 ⋅ 10-6 mg /l 
Concentration in groundwater: PECgrw 5.2 ⋅ 10-5 mg /l 8.7 ⋅ 10-7 mg /l 4.2 ⋅ 10-6 mg /l 
The resulting total daily doses and the routes of exposure are displayed in Table 4.6: 
Table 4.6    Total daily doses and contribution of the different routes of indirect exposure  
Scenario Site specific, site A Formulation of polymer 
dispersions 
Regional 
total daily dose (DOSEtot) 2 ⋅ 10-3 mg.kg bw-1.d-1 3.6 ⋅ 10-4 mg.kg bw-1.d-1 6 ⋅ 10-6 mg.kg bw-1.d-1 
% via drinking water < 0.1 2 2 
% via air 89.4 4.6 2.9 
% via stem (leaf crops) 5.4 0.3 0.2 
% via root crops 1.1 0.1 28.4 
% via meat < 0.1 < 0.1 < 0.1 
% via milk < 0.1 < 0.1 < 0.1 
% via fish 3.9 93 66.6 
The main route of indirect exposure in the local scenario is the intake via air (for site A) and via 
fish consumption (for formulation of polymer dispersions). Other routes of exposure do not 
comprise to a significant extent to the total daily dose. For the regional scenario 2/3 of the total 
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dose is attributed to the consumption of fish followed by nearly 30% uptake via root crops. 
Exposure via air is only of minor importance in the regional scenario.  
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4.1.2 Effects assessment: Hazard identification and Dose (concentration) - 
response (effect) assessment  
4.1.2.1 Toxico-kinetics, metabolism and distribution 
So far no specific studies have been carried out on the metabolism of 2-EHA 
(2-ethylhexyl acrylate). However a variety of studies on rats have indicated that short-chain-
acrylates such as ethylacrylate undergoes the following metabolic reactions: carboxylesterase-
catalyzed hydrolysis of the ester function to release acrylic acid and alcohol (Silver and Murphy, 
1981; De Bethizy et al., 1987; Ghanayem et al., 1987; Vodicka et al., 1990; Frederick et al., 
1992; Linhart et al., 1994; Frederick et al., 1994). The half-life of ethylacrylate-hydrolysis in rat 
liver (in vitro) was approximately 2 seconds. In 13 other tissues it was as much as 15 minutes 
(Frederick et al., 1992). 
Using purified porcine liver carboxylesterase, the enzymatic hydrolysis of several acrylates and 
methacrylates was characterised to determine Km5 and Vmax- values for each ester (McCarthy 
and Witz, 1997). α- Methylsubstitution had only a minor effect upon Km or Vmax, but the 
alcohol chain length significantly affected the Km values for enzymatic hydrolysis. Butyl 
acrylate had a Km value four times lower compared with that for ethyl acrylate. The Vmax for 
butyl acrylate was about six times slower than the Vmax of ethyl acrylate. Data on 2-EHA are 
not available. 
Excretion balance studies were conducted with 2-ethylhexanol (2-EH) in female Fischer 344 rats 
following single high (500 mg/kg) and low (50 mg/kg) oral doses of 14C -2-EH, following 
repeated (14 day) oral dosing with unlabelled 2-EH at the low level, and following a 1 mg/kg i.v. 
dose of 14C-2-EH. All the oral doses were eliminated rapidly, predominantly in the urine during 
the first 24 hours. Urinary metabolites eliminated following the oral doses were predominantly 
glucuronides of oxidised metabolites of 2-EHA (2-ethyladipic acid, 2-ethylhexanoic acid, 
5-hydroxy-2-ethylhexanoic acid and 6-hydroxy-2-ethylhexanoic acid) (Deisinger et al., 1994). 
The acrylic acid is decarboxylated and degraded to carbon dioxide (Gut et al., 1988; Sapota, 
1988). Only a part of 2-8% (vary with the route of administration) of 2-EHA is bound to 
glutathione and excreted as thioether (Gut et al., 1988; Vodicka et al., 1990; Linhart et al., 1994). 
14C-2-EHA (labelled on the vinyl carbons) was administered p.o. or i.p. on rats (100 mg/kg bw) 
(Sapota, 1988). The highest specific radioactivity was found three hours after i.p. administration 
in liver and kidneys, followed by spleen, lungs, brain, adipose tissue and blood. The 14C tissue 
levels decreased continuously. One exception to this was the adipose tissue at the 100 mg/kg 
dose; in this tissue the 14C- level remained constant for 72 hours. After oral dosing about 50% of 
the radioactivity was eliminated via the expired air and about 38% via the urine within the first 
24 hours. A small portion of 2-EHA (about 1% of the dose) was excreted via the faeces. 
Toxicokinetics summary 
One study in experimental animals by the oral route has shown that 2-EHA is rapidly and 
extensively absorbed, distributed and eliminated (about 90% during the first 24 hours). There are 
no specific toxicokinetic studies using dermal administration or inhalative exposure. 
                                                 
5 Km: Michaelis Menten Constant, Vmax: maximal velocity 
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4.1.2.2 Acute toxicity 
4.1.2.2.1 Studies in animals 
Oral  
Acute oral toxicity is characterised by LD50 values of 4,000-6,000 mg/kg. As clinical signs: scant 
droppings, wet yellow stained anogenital area, decreased spontaneous motoric activity and ataxia 
are mentioned: 
Within a list of range finding toxicity data a short abstract of test results is given, stating that for 
2-EHA (no data on purity) an oral LD50 of 6.50 (4.72-8.95) ml/kg (approximately 5,770 mg/kg) 
was detected in a test with male rats (no further data available, Carpenter et al., 1974). 
In a second test with 2-EHA (stabilised with 0.05% hydroquinone, no data on purity) 
administration of 10% aqueous traganth solutions of the substance to rats resulted in an oral LD50 
value of 5.0 ml/kg (approximately 4,430 mg/kg). Clinical signs observed were apathy, narcotic 
state, and diarrhoea; no histologic alterations were detected, no further data are given (BASF 
AG, unpublished report, 1958). 
In a test with ten male mice/dose group (2,500 mg/kg and 5,000 mg/kg, vehicle corn oil), 2-EHA 
(purity > 99.5%, stabilised with 10-20 ppm MMHQ) caused no mortality after administration of 
2,500 mg/kg, but 2/10 mice died within 24 hours after administration of 5,000 mg/kg. Surviving 
animals recovered within 3 days after substance application. Clinical signs observed were scant 
droppings, wet yellow stained anogenital area, decreased spontaneous motor activity, ataxia, and 
abdominal breathing. No gross changes were detected at necropsy (Rohm and Haas, unpublished 
report, 1982).  
Inhalation  
Valid data on acute inhalation toxicity tests are not available; but acute inhalation toxicity of 
2-EHA seems to be low. Several reports on animal tests are mentioned: Within a list of range 
finding toxicity data is stated that no mortality was observed in rats after an 8-hours inhalation of 
“concentrated vapours” of 2-EHA (no data on purity), temperature of that atmosphere is not 
mentioned (Carpenter et al., 1974). 
In a test with rats, after an 8-hour inhalation of an atmosphere saturated with 2-EHA at 20°C 
(stabilised with 0.05% hydroquinone, no data on purity) no mortality and no clinical signs were 
observed in 6 animals, no more details are given (BASF AG, unpublished report, 1958).  
In a range-finding test on ethylhexyl acrylate, substantially saturated vapour was prepared by 
spreading 50 g of the chemical over 200 cm² area on shallow tray placed near the top of a 120 L 
glass chamber at room temperature which was then sealed for at least 16 hours, while an 
intermittently operated fan agitated the internal chamber atmosphere. Rats were then introduced 
in a cage designed and operated to minimise vapour loss. After an 8-hour inhalation of that 
saturated 2-EHA vapour (no data on purity) none of 6 rats died within the inhalation or within 
the 14-day observation period after the inhalation of 2-EHA vapours. Hyperactivity on removal 
from exposure chamber was the only clinical sign documented, gross pathology revealed nasal 
and ocular irritation (Mellon Institute of Industrial Research, unpublished report, 1950).  
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Citations from literature on reports of tests with rats and mice are given within a report on the 
toxicity of 2-EHA. No deaths were observed. All rats exposed to saturated atmospheres at 20°C 
over an exposure time of 8 hours survived; no deaths occurred when mice were exposed to an 
atmosphere saturated with the substance at 60°C (BUA, 1991). 
Dermal  
The acute dermal toxicity of 2-EHA is low. For rabbits, a dermal LD50 value >10,000 mg/kg is 
reported: Only a short abstract of test results is given within a table, stating that for 2-EHA (no 
data on purity) a skin penetration LD50 of 16.00 (4.48-57.2) ml/kg (approximately 14,180 mg/kg) 
was detected for rabbits (Carpenter et al., 1974).  
4.1.2.2.2 Studies in humans 
Human data on the acute toxicity of the substance are not available.  
4.1.2.2.3 Conclusion 
Human data on the acute toxicity of the substance are not available. In animal studies with 
rodents, 2-EHA possesses slight acute toxicity, the primary effect being local irritation or 
corrosion, as judged on the basis of the sparse information on clinical signs reported and on the 
results from local irritation/corrosion testing (see Section 4.1.2.3/4.1.2.4), systemic effects are 
non-specific and much less pronounced. The substance is not to be labelled because of acute 
toxic effects.  
4.1.2.3 Irritation/Corrosion 
4.1.2.3.1 Studies in animals 
Skin 
In a skin irritation test performed similar to OECD and EU test guidelines, 6 rabbits were 
exposed for 4 hours under occlusion to 2-ethylhexyl acrylate (no data on purity). All animals 
exhibited severe erythema (mean values for 24 hours/72 hours: 3.2/2.7) and oedema (mean 
values for 24 hours/72 hours: 2.7/1.2); the severity of the skin lesions enhanced in 1/6 animals 
during the 72 hours observation period and the skin of this animal demonstrated score 4 and 
superficial chemical burns 3 days after exposure when the test was terminated (Hoechst Celanese 
Corp. unpublished report, 1972). It remains unclear whether full thickness destruction would 
have been observed at later observation times. In a series of patch tests the test substance caused 
moderate erythema after a 1 minute and after a 5 minute exposure time which reversed within 
8 days. After an exposure time of 15 minutes severe erythema with scaling after 8 days were 
observed and severe erythema and moderate edema appeared within 24 hours after a 20-hour 
exposure time. Eight days after application scaling was stated (BASF AG unpublished report, 
1978).  
In an occlusive patch test according to US Federal Register Guideline of 1964 four rabbits were 
tested with 0.5 ml of 2-EHA (no data on purity) each, using 24 hours occlusive exposure to intact 
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and abraded skin. Scores (24 hours/72 hours) for erythema of 1.75/2 and for oedema of 3.25/3.25 
were observed for intact skin, for abraded skin the same scores were obtained. No indication of 
necrotic effects are mentioned both in intact and abraded skin (Consultox Laboratories, 
unpublished report, 1980). 
A short summary of the skin responses in rabbits and guinea pigs after repeated uncovered 
contact with 2-EHA is given by Hunter et al.: After 12 daily applications of the material without 
covering foci of necrosis were apparent and the test was terminated due to severity of skin 
damage (Hunter et al. 1966).  
In order to support the decision if the local lesions caused after skin contact are to be classified 
as corrosion or as severe irritation, BASF AG carried out an alternative to the Draize skin test 
which was developed in order to differentiate between irritation and corrosion (EU Guideline 
B.40). The so called EpiDermTM Skin Corrosivity Test was performed using 2-ethylhexyl 
acrylate, purity 99.7%. The potential of 2-EHA to cause dermal corrosion was assessed by a 
single topical application of 50 µl of the test substance to a reconstructed three dimensional 
human epidermal model (EpiDermTM). Dublicates of the EpiDermTM tissue were incubated with 
2-EHA for 3 minutes and 1 hour, followed by a colorimetric determination of the possibly 
induced cytotoxic effects. Viability of the test substance treated tissues determined after an 
exposure period of 3 minutes was 99% and for the exposure period of 1 hour 104% (2-EHA is 
not able to directly reduce MTT, the indicator used for detection of cytotoxicity). It is 
demonstrated that 2-EHA reacts like the negative control, while a caustic compound used as 
positive control proved that this system is able to detect caustic chemicals. Based on the 
observed results and applying the evaluation criteria of the test, 2-EHA does not have a corrosive 
potential in this test under the conditions chosen (BASF AG, unpublished report, 2001). 
Eye 
Eye irritation is reported to be evident but less significant than local effects on the skin of 
rabbits. In a test according OECD test guideline 405 and performed under GLP, 2-EHA (purity 
98%) caused mild eye irritation: 0.1 ml of the substance was instilled into the eyes of 3 Albino 
rabbits, the following mean scores are documented for the 24, 48 and 72 observation times: 
cornea 0/0/0.3, iris 0/0/0.3, conjunctival redness 0.3/0/0.3, conjunctival chemosis 0/0/0.3. All 
signs of irritation were reversible within 3 days (Koch et al., 1985). The other existing tests on 
eye irritation are poorly described. In most cases there exists a general statement with respect to 
the test as to be performed in general, but no information on the specific test carried out with the 
substance 2-EHA. Hence, it is very difficult to decide on the weight of evidence of “grades” or 
“scores” mentioned in the tables of results and on possible consequences for classification 
according to current EU regulations. 
Carpenter and Smyth reported corneal injury grade 6 on a scale of 10 as result of the instillation 
of 0.005 ml of a 40% solution of 2-EHA into the eyes of 5 rabbits. 24 hours after instillation of 
the material into the eyes numerical assessment scores > 5 were determined (meaning of “score 
5”: necrosis on 63-87% of cornea, visible after staining with fluorescein). This result yielded in 
an assessment grade 6 out of a scale of 10 for corneal lesions caused by 2-EHA (Carpenter and 
Smyth, 1946). 
Only a short abstract of test results is given within a list of range finding toxicity data, stating 
that corneal injury grade 1 within a scale of 10 was detected for undiluted 2-EHA (no data on 
purity; grade 1 means that at most a very small area of necrosis resulted from the instillation of 
0.5 ml of the test substance into the eyes of rabbits) (Carpenter et al., 1974). Moderate 
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conjunctival irritation, but no lesions on cornea or iris resulted in an ocular irritation test 
according to US Federal Register Guideline of 1964. Instillation of 0.1 ml of 2-EHA (no data on 
purity) into the eyes of 6 rabbits resulted in either slight or well-defined injection of the vessels 
of the conjunctivae, one example of slight swelling was exhibited (scores after 24, 48, and 
72 hours are stated to exist, but no information on these scores is available). The observation 
period is not mentioned. No corneal or iris lesions were identified in any animal. Since only 1/6 
rabbits displayed a reaction which would be considered to be positive according to US 
regulations of 1964, the test was regarded as being negative (Consultox Laboratories, 
unpublished report, 1980).  
There exists no standard test method for the assessment of respiratory irritation. Thus, the 
labelling of 2-EHA with R 37 according to current EU regulations is not based on results of a 
specific respiratory irritation test, but on considerations on the general irritation potential of 
2-EHA: Nasal and ocular irritation is noted in a test on acute inhalation toxicity with rats 
(see Section 4.1.2.2). The local irritation potential of 2-EHA is detected on the skin and on the 
conjunctivae of the eye; primary respiratory irritation may be one of the origins of the serious 
lesions seen after repeated inhalation of 2-EHA (see Section 4.1.2.6). 
4.1.2.3.2 Studies in humans 
No data available. 
4.1.2.3.3 Conclusion 
Information on human experience with local irritation/corrosion caused by 2-ethylhexyl acrylate 
is not available. In animal experiments 2-EHA caused serious lesions to the skin of rabbits which 
are assessed to be situated at the border between severe irritation and corrosion. Therefore, in 
2001 BASF AG carried out an alternative to the Draize skin irritation test according to the new 
EU test guideline B.40. (Skin Corrosion). This alternative test method is developed for 
differentiation between irritation and corrosion. The result of the new study demonstrates that 
2-EHA does not have a corrosive potential in this test, and hence, the current classification of 
2-EHA as irritant and labelling with “R 38, Irritating to skin” is confirmed. 
Most of the existing tests on eye irritation are poorly described. In the only test according to 
international guidelines, 2-EHA caused mild eye irritation with the following mean scores for the 
24, 48 and 72 observation times: cornea 0/0/0.3, iris 0/0/0.3, conjunctival redness 0.3/0/0.3, 
conjunctival chemosis 0/0/0.3. All signs of irritation were reversible within 3 days (Koch et al., 
1985). 
On the basis of this test the eye irritating properties of 2-EHA does not warrant labelling with 
R 36. 
There exists no standard test method for the assessment of respiratory irritation. Thus, the 
labelling of 2-EHA with “R 37, Irritating to respiratory tract” according to current EU 
regulations is not based on results of a specific respiratory irritation test, but on considerations on 
the general irritation potential of 2-EHA (nasal and ocular irritation noted in a test on acute 
inhalation toxicity with rats, severe local irritation potential detected on the skin and moderate 
irritation potential detected on the conjunctivae of rabbits; serious lesions as seen after repeated 
inhalation of 2-EHA may well be initiated i.a. by primary respiratory irritation). Labelling with 
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R 37 is confirmed on the basis of all of the respective data mentioned within this Risk 
Assessment Report. 
4.1.2.4 Corrosivity 
4.1.2.5 Sensitisation 
4.1.2.5.1 Studies in animals 
In various tests involving guinea pigs 2-EHA proved sensitising, with and without adjuvants.  
2-EHA has shown strong sensitising effects in a Freund's Adjuvant test (FCA test) with 
10 animals in the test and in control group. The test was carried out by injecting or applying a 
0.1% aqueous suspension of 2-EHA to the shorn skin on the backs of the guinea pigs on three 
days per week for three weeks. Challenge was performed 10 days after the last induction 
treatment with a 0.1% aqueous suspension of 2-EHA. After topical application 10/10 and after 
intradermal injection 5-7/10 animals reacted after 24 hours and 5/10 after 48 hours. The treated 
animals showed intense redness and oedema (Hunter et al., 1966).  
Strong sensitising effects were reported also in a second FCA test. Naive guinea pigs were 
treated with a series of 3 intradermal injections on days 0, 5 and 9, with FCA and a 3% or a 9% 
concentration of 2-EHA. Challenges were performed every two weeks from day 21 by open 
epicutaneous application of 0.025 ml 2-EHA (approximately 18%) until day 49 on the shaved 
flanks. With both induction concentrations, sensitisation of guinea pigs to 2-EHA was 
demonstrated. Up to 13/16 treated animals, using an induction concentration of 3% and up to 
11/16 animals, using an induction concentration of 9% 2-EHA revealed a positive response. 
Positive skin reactions were observed until day 105 after rechallenge on day 77. Of the control 
animals, which were treated for the first time epicutaneously with the challenge solution on day 
21, three out of ten reacted as early as day 35 and one out of ten on day 49. Cross reactions of 
animals sensitised to 2-EHA were: for ethylacrylate, three out of eight; for n-butylacrylate, seven 
out of eight; and for hexylacrylate, two out of eight. No cross reactions were observed for tert.-
butyl acrylate, methyl methacrylate or hexyl methacrylate (Waegemaekers and van der Walle, 
1983).  
The sensitising potential of 2-EHA in the guinea pig could be demonstrated by the Polak 
method. Guinea pigs (6 per group) received 4 footpad injections of 0.1 ml of an emulsion 
containing 2 mg/ml of 2-EHA, in ethanol: saline (1:4) in Freund's Complete Adjuvans (FCA). 
Challenge was performed 7 days after the induction treatment with 0.02 ml of the solution of 
2-EHA in acetone: olive oil (4:1). The animals showed positive skin reactions after treatment 
with 0.2% and 0.8% 2-EHA already 7 days after the last treatment (Parker and Turk, 1983).  
There is no information available on the potential for 2-EHA to produce respiratory sensitisation 
in animals.  
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4.1.2.5.2 Studies in humans 
Seven male volunteers developed an allergic contact dermatitis to an acrylic based adhesive. All 
subjects were strongly positive to 2-EHA and three of the subjects were also strongly positive to 
N-tert.-butyl maleamic acid. Test concentrations were 5% in olive oil and 1% of n-tert.-butyl 
maleamic acid in petrolatum (Jordan, 1975). 
A 51-year-old engineer developed hand eczema after contact to products used as anaerobic 
sealants in metal manufacturing. Positive test reactions were seen with the main component 
polyethylenglycoldimethacrylate but also with several other acrylates and methyacrylates 
including ethylhexyl acrylate. The test concentration was 0.5% in ethanol (Senff et al., 1992). 
Four patients developed dermatitis from working with UV-cured inks in printing plants. Patch 
tests with multifunctional acrylate monomers yielded positive results with various acrylates, 
including ethylhexyl acrylate in two patients (Björkner and Dahlquist, 1979). 
Six patients developed contact dermatitis to various acrylates after exposure to tape or glues. All 
patients tested positive to various acrylates. One of these patients developed eczema after 
surgery. The wound had been dressed with a tape, and the eczema was strictly localised under 
the tape. Positive patch test reactions were seen for 2-ethylhexyl acrylate (2% in petrolatum) and 
two other acrylates (Daecke et al., 1994). 
A 51-year-old man with a limb prothesis developed contact sensitivity in the area of the 
amputation stump and in other areas after readjustment of the prothesis to have it revarnished. 
He reacted positive to numerous (Meth)acrylates including 2-ethylhexyl acrylate (test 
concentration: 0.1% in petrolatum) (Romaguera et al., 1990). 
The evaluation of health surveillance examinations since 01.01.1989 in about 900 employees 
potentially exposed to 2-EHA in 5 different plants did not show any cases of sensitisation or 
allergic contact dermatitis. This was explained by the fact that according to the hazardous 
properties of the substance technical measures and personal protective equipment were applied 
(BASF AG, 2001). 
Among 13,833 patients suspected of contact dermatitis examined during the years 1978-1999 
occupational contact allergy to (meth) acrylates was diagnosed in 31 patients. Contact allergy to 
20 different (meth) acrylates was diagnosed. The three most common sensitisers were 
ethylenglycol dimethacrylate (17 positive patch tests), 2-hydroxyethyl methacrylate (14 positive 
patch tests) and triethyleneglycol dimethacrylate (6 positive patch tests). Based on these 
evaluations 2-ethylhexyl acrylate (test concentration 0.5% in petrolatum) was not listed as an 
important occupational contact allergen (Geukens and Gossens, 2001). 
There is no information available on respiratory sensitisation.  
4.1.2.5.3 Conclusion 
The contact sensitisation potential of 2-EHA was demonstrated in various test models involving 
guinea pigs. It was concluded that 2-EHA has moderate sensitising potential in experimental 
animals, and sensitisation in humans has also been reported. Information on respiratory 
sensitisation is not available. According to the data 2-EHA is classified with R 43 (May cause 
sensitisation by skin contact).  
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4.1.2.6 Repeated dose toxicity 
4.1.2.6.1 Studies in animals 
Inhalation studies 
In a valid 90-day inhalation study (BASF, 1989) Wistar rats were administered in a whole-body 
exposition on 6 hours per day, 5 days per week, to 2-EHA vapour at concentrations of 0 ppm, 
10 ppm, 30 ppm or 100 ppm (approximately 0.075 mg/l, 0.225 mg/l or 0.750 mg/l for the 
treatment groups) (2-EHA purity 99.7%). The study design was conducted according to OECD 
413 (1981). Compared to the actual version of the test guideline, validity is restricted in that food 
consumption was not recorded, lung tissues were not perfused, and laryngopharynx was not 
examined. Histopathologic examination was carried out on 31 organs/tissues of high dose and 
control animals. The lungs, nasal cavity, thyroid and parathyroid glands, trachea and liver from 
all animals/all test groups were subjected to histopathology examination.  
There were no treatment-related premature deaths. During exposure period animals of the high 
and mid dose groups exhibited lethargy and ptosis. Body weight gain was lower in both sexes of 
the high dose during and at the end of the study. A transiently reduced body weight gain was 
observed in mid dose females. From day 21 onwards mean body weight (absolute) was lower in 
high dose males compared to the control group. This parameter was not significantly altered in 
any other group at any time point during the study. Activities of ALAT and alkaline phosphatase 
were elevated in high dose females. In high dose males and females lower levels of total protein, 
albumin and glucose were demonstrated. Reduced protein and albumin values were also seen in 
each sex of the mid dose groups.  
Absolute liver weight was reduced in high dose males and relative adrenal weights were lower in 
high dose males and females compared to the control groups. The microscopic examination 
revealed no lesion other than a focal or diffuse degeneration of the olfactory epithelium of the 
cranial nasal cavity in animals of both sexes of the high and mid dose groups. All rats of the 
100 ppm group showed degeneration of the olfactory mucosa in the anterior part of the nasal 
cavity. The incidence of degeneration of the olfactory mucosa but not the severity was increased 
in mid dose rats. No treatment-related lesion of the nasal cavity was diagnosed at the low dose 
level.  
Degeneration of the olfactory epithelium was characterised by a reduction of cell layers, 
reduction or loss of apical cytoplasmic structures such as olfactory knobs and microvilli, and by 
necrosis. Identification of the remaining olfactory mucosa cells was not possible. Occasional 
mitosis were present.  
In detail, degeneration of the olfactory mucosa was diagnosed in the anterior part of the nasal 
turbinates (level 1) in all high dose rats and in four males and four females of the mid dose 
group. At the high dose level, the degeneration affected the olfactory mucosa diffusely in the 
dorsal and dorsolateral area, and the severity was mainly moderate. Mid dose animals showed 
small areas of degeneration of the dorsolateral olfactory mucosa of minimal severity. At level 2 
of the turbinates, degeneration was diagnosed in all high dose rats, one mid dose male, two 
female and one female of the low dose group, and in one control group male. In the high dose 
group, the degeneration was diffuse in the dorsal and dorsolateral region, whereas in the other 
groups the degeneration was focal. The severity was minimal to marked in the high dose group, 
and mainly minimal in the other groups. Slight degeneration of the olfactory mucosa of the level 
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3 was only diagnosed in one male and one female each of the high dose group. 2-EHA induced 
no lesions of the trachea and the lungs, data of the pharynx/larynx were not available.  
Table 4.7    2-EHA induced olfactory degeneration in rats from a 90-day inhalation study (BASF, 1989) 
Dose group Control 10 ppm 30 ppm 100 ppm 
Sex M F M F M F M F 
 
No. of animals  10 10 10 10 10 10 10 10 
Level 1 (anterior)     4 4 10 10 
Mean severity 
grade 
    1 1 2.9 3.1 
Level 2 1  2 1 1  10 10 
Mean severity 
grade 
1  1 1 2  2.9 2.5 
Level 3        1 1 
Nasal cavity 
Mean severity 
grade 
      2 2 
Grading used 1 = minimal, 2 = slight, 3 = moderate, 4 = marked; M = male, F = female 
Treatment-related microscopic lesions outside the respiratory tract were seen in the liver. Fatty 
change (at low and medium severity grades a common finding in well fed rats) occurred in rats 
of all dose groups and control groups. In high dose males, the severity of fatty change was less 
compared to other groups and the control. The mean severity grades of lipid accumulation in the 
periportal zone of the liver lobus decreased from 2.6 in control males to 1.0 in the high 
concentration males, a minimal change was also seen in high concentration females (1.0 versus 
1.6 in controls). No indication of a peroxisomal proliferation was evident in electron microscopy.  
No treatment-related effects were evident at the low dose group.  
Reduced body weight gain, lower levels of parameters of the protein metabolism, the reduced 
serum glucose concentration and the reduced lipid accumulation in liver cells were assumed to 
be induced by a lower food consumption possibly resulting from the irritation effect on the 
respiratory tract of exposed animals. Similar findings were reported from repeated dose 
inhalation studies on acrylic acid (BASF, 1987). Although this study did not include food 
consumption measurement to verify this assumption, the above mentioned effects were not 
considered to represent relevant toxic effects. In high dose groups, a minimal liver damage was 
indicated by elevated activities of transaminase and alkaline phosphatase. This effect was 
considered to be the only systemic one of toxicological significance. In conclusion, the NOAEC 
for local effects on the respiratory tract was considered at 10 ppm, whereas the NOAEC for 
systemic toxic effects was 30 ppm. 
In an early inhalation study (Gage, 1970) two male and female rats exposed on 13 days 
(6 hours/day) to saturated 2-EHA vapour (1 mg/l, 130 ppm) showed initial weight loss, lethargy 
and slight respiratory difficulty. Any abnormality was found in blood and urine tests, and at 
autopsy. No other details were available.  
Dermal studies 
In a less documented study on the skin effects of 2-EHA on two mice strains after 3-month 
epicutaneous application it was shown that skin irritation was more severe in C3H than in NMRI 
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mice (BASF, 1986). 10 male C3H mice and 5 male NMRI mice were administered to 25 µl 
2-EHA solution (86.5% 2-EHA in acetone) on the clipped dorsal skin (approximately 
1,081 mg/kg bw/day, based on mouse body weight of 20 g) at three days per week, additionally 
5 NMRI mice were treated with a 21% solution of 2-EHA in acetone (approximately 
262 mg/kg bw/day), 10 male NMRI mice treated with acetone served as controls. Clinical 
symptoms, mortality and body growth were recorded. Macroscopic skin effects were reported 
from all C3H mice and five of the NMRI mice of all other groups. Histopathological 
examinations were restricted to the skin of the application area and of tissues with macroscopic 
abnormalies of 5 animals of each group. 
No other clinical abnormalities other than crust formation in 10/10 C3H mice and reddening in 
2/5 NMRI mice at the application site at 2-EHA concentration of 86.5% were observed. 
Epidermal hyperplasia was found in some C3H mice but not in the NMRI strain at 2-EHA 
concentrations of 86.5%. A condensation of the subcutis was reported for both strain at this 
concentration. No clinical or microscopic lesions were observed in NMRI mice treated with 21% 
2-EHA and in vehicle control mice. With respect to local effects on the skin, a NOAEL of 25 µl 
of a solution containing 21% 2-EHA in acetone (262 mg/kg bw/day) administered on three 
days/week during 3 months was delivered for the NMRI mice. No conclusion on a systemic 
NOAEL can be drawn from this study. 
Chronic irritative skin damage was noted in mice of a carcinogenicity study treated by dermal 
application of 2-EHA in acetone on weekly clipped interscapular region (Wenzel-Hartung et al., 
1989; Brune and Deutsch-Wenzel, 1986, see Section 4.1.2.8 and Table 4.16). No data on the 
size of treated area were reported, 10% of the total body surface area can be used as a default 
assumption. Groups of 80 C3H/HeJ mice received 25 µl 2-EHA solution with 2.5%, 21% and 
86.5% (corresponding to 1,081, 262 or 31 mg/kg/treatment day, calculation basis: 20 g bw at 
study begin) on 3 times/week during life time or served as controls (untreated control and vehicle 
group). An additional group was treated with a 43% solution during 24 weeks and was observed 
until end of life (stop-test). Beginning within the first few weeks scaling, and/or scabbing were 
observed at all dose levels. Lesions observed in animals treated with 2.5% showed a trend to 
regression after weeks 4 and 5 of treatment. Whereas regression of the skins lesions occurred 
within 7 weeks after termination of the treatment with 43% 2-EHA solution, further skin lesions 
developed in the 21% and 86.5% groups. At the end of study, numbers of animals with 
histological findings at the application site were: 
Table 4.8    Skin examinations of different groups of mice treated with a solution of 2-EHA 
 2-EHA-dose 
 86.5% 43%* 21% 2.5% Acetone 
control 
Untreated 
control 
Hyperplasia grade 1 35 5 21 6 - - 
Hyperplasia grade 2 23 1 25 - - - 
Hyperplasia grade 3 6 - 6 - - - 
Hyperkeratosis 66 4 54 7 1 - 
Scabbing 23 5 41 11 1 - 
Thickened subcutis 68 37 56 79 - - 
Pigmentation in subcutis 72 10 54 42 - - 
* Stop-test;  
Grading used: 1 mild, 2 moderate, 3 severe. 
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There are no repeated dose studies with oral application.  
4.1.2.6.2 Studies in humans 
No data available.  
Other information  
Toxic effects of 2-EHA with repeated application via the inhalation route at doses > 30 ppm 
(0.225 mg/l) were comparable to the effects of acrylic acid in 90-day inhalation studies at doses 
>75 ppm (0.221 mg/l). Further information; see risk assessment report acrylic acid.  
No-observed-adverse-effect-level (NOAEL) 
NOAEC for local effects on the respiratory tract 
10 ppm (and 0.075 mg/l), 90-day inhalation, rats (BASF, 1989)  
NOAEC for systemic toxic effects 
30 ppm (and 0.225 mg/l), 90-day inhalation, rats (BASF, 1989)  
LOAEL for local effects on the skin 
25 µl 2-EHA solution (2.5% 2-EHA in acetone) (31 mg/kg bw/day), dermal lifetime study 
(3 days/week), mice (Wenzel-Hartung, 1989) 
4.1.2.6.3 Conclusion 
The relevant toxic effect after 90-day inhalation exposure of rats to 2-EHA was dose-related 
increased degeneration of the olfactory epithelium at concentrations from 30 ppm and higher 
(0.225 mg/l). The NOAEC for local effects on the respiratory tract was 10 ppm (0.075 mg/l). 
Animals exposed to 2-EHA concentrations of 30 ppm or higher showed poor health condition 
(lethargy, ptosis) during exposure period and reduced body weight gain, but no toxic effect on 
internal organs was identified (NOAEC for systemic effects). Minimal liver damage was 
indicated by elevated liver enzyme activities at a concentration of 100 ppm (0.75 mg/l). Valid 
studies with dermal or oral application routes are not available. Cancer studies and less 
documented subchronic studies with dermal application revealed that 2-EHA causes skin 
irritation at concentrations > 2.5% (LOAEL).  
4.1.2.7 Mutagenicity 
In vitro studies 
Bacterial systems 
Two bacterial gene mutation assays were negative in doses up to 10,000 µg/plate with and 
without S-9 mix in Salmonella typhimurium strains TA 98, TA 100, TA 1535 and TA 1537 
(Scribner and O'Neill, 1979; Zeiger et al., 1985).  
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Table 4.9    Mutagenicity-In vitro tests: bacterial systems 
 Concentration range  
Test system With S-9 mix Without S-9 mix Result Remarks Rreference 
Salm. Typh. TA98, TA100, 
TA1535, TA1537  
up to 5 µl/plate up to 5 µl/plate neg  Scribner and O'Neill, 
1979 
Salm. Typh. TA98, TA100, 
TA1535, TA1537  
up to 10'000 g/plate up to 10,000 µg/plate neg rat and hamster 
liver S-9 mix 
Zeiger et al., 1985 
In vitro studies 
Chromosomal aberration and micronucleus tests  
In mouse lymphoma cells, parallel investigation of structural chromosomal aberrations and 
micronuclei was performed by Dearfield et al. (1989). Treatment with doses of 20, 25, 31 and 
34 µg/ml 2-EHA was done for 4 hours, only without S-9 mix. All treatments resulted in strong 
cytotoxicity (27, 16, 12 and 12% relative survival).  
For analysis of chromosomal aberrations, cultures were exposed to BrdUrd after treatment and 
were sampled 14 to 15 hours after start of treatment. This was to enable the selection of 
1st-division mitoses for analysis; however, co-treatment with BrdUrd, which is a genotoxin, is 
not recommended by the guidelines and makes findings difficult to interpret. No more than 
100 mitoses were analysed per experimental point. Aberration frequencies in treated cultures 
varied from 5 to 9% (negative control, 4%). Given the various methodological insufficiencies, 
the findings are evaluated as inconclusive.  
For analysis of micronuclei, cultures were exposed to cytochalasin B (3 µg/ml) after treatment; 
sampling was 16 to 17 hours after start of treatment; 1,000 cells were analysed per experimental 
point. The micronucleus frequency was 1.2% in the negative control and varied from 0.8 to 1.1% 
in the treated cultures, i.e. the result was negative.  
In conclusion, there is no relevant evidence for clastogenicity of 2-EHA; a fully reliable finding, 
however, is lacking. 
Table 4.10  Mutagenicity-In vitro tests: chromosomal aberrations and micronuclei 
 Concentration range  
Test system With S-9 
mix 
Without S-9 
mix 
Result Toxicity  Remarks Reference 
chrom. Ab. in mouse 
lymphoma cells 
 20-34 µg/ml inconcl strong toxicity at all 
tested doses 
various 
methodological 
insufficiencies 
Dearfield et al., 
1989 
Micronuclei in mouse 
lymphoma cells 
 20-34 µg/ml negative strong toxicity at all 
tested doses 
 Dearfield et al., 
1989 
In vitro studies 
Mammalian cell gene mutation test  
Two mouse lymphoma assays and two HPRT tests with CHO cells were performed.  
Cifone and Myhr (1984) reported on a mouse lymphoma assay which was weakly positive at 
doses in the toxic range. Doses of 15.6 to 150 nl/ml (with S-9 mix from Aroclor-induced rat 
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livers) or 1.95 to 60 nl/ml (without S-9 mix) were tested in a 4-hour treatment. Effects were 
slightly more pronounced with S-9 mix. Here, combining the data from two experiments, more 
than a doubling of the mutation frequency was achieved at doses ranging from 70 to 150 nl/ml, 
increases were 2.2- to 4.6-fold and were accompanied by moderate to strong cytotoxicity 
(relative growth varied from 4.8 to 54.6% without clear dose-dependency).  
Without S-9 mix, combining the data from 3 experiments, more than 2-fold increases in mutation 
frequencies were obtained for doses of 15.6 to 60 nl/ml, maximum increase was 2.9-fold at the 
highest dose with only 8.5% relative survival.  
Another mouse lymphoma assay, with 4-hour treatment only without S-9 mix, was reported by 
Dearfield et al. (1989). Slightly positive effects were obtained in high doses with strong 
cytotoxicity. Doses of 30, 31, 32, 33 and 34 nl/ml were tested in three independent experiments; 
according to combined data, mutation frequencies increased by factors of 1.6 to 1.9 without 
dose-effect relationship; relative survival ranged from 11 to 20.3%.  
Two investigations were done on induction of HPRT mutations in CHO cells. 
According to Slesinski et al. (1980) 2-EHA does not induce HPRT mutations after 5-hour 
treatment with or without S-9 mix. Doses of 3.13 to 50 . 10-5% (v/v; with S-9 mix) or 6.25 to 
100 . 10-5% (without S-9 mix) were used; the maximum doses correspond to 5 and 10 nl/ml; 
only minor toxicity was seen.  
In a 2nd investigation, cells were treated with doses of 5 to 80 µg/ml (monolayer assay) or 14 to 
26 µg/ml (suspension assay) in the absence of S-9 mix (Moore et al, 1991). Whereas the 
suspension assay was clearly negative for all tested doses up to extreme toxicity, sporadic 
increases in mutation frequency were seen in the monolayer assay. In a 1st experiment, weak 
effects were seen at doses of 35 and 40 µg/ml which led to less than 20% relative survival. In the 
2nd experiment doses of 60 and 70 µg/ml resulted in increased mutation frequencies, toxicity was 
moderate (33% relative survival). Higher doses of 75 and 80 µg/ml were negative (40 and 7% 
relative survival).  
In conclusion, 2-EHA seems to have a low potential for induction of gene mutations in 
mammalian cells. Since the genetic effects were limited to doses with strong cytotoxicity, the 
potential will probably not be expressed in vivo.  
Table 4.11  Mutagenicity-In vitro tests: mammalian cell gene mutations 
 Concentration range  
Test system With S-9 
mix 
Without S-
9 mix 
Result Toxicity  Remarks Reference 
Mouse 
lymphoma 
assay 
15.6-150 
nl/ml 
1.96-60 
nl/ml 
weakly 
positive 
strong toxicity at 
high doses 
genetic effects were limited to 
doses with strong cytotoxicity 
Cifone and 
Myhr, 1984 
Mouse 
lymphoma 
assay 
 30-24 nl/ml weakly 
positive 
strong toxicity at 
all doses 
genetic effects were limited to 
doses with strong cytotoxicity 
Dearfield et al., 
1989 
HPRT test with 
CHO cells 
up to 5 nl/ml up to 10 
nl/ml 
negative minor toxicity  Slesinski et al., 
1980 
HPRT test with 
CHO cells 
 5-80 µg/ml weakly 
positive 
strong toxicity at 
high doses 
negative in a suspension 
assay; weakly positive in a 
monolayer assay for cytotoxic 
doses  
Moore et al., 
1991 
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In vitro studies 
Mammalian cell indicator tests 
Slesinski et al. (1980) reported on a weak positive effect in an SCE test with CHO cells after 
2-hour treatment in the presence of S-9 mix; without S-9 mix a negative finding was described 
for 5-hour treatment. Doses ranging from 3.1 to 100 . 10-5 % (v/v; 0.31 to 10 nl/ml) were tested. 
Due to severe methodological insuffiencies, these results are not reliable (extremely high 
‘spontaneous’ SCE frequencies in negative controls of 13 to 18 SCE per cell; only 15 cells per 
entry were analysed in a single experiment). 
A test for induction of unscheduled DNA synthesis (UDS) with primary rat hepatocytes was 
performed with the ‘liquid scintillation counting’ methodology which is known to be quite 
insensitive (Slesinski et al., 1980). A single experiment was conducted. The overall result for this 
test was negative for doses up to 100 . 10-5 % (10 nl/ml).  
In conclusion, the data from mammalian cell indicator tests do not add relevant information.  
Table 4.12  Mutagenicity-In vitro tests: Mammalian cell indicator tests 
 Concentration range  
Test system With S-9 
mix 
Without S-9 
mix 
Result Remarks Reference 
SCE test with 
CHO cells 
0.31-10 
nl/ml 
0.31-10 
nl/ml 
weakly 
positive  
weak effects with S-9 mix; severe 
methodological insuffiencies 
Slesinski et al., 1980 
UDS test with rat 
hepatocytes 
 up to 10 
nl/ml 
negative insensitive LSC methodology Slesinski et al., 1980 
In vivo studies 
Bone marrow chromosomal aberration test 
The possible induction of chromosomal aberrations in vivo was investigated in bone marrow 
cells of male Charles River CD-1 mice (Sames et al., 1984). Oral doses of 2,500mg/kg 
bodyweight were given acute or repeatedly on 5 consecutive days; toxic signs were seen. 
Sampling was 6 hours, 24 hours and 48 hours after single treatments and 6 hours after the last 
repeated application; treatment groups consisted of 5 animals each. At the 24 hours sampling 
after acute treatment an aberration frequency of 2.2% was obtained which differed in a 
statistically significant manner from the concurrent negative control, but not from the historical 
negative control. Since no more than 272 metaphse cells were analysed in this group, a 
biologically meaningful conclusion cannot be drawn from this finding. Furthermore, the whole 
investigation suffers from the drawback that less than 50 cells were analysed for 24 out of 
72 animals, indicating severe methodological problems. Therefore, the overall result is 
inconclusive.  
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Table 4.13  Mutagenicity-In vivo tests: bone marrow test 
Test 
system 
Doses Expos. 
regimen 
Sampl. 
Times 
Result Local 
cyto-
tox. 
General 
toxi-city 
Remarks Reference 
chrom. 
ab. test 
with mice 
2,500 
mg/kg 
a) acute; 
b) 5 daily 
administratios 
a) 6, 24, 48 hours 
b) 6 hours after 
last administration. 
inconcl no yes severe 
methodologica
l problems 
Sames et al., 
1984 
Genotoxicity data on 2-EHA cleavage products 
Acrylic acid (CAS no. 79-10-7) was negative in bacterial mutations tests (Cameron et al., 1991; 
Zeiger et al., 1987; BASF, 1977) and in an HPRT mammalian cell gene mutation test (McCarthy 
et al., 1992). Positive effects were obtained in mammalian cell chromosomal aberration tests 
(McCarthy et al., 1992; Moore et al., 1988; Ishidate, 1988) and in mouse lymphoma assays (with 
preferential induction of small colonies, indicating clastogenicity; Cameron et al., 1991; Moore 
et al., 1988). In vivo, negative results were reported for structural chromosomal aberrations in 
mouse bone marrow cells and for a mouse dominant lethal test (McCarthy et al., 1992). 
2-Ethylhexanol (CAS no. 104-76-7) was negative in bacterial and mammalian cells assays 
(Kirby et al., 1983) and an in vivo bone marrow cytogenetic assay (Putman et al., 1983). 
Table 4.14  Mutagenicity-OVERVIEW ON FINDINGS 
Negative effects Inconclusive Positive effects 
In vitro tests 
Bacterial mutations chromosomal aberrations  
micronuclei gene mutations in mammalian cells at 
cytotoxic doses 
 
 SCE, UDS  
in vivo tests 
 chromosomal aberrations  
4.1.2.7.1 Conclusion 
2-EHA is negative in bacterial mutation tests. Data from mammalian cells give no relevant 
evidence for clastogenicity; however, a fully reliable study is lacking. 2-EHA seems to have a 
low potential for induction of gene mutations in mammalian cells. Since this effect is limited to 
doses with strong cytotoxicity, it is highly unlikely that this potential will be expressed in vivo. 
The data from mammalian cell indicator tests do not add relevant information. An in vivo 
cytogenetic assay was inconclusive (neither positive nor negative); due to severe methodological 
insuffiencies this study cannot be used for evaluation purposes. Cleavage products of 2-EHA 
were negative in in vivo mutagenicity tests. 
Since a fully reliable in vitro chromosome abberration test is lacking, it might be argued that the 
minimum requirements for genotoxicity testing are not met. However, the number of studies 
available from various test systems and the negative data on 2-EHA cleavage products 
2-ethylhexanol and acrylic acid are regarded as a sufficient substitute. From all these data there 
is no relevant evidence that 2-EHA might be an in vivo mutagen.  
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4.1.2.8 Carcinogenicity 
There are dermal carcinogenicity studies in mice, summarised in Table 4.16, but no cancer 
studies with oral or inhalative application route.  
In an early dermal life-time carcinogenicity study (DePass et al., 1985; DePass, 1982; Peterson, 
1979; Slesinski et al., 1980) 40 male C3H/HeJ mice were treated 3 times/week with 2-EHA 
(75% w/v) dilution in acetone at an average dose of 20 µg 2-EHA/application (approximately 
750 mg/kg bw/day). 6 of 40 treated males developed neoplastic skin lesions. Four males had 
squamous cell papillomas and two others had squamous cell carcinomas. One out of 40 animals 
of the vehicle control group developed a skin carcinoma near the eye. The authors concluded that 
2-EHA is carcinogenic in C3H mice.  
The study is less reliable due to the method defaults. Only 40 males were investigated, 
exclusively gross lesions of skin and internal organs were examined histologically. Several 
tumours were documented grossly and most of them were examined histologically. Peterson 
(1979) reported several cases of chronic nephritis in 13 of 19 kidneys examined and 
necropurulent nephritis in several cases. Survival rate after one year of treatment was reduced 
(75%); the first skin tumour was seen at 11 months of treatment. At 18 months only 15/40 male 
and at 24 months none of them were still alive. As skin tumours were seen in a total of 
6/40 mice, the cause of premature deaths remained unclear. Furthermore there were no data on 
irritative skin effects due to the treatment, histopathology of the skin were reported from seven 
males only. Tumours in non-cutaneous tissues were reported to be comparable between treated 
and control groups, however tumour data in internal organs were insufficient.  
In order to confirm the preliminary findings of the above cited study a further study with the 
same strain, sex and 2-EHA-concentration was done, two additional dose groups were tested 
(Wenzel-Hartung, 1989; Brune and Deutsch-Wenzel, 1986). In this carcinogenicity study 25µl of 
2-EHA (86.5%, 21%, or 2.5% solution in acetone, approximately 1,081, 262, 31 mg/kg bw/day) 
was applied 3 times/week to the clipped dorsal skin of male C3H/HeJ mice (80 per group) over 
their lifetime. Another group was treated with a 43% 2-EHA solution for 24 weeks and thereafter 
observed for lifetime (stop-test). An untreated group and acetone group served as controls. Body 
weight, clinical symptoms, and skin irritation were recorded. Gross lesions and the dorsal skin 
were fixed. The skin tissue from the application site was the only tissue that was examined 
histologically. Body weight was increased in all dosed groups; the survival time was comparable 
to that of the control groups. Treatment-related scale and eschar formation indicative of skin 
irritation were found in all 2-EHA groups beginning after the first few weeks of treatment. The 
subcutis was thickened and sometimes pigmented. The cutis showed hyperkeratosis, hyperplasia 
and scabbing in the 86.5% and 21% dose groups and with smaller incidence in the 43% and 
2.5% groups. The observed skin changes were reversible in the 2.5% group after the 11th week of 
treatment and in the 43% group of the stop test immediately after treatment was stopped. Only in 
the 86.5% and 21% test groups papillomas of the skin were found and in a large percentage of 
animals cornified squamous cell carcinomas, melanocarcinomas and fibrosarcomas were 
identified without any dose dependency. No skin tumours were found in the control groups, in 
the groups treated with 2.5% 2-EHA for lifetime or in the group treated with 43% 2-EHA for 
about 6 months and observed for lifetime. Hepatic tumours were found in more than half of the 
mice of each dose group and control groups without any relation to treatment. Histologic 
examination of other organs was less extensive. The authors concluded that irritative skin lesions 
were precursors of the neoplasia. From this dermal lifetime study a LOAEL for local 
nonneoplastic effects on the skin was 25 µl 2-EHA solution at a concentration of 2.5% 2-EHA in 
acetone was derived (31 mg/kg bw/day). Incidences for skin tumours in animals were as follows: 
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Table 4.15  Incidences for skin tumours in animals 
Number of animals with skin tumours 2-EHA-dose 
Tumours 86.5% 43%* 21% 2.5% Acetone control Untreated control 
Papilloma 8 - 4 - - - 
Papilloma with strong cornification 2 - 1 - - - 
Cutaneous horn  2 - 1 - - - 
Haemangioma 1 -  - - - 
Basal cell carcinoma  - 1 - - - 
Corinified squamous-cell carcinoma 16 - 20 - - - 
Malignant melanoma 9 - 7 - - - 
Fibrosarcoma - - 5 - - - 
* Stop-test 
2-EHA was also tested for carcinogenicity in male NMRI mice exposed dermally 3 times/week 
to 25 µl of 21.5%, 43%, or 85% 2-EHA (w/w) diluted in acetone (approximately 269, 538 and 
1,063 mg/kg bw/day). 39-40 of 80 males tested were treated with 2-EHA alone, acetone (solvent 
control) or 0.015% (w/w) of benzo(a)pyrene in acetone (positive control, results were not 
reported here) for up to 24 months (BASF, 1992). Two animals of each group were killed at 
week 13 to examine the skin lesions. Nearly half of the animals (30-39 males) of each dose and 
control groups were treated as above for 7 months, after a treatment-free period of two months 
animals were treated with a promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA), for 
20 weeks. Thereafter there was no further treatment until the end of the study. Histopathology 
data were reported on the treated skin of all test animals and on the untreated skin area of 
5-10 animals per group. Other organs/tissues were not included in histopathology examinations. 
Whereas premature deaths were seen in the benzo(a)pyrene control group no treatment-related 
effect on mortality was observed in the 2-EHA groups. Neither 2-EHA nor the promoter TPA 
caused clinical signs besides the skin effects. Treatment-related lesions of the treated skin region 
were observed after 13 weeks and after 24 months in all 2-EHA groups. Some findings as 
hyperkeratosis, hyperplasia, crust formation and ulceration increased in severity or incidence 
related to the doses of 2-EHA, others (lymphocyte/macrophage infiltration, dermal fibrosis) were 
observed without any relation to the treatment groups. Reddening and thickening of the skin and 
similar microscopic skin lesions were reported during the promoter-phase. The authors 
concluded an irritative effect of the promoter TPA itself.  
6/41 animals of the acetone group showed mild clinical symptoms (hyperkeratosis, hyperplasia, 
ulceration or lymphocytic/macrophage infiltrations).  
None of animals treated with 2-EHA for up to 24 months showed a neoplastic lesion of the skin. 
2-EHA and TPA promotion caused a squamous cell papilloma in one animal in each dose groups 
(of 30, 39, and 36 animals). One squamous cell papilloma was found in untreated skin of one 
male out of 41 of the acetone group.  
The authors concluded that these tumours were related to the irritative effects of TPA, not to the 
treatment with 2-EHA. The LOAEL for nonneoplastic toxic effects of 2-EHA on the skin was 
25 µl 2-EHA solution at a concentration of 21.5% 2-EHA in acetone (269 mg/kg bw/day). 
The findings did not indicate a carcinogenic potential of 2-EHA on the skin of male NMRI mice.  
CHAPTER 4. HUMAN HEALTH 
 61 
Other information 
Carcinogenicity data from cleavage products, acrylic acid and 2-ethylhexanol, were 
supplemented: 
Cancer data from one oral rat study and two dermal mice studies (without conformance to 
requirements of the actual carcinogenicity testing protocols) using acrylic acid as test substance 
were considered.  
In a valid carcinogenicity study (BASF AG, 1989; Hellwig et al., 1993) Wistar rats were 
administered to doses of 120, 400 or 1,200 ppm (mean substance uptake 9, 31, or 
88 mg/kg bw/day) acrylic acid (99%, stabilised with 200 ppm hydroquinone monomethylether) 
in the drinking water for 26 months (males) or 28 months (females). Except a slightly reduced 
water consumption of high dose males and females no treatment-related clinical, hematological 
or histopathological changes were detected in comparison with the controls. The incidence and 
organ distribution of tumours found in the groups treated with acrylic acid did not differ from 
those of the controls (Table 4.17).  
In a dermal carcinogenicity study no tumour of the skin or subcutis were induced in treated mice 
or in the vehicle controls. (Intercompany Acrylate Study Group, 1982 (Table 4.18). A group of 
40 C3H/HeJ male mice received 25 µl applications of acrylic acid as 1.0% (v/v) dilutions in 
acetone. A negative control group received acetone only. The substances were applied to the skin 
of the back three times weekly for the lifetime of the animals. Histologic examination was 
performed on the dorsal skin of all treated mice and on gross lesions. The mortality rate was not 
affected by treatment (mean survival time in the acrylic acid group 515 days, in the acetone 
group 484 days). No signs of skin irritation were observed. One male of the acrylic acid group 
had an epidermal hyperplasia.  
In another dermal carcinogenicity study 25 or 100 µl of 1% (v/v) acrylic acid in acetone was 
administered to two strains of mice (C3H/HeN Hsd BR, Hsd:(ICR)BR) during 21 months 
(3 times/week). Histopathology was done on the skin, some internal organs and every unusual 
gross lesion. No treatment-related signs of skin irritation, toxicity, clinical signs or skin tumours 
were observed. There was no treatment-related effect on body weight gain or mortality rate. 7/50 
female C3H-mice of the 100 µl acrylic acid treated group revealed a significant increased 
frequency of lymphosarcoma compared to the acetone control group (BAMM, 1990, 1991; 
TSCATS, 1990, 1992a, 1992b) but lymphosarcomas are commonly seen in most strains of mice 
which are 18-24 months of age (Frith and Wiley, 1981) and their relation to the treatment was 
considered to be uncertain.  
2-Ethylhexanol is known as peroxisome proliferator in animals, however this mechanism of 
tumour growth is considered not to be significant for humans. Results from long-term studies in 
rats and mice (EPA, 1992a, b) did not indicate that 2-ethylhexanol is carcinogenic in animals. 
Arneson et al (1995) reported that the US-National Toxicology Program nominated 
2-ethylhexanol for further cancer studies.  
4.1.2.8.1 Summary and conclusion  
The carcinogenic potential of 2-EHA was tested in skin painting studies on the shaved back skin 
of male mice of different strains. None of the studies was performed according to the current 
regulatory recommendations on the EEC methods B 32 or B 33. The main defaults were that 
exclusively male mice were tested and that the effects on internal organs were not or 
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insufficiently examined and documented resulting in an incomplete database on carcinogenic 
activities after absorption. 
2-EHA induced skin irritation and in nearly half the male C3H/HeJ mice treated dermally with 
2-EHA solutions > 21% benign and malignant skin tumours (Wenzel-Hartung et al., 1989; Brune 
and Deutsch-Wenzel, 1986). Tumour incidence showed no relation to the dosage group of 21% 
or 86.5%. The additional study where treatment of 43% of 2-EHA were stopped at week 24 did 
not reveal any skin tumour. The weight of evidence that the test substance is carcinogenic is 
limited by the occurrence of skin irritation assumed to represent the precursor lesion of tumour 
growth. Repeated regenerative or proliferative reactions to irritative substances are discussed to 
be strongly associated to tumour development (Hasegawa et al., 1989). Even chronic physical 
stimuli such as abrasion in untreated skin were demonstrated to play a role in skin tumour 
induction. In general, dermal carcinogenicity studies should use test substance concentrations 
which did not induce irritative effects. In the BASF study (1986), no tumours were seen in the 
low dose group applicating 2.5% 2-EHA, although transient mild skin irritation was seen up to 
the 11th week of treatment. Contrary to positive cancer studies, skin irritation but no skin tumour 
was found in male NMRI mice treated dermally with 21.5%, 43% or 85% of 2-EHA in acetone 
for 24 months (BASF, 1992). 
Higher incidences of skin tumours were also evident in two other dermal studies in mice. 
However in first study only one dosage (75% 2-EHA in acetone) was tested in C3H/HeJ mice 
where the mortality of unknown cause was markedly increased (94-97) already at one year of the 
treatment period. No clear tumour response was demonstrated in the two-stage carcinogenicity 
model using 2-EHA as the initiator substance and TPA as promoter in the study on NMRI mice 
(BASF, 1992). The negative response in this study may be related to the different strain used in 
this study (NMRI mouse) compared to the C3H/HeJ80 mouse of earlier studies that were 
positive. One skin tumour bearing animal occurred at each dose after 7 months treatment to 
2-EHA and an additional treatment period to the promoter TPA. 2-EHA as well as TPA was 
shown to be irritative to the skin. Both studies were considered to be inadequate to detect the 
presence of carcinogenic effects. 
Skin tumours from spontaneous origin are known to be variable in different mouse strains. One 
out of 41 control animals of the study of BASF (1992) had a squamous cell papilloma at an 
untreated skin area. No other spontaneous skin tumour was reported in the control groups of 
treated and untreated skin areas of the above cited studies.  
From oral (the only study with validity according to the cancerogenicity test guidelines) and 
dermal studies on acrylic acid, the hydrolysis product of 2-EHA, there is no evidence on 
carcinogenic properties. Also, there is no concern from cancer data on 2-ethylhexanol. 
In conclusion, there are no data available to the carcinogenic effects with respect to oral or 
inhalative exposure routes. 
Findings from the dermal mouse carcinogenicity study showed that 2-EHA induces skin tumours 
at concentrations which were highly irritative. It was concluded, that tumour growth is associated 
the highly irritative properties of 2-EHA. At a low concentration of 2.5% 2-EHA with transient 
irritation no tumour response of the skin was observed. Other long-term studies on different 
mouse strains did not confirm tumour induction of the mouse skin. Additionally, there is no 
concern from tumour data of acrylic acid and 2-ethylhexanol, the hydrolysis products of 2-EHA. 
Taking into account the negative results from in-vivo genotoxicity testing, it is concluded that 
2-EHA induces skin tumours by a non-genotoxic mechanisms. Irritative skin damage was 
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identified as presumed mode of tumourigenicity as to was associated with carcinogenic effect of 
2-EHA. Due to the limited reliability of skin painting studies in mice as a tool to identify the 
carcinogenic potential of a test substance these studies give some concern but no clear evidence 
that 2-EHA has carcinogenic potential. Based on limited database from dermal studies and 
absence of carcinogenicity data for the oral and inhalation routes, no conclusion could be drawn 
about the carcinogenic potential of 2-EHA. However taking into account the negative 
experimental results from long term animal studies with the cleavage product acrylic acid after 
oral and dermal application (cf. EU Risk Assessment Report Acrylic acid) there are no reasons to 
assume that 2-EHA should be considered as a carcinogenic substance.  
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 64 Table 4.16  Dermal carcinogenicity studies with 2-Ethylhexylacrylate (2-EHA) 
Species/ 
Strain 
no. of 
animals/sex/ 
group 
Exposure time Treatment 
schedule 
Mortality rate Skin 
irritation 
Skin 
hyperplasia 
Skin tumours Tumour 
response of 
internal organs 
Study design 
according to the 
B32/B33 method 
Reference 
mice/ 
C3H/HeJ 40 
males 
life time 
3x/week 
20 µg of 
 2-EHA (75% in 
acetone) 
increased no data no data squamous cell papilloma/ 
carcinoma in 6/40 males 
no (no exact data) no DePass et 
al.,1985 
DePass ,1982 
Peterson, 1979 
Slesinski et 
al.,1980 
mice/ 
C3H/HeJ 80 
males/ group 
life time 
3x/week 
25 µl of  
 2-EHA (2.5, 21, 
86.5% in 
acetone) 
Ø yes, 
2.5%: 
symptoms 
until week 
11, other 
findings see 
4.1.2.6 
yes squamous cell papilloma/ 
carcinoma, melanoma 
fibrosarcoma in 
21% group:  
39/80 males 
86.5% group 
38/80 males 
no (no exact data) no Wenzel-
Hartung et al., 
1989 
Brune and 
Deutsch-
Wenzel, 1986 
 
mice/ 
C3H/HeJ 80 
males 
24 week 
3x/week, 
thereafter 
observation 
until death 
25 µl of  
2-EHA (43% in 
acetone) 
Ø yes, lesions 
reversible 
no 0/80 males no (no exact data) no Wenzel-
Hartung et al., 
1989 
Brune and 
Deutsch-
Wenzel, 1986  
Table 4.16 continued overleaf 
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Table 4.16 continued  Dermal carcinogenicity studies with 2-Ethylhexylacrylate (2-EHA) 
Species/ 
Strain 
no. of 
animals/sex/ 
group 
Exposure time Treatment 
schedule 
Mortality rate Skin 
irritation 
Skin 
hyperplasia 
Skin tumours Tumour 
response of 
internal organs 
Study design 
according to the 
B32/B33 method 
Reference 
mice/NMRI 39-
40 males/ group 
Life time (max. 
24 months) 
25 µl of 21.5, 
43, 85% 2-EHA 
in acetone 
Ø yes,all doses yes, all doses 0/39-40 males of each 
group 
no data no BASF 1992 
mice/NMRI 30-
39 males/ group 
Life time  
3x/week for 7 
months, 
thereafter 
treatment* 
25 µl of 21.5, 
43, 85% 2-EHA 
in acetone + 
TPA*) 
Ø yes, all 
doses 
yes, all doses squamous cell papilloma 
in 
21.5%+TPA 1/36 males 
43% + TPA 1/39 males 
85%+TPA: 
1/30 males 
no data no BASF 1992 
* Treatment with the promoter O-tetradecanoylphorbol-13-acetate (TPA) for 20 weeks after a 2 months treatment - free period. 
Ø No treatment-related effects on the mortality rate. 
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 66 Table 4.17  Oral carcinogenicity study on Acrylic acid (AA) 
Species/strain 
no. of animals/ 
sex/group 
Exposure time Treatment schedule Mortality rate Treatment- related tumour 
response 
Study design according to the 
B32 / B33 method  
Reference 
rat/ Wistar, 
50/sex/ group 
26/28 months 120, 400, 1,200 ppm AA 
in drinking water 
Ø no yes BASF, 1989 
Ø No treatment-related effects on the mortality rate and mean survival time 
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Table 4.18  Dermal carcinogenicity studies with Acrylic acid (AA) 
Species/strain 
no. of animals/ 
sex/group 
Exposure 
time 
Treatment 
schedule 
Mortality 
rate 
Skin 
irritation 
Skin hyper 
plasia 
Skin tumours Tumour 
response of 
internal organs 
Study design 
according to the 
B32 / B33 method 
Reference 
Mouse/C3H/ HeJ 
40males 
life time 25 µl AA (1% v/v in 
acetone) 
Ø no 1/40 0/40 no no Intercompany  
Acrylate Study 
Group, 1982 
Mouse/ 
C3H/ HeN Hsd BR,  
50/sex/ group 
 
life time 25 or 100 µl AA 
(1% v/v in acetone) 
Ø no 0/50 for each sex 0/50 for each sex 100µl AA: 7/50 
females with 
lympho sarcoma 
no BAMM, 1990 
BAMM ,1991 
Mouse/Hsd: (ICR)BR 
50/sex/ group 
life time 
(86-92 weeks) 
25 or 100 µl AA 
(1% v/v in acetone) 
Ø no 0/50 for each sex 0/50 for each sex no no BAMM ,1990 
BAMM, 1991 
Ø No treatment-related effects on the mortality rate and mean survival time 
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4.1.2.9 Toxicity for reproduction 
4.1.2.9.1 Studies in animas 
Fertility impairment 
There are no generation studies, and fertility studies on 2-EHA available. 
Data on reproductive organ toxicity (testes weights as well as information on gross and 
microscopic pathology for testes, seminal vesicles, ovaries, and uteri can be derived from a 
3 month inhalation study (10, 30, 100 ppm 2-EHA, 6 hours/day, 10 animals/sex/dose level) with 
Wistar rats according to OECD Guideline 413 (BASF, 1989). Respective results from animals 
exposed to the highest dose level of 100 ppm (approximately 0.750 mg/l) did not give evidence 
for any impairment of the investigated reproductive organs of both sexes. 
Developmental toxicity 
Developmental toxicity studies with the oral route of administration are not available. 
2-EHA was investigated during a study on the relative developmental toxicities of a set of 
various acrylates (acrylic acid, methyl acrylate, butyl acrylate, hydroxyethyl acrylate, 
hydroxypropyl acrylate) in Sprague-Dawley rats (Saillenfarth et al., 1999). For the investigation 
with 2-EHA groups of 23 to 25 dams were exposed (6 hours/day, whole-body) to atmospheres 
containing 2-ethylhexyl acrylate (99.7% purity) at 0, 50, 75, and 100 ppm (approximately 0.375, 
0.563, and 0.750 mg/l) during day 6 to day 20 of gestation. From preliminary level-setting 
studies (no details available) a level of 100 ppm 2-EHA had been reported to provide the highest 
reliable vapour concentration. Maternal food consumption was measured for the intervals of g.d. 
6-13 and of g.d. 13-21. Maternal body weights were recorded on g.d. 0, 6, 13, and 21. Dams 
were sacrificed on day 21 of gestation and the uteri were removed and weighed. The number of 
implantation sites, resorptions, and dead and live fetuses were recorded. Uteri, which had no 
visible implantation sites, were stained with ammonium sulfite (10%) for the detection of early 
resorptions. At sacrifice live fetuses were weighed, sexed, and examined for external anomalies 
including those of the oral cavity. Half of live fetuses from each litter were examined for either 
internal soft tissue or for skeletal changes. 
There were no maternal deaths in any of the treatment groups. Dams from the 100-ppm groups 
showed an absolute weight gain of 24+16 g through the period of exposure, which was lower and 
statistically significantly different from that of the concurrent control group (42+11 g). Also food 
intake of 24+3 g food/dam/day through the period of exposure of the 100-ppm group was 
somewhat lower and statistically significantly different in comparison to that of the concurrent 
control group (27+2 g food/dam/day). No adverse effects were observed on the mean number of 
implantation sites per litter and on the mean number of live fetuses per litter in any of the 2-EHA 
exposed groups. The incidences of non-live implants (3.7-6.4%) and of resorption sites per litter 
(3.7-6.1%) in the treated groups were lower than those of the concurrent control (both 10.1%). 
This observation, however, is not considered to be of toxicological significance. Mean fetal body 
weights were slightly lower in the treated groups, however not statistically significantly different 
from that of the concurrent control fetuses. Sex ratio was unaffected. No significant differences 
were observed between the control and the 2-EHA-treated groups in the incidences of gross 
anomalies or of visceral or skeletal malformations or variations.  
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In summary, no embryotoxic, teratogenic or fetotoxic properties of 2-EHA had been revealed 
from this study for concentrations of up to and including 100 ppm. Due to technical limitations 
exposure to higher concentrations could not be tested. Based on slightly reduced food intake and 
lower maternal weight gain at the higher exposure level a NOAEC/maternal toxicity of 75 ppm 
(approximately 0.563 mg/l) is derived from this study. No embryo-/fetotoxic effects were 
revealed even at the highest tested concentration at which some signs of maternal toxicity had 
been observed. Therefore, a NOAEC/developmental toxicity of 100 ppm (approximately 
0.750 mg/l) is derived from this study. 
4.1.2.9.2 Studies in humans 
No data available. 
4.1.2.9.3 Conclusion 
There are no human data available on the reproductive toxicity of 2-EHA. The available data 
base for hazard assessment of toxicity for reproduction from animal testing consists of data from 
a 3 month repeated dose study (rats) and a developmental toxicity study (rats), both with the 
inhalatory route of administration. According to the TGD (Chapter 2, Section 3.12) these data 
should be considered a sufficient investigation of reproductive toxicity of 2-EHA for screening 
purposes. Evaluation of the available screening information so far does not provide evidence for 
significant reproductive toxicity of 2-EHA. For doses up to and including 100 ppm 
(approximately 0.75mg/l) so far no adverse effects on reproductive organs (organ weight, 
histopathology) and on embryo-/fetal development had been observed. 
4.1.3 Risk characterisation 
4.1.3.1 General aspects 
2-Ethylhexyl acrylate (2-EHA) is rapidly and extensively absorbed, distributed and eliminated 
after oral administration. There are no specific toxicokinetic studies using dermal administration 
or exposure by inhalation available. Studies on rats have indicated that short-chain acrylates such 
as 2-EHA undergo carboxylesterase-catalysed hydrolysis to acrylic acid and 2-ethylhexanol.  
Human data on the acute toxicity of 2-EHA are not available. In animal tests, single oral or 
dermal administration or inhalation of saturated atmospheres of 2-EHA demonstrated only low 
toxicity. Acute oral toxicity in rats is characterised by LD50 values of 4,000-6,000 mg/kg with 
slight toxic effects (scant droppings, wet yellow stained anogenital area, decreased spontaneous 
motoric activity and ataxia). For rabbits, a dermal LD50 value > 10,000 mg/kg is reported. Valid 
data on acute inhalation toxicity tests are not available. In a test with rats, after an 8-hour 
inhalation of an atmosphere saturated with EHA at 20°C no mortality and no clinical signs were 
observed. The substance is not to be labelled because of acute toxic effects.  
Information on human experience with local irritation/corrosion caused by 2-ethylhexyl acrylate 
is not available. In animal experiments 2-EHA caused serious lesions to the skin of rabbits which 
are assessed to be situated at the border between severe irritation and corrosion. As an alternative 
to the Draize skin irritation test the new test method according to the EU test Guideline B.40 
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(Skin Corrosion) has been developed for differentiation between irritation and corrosion. The 
result of a new study according to this guideline demonstrates that 2-EHA does not have a 
corrosive potential, and hence, the current classification of 2-EHA as irritant and labelling with 
“R 38, Irritating to skin” is confirmed. 2-EHA caused mild eye irritation in animal experiments. 
On the basis of these tests a labelling with R 36 is not warranted. 
There exists no standard test method for the assessment of respiratory irritation. Thus, the 
labelling of 2-EHA with “R 37, Irritating to respiratory tract” according to current EU 
regulations is not based on results of a specific respiratory irritation test, but on considerations on 
the general irritation potential of 2-EHA (nasal and ocular irritation noted in a test on acute 
inhalation toxicity with rats, severe local irritation potential detected on the skin and moderate 
irritation potential detected on the conjunctivae of rabbits; serious lesions as seen after repeated 
inhalation of 2-EHA may well be initiated i.a. by primary respiratory irritation). Thus, labelling 
with R 37 is confirmed on the basis of all of the respective data.  
Positive patch-tests are reported for humans. In various test models involving guinea pigs, 
2-EHA proved sensitising, with and without adjuvants. 2-EHA has a moderate sensitising 
potential in experimental animals. Information on respiratory sensitisation is not available. 
According to the data 2-EHA is classified with “R 43, May cause sensitisation by skin contact”.  
The relevant toxic effect after 90-day inhalation exposure of rats to 2-EHA was dose-related 
increased degeneration of the olfactory epithelium at concentrations from 30 ppm and higher 
(0.225 mg/l). The NOAEC for local effects on the respiratory tract was 10 ppm (0.075 mg/l). 
Animals exposed to 2-EHA concentrations of 30 ppm or higher showed poor health condition 
(lethargy, ptosis) during exposure period and reduced body weight gain, but no toxic effect on 
internal organs was identified (NOAEC for systemic effects). Minimal liver damage was 
indicated by elevated liver enzyme activities at a concentration of 100 ppm (0.75 mg/l). Valid 
studies with dermal or oral application routes are not available. Cancer studies and less 
documented subchronic studies with dermal application revealed that 2-EHA causes skin 
irritation at concentrations > 2.5% (LOAEL).  
2-EHA is negative in bacterial mutation tests. Data from mammalian cells give no relevant 
evidence for clastogenicity; however, a fully reliable study is lacking. 2-EHA seems to have a 
low potential for induction of gene mutations in mammalian cells. Since this effect is limited to 
doses with strong cytotoxicity, it is highly unlikely that this potential will be expressed in vivo. 
The data from mammalian cell indicator tests do not add relevant information. An in vivo 
cytogenetic assay was inconclusive (neither positive nor negative); due to severe methodological 
insuffiencies this study cannot be used for evaluation purposes. Cleavage products of 2-EHA 
were negative in in vivo mutagenicity tests. Taken together, the number of studies available from 
various tests systems and the negative data on 2-EHA cleavage products are regarded as a 
sufficient substitute for a fully reliable in vitro chromosome aberration test (minimum 
requirements for genotoxicity testing). From all these data there is no relevant evidence that 
2-EHA might be an in vivo mutagen.  
There are no data available to the carcinogenic effects with respect to oral or inhalation exposure 
routes. Findings from the dermal mouse carcinogenicity study showed that 2-EHA induces skin 
tumours at concentrations which were highly irritative. However, other studies on different 
mouse strains did not confirm this finding. Acrylic acid, the hydrolysis product, did not induce 
tumours in mice treated dermally and in rats administered orally. Also, there is no concern from 
cancer data on 2-ethylhexanol. It is concluded that equivocal results from mice painting studies 
give no significant evidence of carcinogenic properties of 2-EHA.  
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There are no human data available on the reproductive toxicity of 2-EHA. From animal testing 
screening information on reproductive toxicity is available from a developmental toxicity study 
supplemented with data on reproductive organ toxicity investigations from a 3 month repeated 
dose study. Evaluation of the available screening information so far does not provide evidence 
for significant reproductive toxicity of 2-EHA. In rats no adverse effects on reproductive organs 
or on embryo/fetal development had been revealed for inhalation exposures to 2-EHA at 
concentrations of up to and including 100 ppm (approximately 0.75 mg/l). 
4.1.3.2 Workers 
4.1.3.2.1 General aspects of occupational risk assessment  
Route specific systemic availabilities 
Systemic availability via different routes has to be considered, since the assessment of inhalation 
and dermal exposure is partly based on studies that were not conducted with the relevant route of 
exposure. 
Concerning the oral route a high systemic availability can be concluded from Section 4.1.2.1. 
Only 1% of C14 labelled 2-EHA was detected in faeces. There is no information available on the 
dermal and inhalation route and as default assumption an equivalent availability is used for risk 
assessment. 
The following assumptions on systemic availability are taken forward for the calculation of 
MOS. 
Systemic availability after oral intake:  approximately 100% (experimental data) 
Systemic availability after dermal contact: approximately 100% (default assumption) 
Systemic availability after inhalation:  approximately 100% (default assumption) 
Occupational exposure and internal body burden 
Inhalation exposure to vapours and skin exposure are the relevant routes of occupational 
exposure. Workplace exposure is expected during production and polymerisation of 2-EHA 
(Scenario 1), formulation of preparations containing up to 21% 2-EHA (Scenario 2), use of 
formulations containing monomeric 2-EHA in the building trade (Scenario 3) and use of 
dispersions with residual 2-EHA (< 0.08%) (Scenario 4). In Table 4.19 the exposure levels of 
Table 4.2 are summarised and the route specific and total internal body burden is identified. In 
case of exposure ranges the higher values are taken forward for the calculation.  
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Table 4.19  Occupational exposure levels and internal body burden 
Internal body burden(1) 
in mg/kg/day 
Area of production and use Frequency Inhalation 
shift average 
in mg/m3 
Dermal 
shift average 
in mg/kg/d(2) 
Inhalation
(4) 
Derm
al 
Com
bined 
not daily 0.15 0.4 0.15 0.55 1 Production and polymerisation of 2-
EHA 
daily 
 
2.8(3) 
- 0.4 - 0.4 
not daily 0.15 2.7 0.15 2.85 2 Formulation of preparations 
containing up to 21% 2-EHA (without 
LEV) daily 
 
19(2) 
- 2.7 - 2.7 
not daily 3(2) 13 0.42 13 13.4 3 Use of formulations containing 
monomeric 2-EHA in the building 
trade daily - - - - - 
not daily 4 Use of dispersions with residual 2-
EHA (< 0.08%) 
daily 
 
< 1 
 
0.042 
 
0.14 
 
0.042 
 
0.18 
1) Based on the assumption of 100% systemic availability; breathing volume of 10 m3 per 8 hour; body weight: 70 kg 
2) EASE 
3) Highest 95th percentile of measurements (reasonable worst case) 
4) Shift average x 10 m3/70 kg 
Calculation of MOS values 
Irritation after inhalation and repeated dose toxicity are assessed on the basis of MOS values. 
MOS values of irritation after inhalation and repeated inhalation are calculated with the NOAEC 
of an inhalation study and the occupational exposure concentration. Since a repeated dermal 
study is not available, systemic effects after dermal exposure are assessed on the basis of 
calculated internal body burden derived from the inhalation NOAEC and dermal exposure.  
The following default values of body weights and physiological parameters are used for the 
calculation of MOS. 
Body weight, rat     250 g 
Body weight, worker     70 kg 
Respiratory volume of rats     0.8 l/min/kg 
Respiratory volume of worker during 8 hours of light activity  10 m³ 
Evaluation of MOS values 
According to TGD (Chapter 4) several aspects have to be considered to decide on the 
acceptability of MOS values. A minimal MOS is derived by the multiplication of subfactors, that 
are described below and under the toxicological endpoints. Based on the minimal MOS and the 
toxicological starting point (e g NOAEC/L) a critical exposure concentration/level is calculated. 
Differences in exposure route 
An equivalent systemic availability of 100% for all routes of exposure is assumed. No specific 
factor is applied in the risk assessment. 
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Differences in exposure duration 
Since the assessment of acute and chronic occupational exposure is based on a subchronic study, 
differences in exposure duration have to be considered. The factors are explained under the 
respective endpoints. 
Interspecies differences 
The assessment is mainly based on animal data. Substance specific experimental and human data 
allowing a quantitative assessment of interspecies differences are not available. 
Concerning the local effects in the nose it is known that rodents show a nasal anatomy and 
respiratory physiology different from man. These differences will influence the toxicokinetics of 
substances in the upper respiratory tract. A further important point is the hydrolysis of the ester. 
Release of acrylic acid in the olfactory epithelium is presumed to be an important cause of site-
specific effects and the carboxylesterase activity, responsible for the cleavage might be different 
in rats and humans. However it is not known whether these species differences lead finally to 
marked sensitivity differences of rats and humans. For that reason a species extrapolation factor 
of 1 is used. 
The assessment of systemic effects relies upon the concept of metabolic rate scaling, because 
substance specific information on interspecies differences is not available. For inhalation 
exposure, this principle implies that a specific inhalation exposure level (in mg/m³) is 
toxicologically equivalent in rats and humans (if the duration of exposure and the status of 
physiological activity are identical). For interspecies extrapolation of oral or dermal data 
metabolic rate scaling results in 4-times and 7-times lower effective dose levels in humans (in 
mg/kg/day) compared to rats and mice. 
Adjustment for breathing volume of workers (light activity for 8 hours/day) 
For the assessment of local and systemic effects via inhalation the following aspect is considered 
in the risk assessment. In inhalation studies with repeated administration rats are routinely 
exposed for 6 hours per day; the respiratory minute volume for the rat is assumed to be 
0.8 l/min/kg. Metabolic rate scaling implies that the human NAEL (in mg/p/day) is calculated 
based on a daily exposure of 6 hours, a human respiratory rate of 0.2 l/min/kg (which is 
determined by the scaling model) and the experimental NOAEC in mg/m³. Thus, the metabolic 
rate scaling model determines the human NAEL. A breathing rate of 0.2 l/min/kg for 6 hours is 
identical to a breathing volume of 5 m³ for a person of 70 kg. That implies a human NAEL (in 
mg/p/day) that results from the NOAEC in mg/m³ multiplied with 5 m³.  
For risk characterisation purposes however, a daily breathing volume of 10 m3 is assumed for 
workers (8 hour exposure and light activity). According to Haber’s law the toxicological 
consequence of breathing 10 m³ is different from breathing 5 m³ of the same contaminated air. 
Thus, for evaluation of direct MOS values, based on the experimental NOAEC (experimental 
animal, 6 hours per day) and assuming a human breathing volume of 10 m³, a factor of 2 is used 
for adjustment for breathing volumes. 
Further aspects (e. g. intraspecies variability) 
Further relevant parameters of MOS evaluation are not covered by scientifically based 
adjustment factors and are included in a further uncertainty factor. Especially intraspecies 
variability, but also nature and severity of effects, dose-response relationship, variability in the 
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experimental data and overall confidence in the database have to be considered. A standard 
uncertainty factor of about 5 is proposed when risk assessment is based on oral animal data and 
an available NOAEL. The uncertainty factor may be lower in case of additional relevant data 
(e.g. human data available, route-to-route extrapolation not necessary) or in case of adverse 
effects that are not considered severe. The uncertainty factor usually is higher than 5 for e.g. 
specific reproductive toxicity or lack of NOAEL. The uncertainty factors for the single endpoints 
are described in the respective chapters. 
4.1.3.2.2 Endpoint-specific risk assessment for workers 
Acute toxicity 
Inhalation 
No lethality was observed in rats after 8 hours exposure to a vapour-saturated atmosphere at 
20°C (room temperature). Gross pathology revealed nasal and ocular irritation. The calculated 
saturation concentration for the vapour pressure of 12-17 Pa (20°C) would be approximately 
920-1,310 mg/m3 (120-170 ppm). 
This value is compared with the highest estimated inhalation exposure of 77 mg/m3 (2-hour, 
EASE, Scenario 2) and 19 mg/m3 (8-hour, EASE, Scenario 2). As to acute effects concern is not 
derived. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Dermal 
A dermal LD50 of approximately 14,000 mg/kg was determined in rabbits. For comparison the 
oral LD50 for rats and mice lies between 4,000 and 6,000 mg/kg. Comparing the dermal LD50 of 
approximately 14,000 mg/kg with the highest acute dermal exposure of about 13 mg/kg 
(880 mg/person, Scenario 3) concern is not derived. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Irritation/Corrosivity 
Dermal 
2-EHA is strongly irritating to the skin of rabbits in studies on acute irritation, but should not be 
considered as corrosive (See Section 4.1.2.3). 2-EHA induced local effects at the skin in several 
subchronic and chronic dermal studies with different mice strains. In a chronic study with male 
CH3/HeJ-mice a 2.5% solution (3 days/week, lowest concentration) led to transient skin 
irritations. Concentrations of 21% and 86.5% were highly irritative and induced skin tumours 
(see Section 4.1.2.6 and 4.1.2.8).  
Conclusion (ii) is proposed on the grounds that control measures exist which can minimise 
exposure and risk of irritation/corrosivity, thereby reducing concern. However, these controls 
must be implemented and complied with to reduce the risk of damage to skin. 
CHAPTER 4. HUMAN HEALTH 
 75 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Eyes 
Eye irritation is reported to be evident but less significant than local effects on the skin. The mild 
and reversible eye irritation does not warrant labelling with R 36. Concern as to eye irritation is 
not derived.  
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Inhalation 
2-EHA is considered to be a respiratory irritant based on the results of the acute inhalation 
testing, skin and eye irritation studies and investigations on repeated inhalation (see 
Section 4.1.2.3). There are no experimental data to describe a precise threshold for respiratory 
irritation of single exposures, but some information can be derived from a single 8-hour exposure 
of rats to a vapour-saturated atmosphere. The calculated saturation concentration for the vapour 
pressure of 12-17 Pa (20°C) would be approximately 920-1,310 mg/m3 (120-170 ppm). Gross 
pathology revealed nasal and ocular irritation, a NOAEC was not determined. Subchronic 
inhalation exposure of rats demonstrated a NOAEC of 77 mg/m3 (10 ppm) and minimal 
degeneration of the olfactory epithelium at 230 mg/m3 (30 ppm). Due to the limited reliability of 
the acute inhalation study and the uncertainties about the exposure concentration the subchronic 
NOAEC of 77 mg/m3 (10 ppm) is used for the MOS calculation. 
For the selection of a minimal MOS the following subfactors are applied: 
• duration adjustment (subchronic to acute): 1/3 
• Data from acute inhalation with limited reliability indicate that the NOAEC for single 
exposures and histopathological effects should not be substantially higher than the 
subchronic NOAEC. In addition other substances like methyl methacrylate and vinyl acetate 
that affected also the olfactory epithelium, showed no very marked change comparing acute 
and subacute/subchronic NOAECs. A factor of 1/3, that implies a 3-fold higher acute NAEC 
compared to the subchronic one, is considered to be appropriate. 
• adjustment of breathing volumes (6 to 8 hours; light activity of workers): 2 
• interspecies adjustment: 1 
• a further uncertainty factor of 3 is considered appropriate to cover intraspecies variability, 
the nature and severity of effect (minimal nasal effects) and the quality of the database 
(NOAEC and LOAEC were determined) (see also above under “further aspects”). 
A minimal MOS of 2 is derived which results in a critical exposure concentration of 39 mg/m3 
(8 hours). Comparing this concentration with the highest 8-hour concentration of 19 mg/m3 
concern is not derived. Due to the 4-fold reduced exposure time the short term exposure of 
77 mg/m3 for 2 hours (Scenario 2) is also not considered to be of concern. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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Sensitisation 
Dermal 
2-EHA is moderately sensitising in guinea pigs. Sensitisation has also been reported in humans, 
however human data also indicate that 2-EHA has not been an important occupational contact 
allergen during 1978-1999 (Geukens and Gossens, 2001). This implies that very low 
concentrations of 2-EHA (< 0.08% in the widespread applicated polymer dispersions) should not 
be expected to have a considerable sensitising potency in humans. 
Since also single contacts might lead to skin sensitisation concern is raised for Scenario 1, 2 and 
3. Concern is not expressed as to Scenario 4 because of the very low 2-EHA-concentration in 
combination with the lacking indications from a comprehensive human survey. 
Conclusion (iii) There is a need for limiting the risks: risk reduction measures which are 
already being applied shall be taken into account. (Scenario 1, 2 and 3) 
Inhalation 
Data on respiratory sensitisation in man (e.g. case reports) and in experimental animals is not 
available. Some potential of 2-EHA to cause respiratory sensitisation cannot be excluded with 
certainty since in the substance demonstrated skin sensitising properties. However at the 
background of occupational exposure in former years 2-EHA seems at least not to be a strong 
respiratory sensitiser in humans. For the time being no generally accepted animal model is 
available which would be able to verify the question of respiratory sensitisation. Concern is not 
expressed. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Repeated dose toxicity 
Inhalation (local effects) 
A NOAEC of 77 mg/m3 (10 ppm) was determined in a subchronic inhalation study on rats 
(6 h/d). Minimal degeneration was observed in the olfactory epithelium of the nose at 230 mg/m3 
(30 ppm). At 770 mg/m3 (100 ppm) the degeneration was more marked. The NOAEC of 
77 mg/m3 (10 ppm) is used for the MOS calculation (see Table 4.20). 
For the selection of a minimal MOS the following subfactors are applied: 
• duration adjustment (subchronic to chronic): 2  
• The application of a duration adjustment is confirmed by the structurally related compound 
butyl acrylate. Butyl acrylate was preferred to the other available acrylate studies (methyl or 
ethyl acrylate) due to the longer and so more comparable side chain. A chronic inhalation 
study (with interim sacrifices at 12 months of exposure, Reininghaus et al. (1991) showed a 
change of dose response relationship with time. A default value of 2 is applied (Kalberlah et 
al., 1999). 
• adjustment of breathing volumes (6 to 8 hours; light activity of workers): 2 
• interspecies adjustment: 1 
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• a further uncertainty factor of 3 is considered appropriate to cover intraspecies variability, 
the nature and severity of effect (minimal nasal effects) and the quality of the database 
(NOAEC and LOAEC were determined) (see also above under “further aspects”). 
A minimal MOS of 12 is derived which results in a critical exposure concentration of 6.4 mg/m3. 
Concern is raised for Scenario 2. 
Conclusion (iii) There is a need for limiting the risks: risk reduction measures which are 
already being applied shall be taken into account. (for Scenario 2) 
Table 4.20  MOS values of repeated dose toxicity and scenarios with daily exposure (local and systemic effects via inhalation) 
 Local effects Systemic effects 
Starting point for MOS calculation 77 mg/m3 230 mg/m3 
Minimal MOS 12 12 
Critical exposure concentration  6.4 mg/m3 19 mg/m3 
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1 Production and polymerisation 2.8 28 ii 82 ii 
2 Formulation of preparations containing up to 21% 2-EHA 19 4 iii 12.1 ii 
4 Use of dispersions with residual 2-EHA (< 0.08%) < 1 > 77 ii > 230 ii 
Inhalation (systemic effects) 
Based on the above mentioned inhalation study a systemic NOAEC of 230 mg/m3 (30 ppm) was 
determined. At 770 mg/m3 (100 ppm) elevated activities of transaminase and alkaline 
phosphatase indicated a minimal liver damage. The NOAEC of 230 mg/m3 (30 ppm) is used for 
the MOS calculation (see Table 4.20). 
For the selection of a minimal MOS the following subfactors are applied: 
• duration adjustment (subchronic to chronic): A default value of 2 is used (Kalberlah and 
Schneider, 1998). 
• adjustment of breathing volumes (6 to 8 hours; light activity of workers): 2 
• interspecies adjustment: 1 
• a further uncertainty factor of 3 is considered appropriate to cover intraspecies variability, 
the nature and severity of effect (indications for a minimal liver damage) and the quality of 
the database (NOAEC and LOAEC were determined) (see also above under “further 
aspects”). 
A minimal MOS of 12 is derived which results in a critical exposure concentration of 19 mg/m3. 
Scenario 2 is a borderline scenario (MOS: 12.1), but it is not considered to be appropriate to raise 
concern. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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Dermal (local effects) 
A quantitative risk characterisation can be made for local effects after repeated dermal exposure 
in Scenario 4 using the chronic study from Wenzel-Hartung (1989) with male CH3/HeJ-mice. 
Transient skin irritations were observed at the LOAEL of 2.5% solution (25 microliter, 
3 days/week, lowest concentration). Assuming that the body surface of a mouse is approximately 
40 cm2 and that 10% of the body surface (4 cm2) was exposed an effect level of approximately 
0.2 mg/cm2 can be calculated. Comparing this area dose with the assumed daily exposure of 
0.004 mg/cm2 a MOS of approximately 50 is derived which is considered to be sufficiently high 
to derive no concern. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Dermal (systemic effects) 
Valid experimental data for the assessment of systemic toxicity by skin contact is not available. 
A long term dermal study in male mice with limited histopathological examination (Wenzel-
Hartung (1989); Brune and Deutsch-Wenzel (1986)) showed that the highest dose tested (25 µl 
86.5% 2-EHA (3 days/week), approximately 1,081 mg/kg/day) is probably without severe 
systemic effects. 
The subchronic inhalation study with rats is however preferred as starting point for MOS 
calculation, since it is regarded as valid (see Section 4.1.2.6) and included histopathological 
examinations in both sexes. The NOAEC of 230 mg/m3 (30 ppm) is used for the MOS 
calculation (see Table 4.21). The NOAEC of 230 mg/m3 (30 ppm) corresponds to an intake by 
inhalation of 66 mg/kg/day (respiratory rate of 0.8 l/min/kg for rats), that is used as internal 
NAEL for MOS calculation (see Table 4.21).  
For the selection of a minimal MOS the following subfactors are applied: 
- duration adjustment (subchronic to chronic): A default value of 2 is used (Kalberlah and 
Schneider, 1998). 
- interspecies adjustment (metabolic rate scaling): 4 
- a further uncertainty factor of 3 is considered appropriate to cover intraspecies variability, the 
nature and severity of effect (indications for a minimal liver damage) and the quality of the 
database (NOAEC and LOAEC were determined) (see also above under “further aspects”). 
A minimal MOS of 24 is derived which results in a critical exposure level of 2.8 mg/kg/day. A 
chronic and daily exposure was only estimated for Scenario 4. No concern is derived. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Combined inhalation and dermal exposure 
The combined exposure values are listed in Table 4.19 and the respective MOS in Table 4.20. 
The minimal acceptable MOS is the same as for dermal exposure. Scenario 2 is a borderline 
scenario (MOS: 24.4), but it is not considered to be appropriate to raise concern. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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Table 4.21  MOS values of repeated dose toxicity with daily exposure (dermal and combined exposure) 
 Dermal Combined 
Starting point for MOS calculation 66 mg/kg/day 66 mg/kg/day 
Minimal MOS 24 24 
Critical exposure level 2.8 mg/kg/day 2.8 mg/kg/day 
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1 Production and further processing in the large-scale chemical industry - - - 0.4 170 ii 
2 Manufacturing of formulations (< 21% 2-EHA) in the large-scale chemical industry - - - 2.7 24.4 ii 
4 Use of dispersions containing residual 2-EHA (< 0.08%) 0.042 1,600 ii 0.18 370 ii 
Mutagenicity 
Based on data on 2-EHA and related compounds 2-EHA is not considered to be an in vivo 
mutagen (see Section 4.1.2.7). Corresponding risks at workplaces are not anticipated to occur. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Carcinogenicity 
Dermal 
Skin tumours were observed in chronic dermal studies in C3H/HeJ-mice, but not in NMRI-mice 
at concentrations of 21% and above. The carcinogenic effect is considered to be associated with 
the highly irritating concentrations tested. Regarding additionally the negative in vivo 
mutagenicity tests and data from related compounds skin tumours are not expected at exposure 
conditions that do not result in strong chronic irritation (please refer also to the section 
“Irritation/dermal”). Based on the available data it is concluded, that 2-EHA induces skin 
tumours by a non-genotoxic mechanism. 
The daily dermal exposure is assumed to be negligible (Scenarios 1, 2) or up to 0.04 mg/kg/day 
(3 mg/person/day, Scenario 4). The non-daily exposure can reach 13 mg/kg/day (Scenario 3). 
Overall a strong chronic irritation that might lead to skin tumours is not expected in all scenarios. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Inhalation 
Experimental data for the assessment of carcinogenicity by inhalation is not available. Taking 
account of the negative in vivo mutagenicity and of negative long term inhalation studies of 
specific acrylates/methacrylates 2-EHA is not suspected to be carcinogenic by inhalation. 
Corresponding risks at workplaces are not anticipated to occur. 
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Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Fertility impairment 
A fertility study on 2-EHA is not available, but in the 90-day inhalation study with rats no effect 
was observed in reproductive organs (testes, seminal vesicles, ovaries, uteri) up to the highest 
concentration of 770 mg/m3 (100 ppm). Comparing this NOAEC with the NOAECs of repeated 
dose toxicity in the same study (local effects: NOAEC of 77 mg/m3 (10 ppm), systemic effects: 
230 mg/m3 (30 ppm)) fertility impairment is not expected as a specific effect independent of 
general toxicity. A MOS-calculation is not performed, since no indication of an effect on 
reproductive organs was observed. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Developmental toxicity 
In a study on developmental toxicity in rats no adverse effect on embryo/fetal development was 
observed up to the highest tested concentration of 770 mg/m3 (100 ppm). At this concentration a 
slightly reduced food intake and lower maternal weight gain was observed, leading to a NOAEC 
for maternal toxicity of 580 mg/m3 (75 ppm). Developmental toxicity is not expected as a 
specific effect independent of general toxicity. A MOS-calculation is not performed, since no 
effect on development was observed. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
4.1.3.2.3 Summary of occupational risk assessment 
In the following Table 4.22 the results of the toxicological endpoints and scenarios with 
conclusion (iii) are summarised. All other endpoints resulted in conclusion (ii).  
Table 4.22  Summary of conclusions for the occupational risk assessment of 2-EHA 
Area of production and use Sensitisation 
Dermal 
Repeated dose toxicity 
local effects after inhalation 
1 Production and polymerisation of 2-EHA iii ii 
2 Formulation of preparations containing up to 21% 2-
EHA 
iii iii 
3 Use of formulations containing monomeric 2-EHA in 
the building trade 
iii ii 
4 Use of dispersions with residual 2-EHA (<0.08%) ii ii 
4.1.3.3 Consumers 
Exposure 
The measured maximum air concentration during short-term use (painting) was 1 ppm (and 
0.0075 mg/l). Taking into account that monomeric 2-EHA was not detectable 25 hours after 
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painting; there is no reasonable suspicion for repeated exposure by inhalation for consumers after 
painting. Dermal exposure is considered to be negligible (maximum 11.2 µg/kg bw per event). 
Acute toxicity 
Following the exposure assessment, consumers are not exposed to 2-EHA in the range of doses 
which can be derived from acute oral toxicity figures based on animal LD50 values (LD50 oral 
(rats, mice): 4,000-6,000 mg/kg). In an experiment with rabbits, the substance has demonstrated 
very low dermal toxicity (LD50 dermal: (rabbits): > 10,000 mg/kg). Following inhalation 
exposure in rats there were no deaths in a saturated 2-EHA- atmosphere up to 8 hours. The 
substance is assumed not to justify concern for the consumer in relation to acute oral, inhalation 
or dermal toxicity. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Irritation/Corrosivity  
2-EHA caused severe irritation near corrosion after application to the skin of rabbits. Eye 
irritation was less severe in animal experiments.  
The concentration of 2-EHA in the final products for consumer (0.08%) is under the 
concentration limit which would lead to classification and labelling.  
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Sensitisation  
2-EHA has a moderate sensitising potential in experimental animals. There is also evidence of 
sensitisation in humans.  
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Repeated dose toxicity  
Following the exposure assessment there is no real chronic exposure to 2-EHA.  
Taking into account that monomeric 2-EHA was not detectable 25 hours after painting; there is 
no reasonable suspicion for repeated exposure by inhalation for consumers after painting. 
Dermal and oral exposure is considered to be negligible. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Mutagenicity 
The bacterial mutation assays was negative, but various in vitro studies on mammalian cell 
cultures produced weakly mutagenic effects. No mutagenic effect was observed in an in vivo 
chromosomal aberration test after treatment with high doses of 2-EHA. Cleavage products of 
2-EHA were negative in in vivo mutagenicity tests. The overall data-base on structurally related 
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acrylic compounds supports that there is no in vivo mutagenicity. The substance is of no concern 
in relation to mutagenic effects. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Carcinogenicity 
Consumer exposure is considered to be negligible. Based on the exposure assessment, there is no 
chronic exposure to 2-EHA. 
There are no data on carcinogenic effects of 2-EHA with respect to oral or inhalative exposure 
routes. There are data that 2-EHA produced skin tumours in animals; this was found, however, 
only in case of established irritative skin lesions. Based on the limited actual knowledge on 
2-EHA but taking into account the negative results from long term carcinogenic studies with 
acrylic acid after oral and dermal administration no concern can be assumed. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Toxicity for reproduction 
Following the exposure assessment, consumer exposure is considered to be negligible. 
Evaluation of the available screening information about 2-EHA does not provide evidence for 
significant reproductive toxicity of 2-EHA up to 750 mg/m³. As to the relevant metabolites of 
this compound, for 2-ethylhexanol and for acrylic acid there are no indications for a specific 
embryo-/fetotoxic or teratogenic potential and for acrylic acid there are no indications for a 
substance-induced impairment of reproductive functions. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
4.1.3.4 Man exposed indirectly via the environment 
The main route of indirect exposure in the local scenario is the intake via air, on a regional scale 
a predominant intake via the consumption of fish is expected. 
Repeated dose toxicity  
Local scenario 
Following the local scenario data (at a point source) a concentration of 8.3 µg/m3 2-EHA in the 
air is calculated. The most sensitive effect of 2-EHA in animals was degeneration of the 
olfactory epithelium in a 90-day inhalation study on rats. The local NOAEC in this study was 
0.075 mg/l (and 75 mg/ m³). 
Comparison indirect exposure - Local scenario/local effect/NOAEC 
Indirect exposure (local)   0.0083 mg/m3 
NOAEC    75 mg/ m3 
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The margin of safety expressed by the magnitude between the calculated exposure and the 
NOAEC is high for the local scenario. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Regional scenario/systemic effect 
For the regional scenario (mainly consumption of fish and root crops), the respective figure is 
6 ng/kg bw/day. In repeated dose toxicity studies on rats (90-day inhalation) the NOAEC for 
systemic effects was 30 ppm (and 0.225 mg/l). This NOAEL is converted as follows to the 
inhaled amount of the substance using the respiratory minute volume 1.3 l/min/kg and exposure 
duration of 360 min/day: 
0.225 mg/l . 0.8 l/minutes/kg . 360 minutes/day =  65 mg/kg bw/day 
Comparison indirect exposure - Regional scenario/NOAEL 
Indirect exposure (regional)   0.000006 mg/kg bw/day 
NOAEL     65 mg/kg bw/day 
The margin of safety expressed by the magnitude between the calculated exposure (regional 
scenario) and the NOAEL is very high for the regional scenario. Thus, the substance is of no 
concern in relation to indirect exposure via the environment.  
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Toxicity for reproduction 
Evaluation of the available screening information about 2-EHA does not provide evidence for 
significant reproductive toxicity of 2-EHA. 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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4.2 HUMAN HEALTH (PHYSICO-CHEMICAL PROPERTIES) 
4.2.1 Exposure assessment 
4.2.1.1 Occupational exposure 
4.2.1.2 Consumer exposure 
4.2.1.3 Indirect exposure via the environment 
4.2.2 Effects assessment: Hazard identification and Dose (concentration) - 
 response (effect) assessment  
4.2.2.1 Explosivity 
2-ethylhexyl acrylate is not explosive. 
4.2.2.2 Flammability 
2-ethylhexyl acrylate is not flammable. 
4.2.2.3 Oxidising potential  
Due to its chemical structure, 2-ethylhexyl acrylate is not expected to possess any oxidising 
properties. 
4.2.3 Risk characterisation 
4.2.3.1 Workers 
Not applicable 
4.2.3.2 Consumers 
4.2.3.3 Humans exposed via the environment 
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5 RESULTS 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
Conclusion (iii) There is a need for limiting the risks: risk reduction measures which are 
already being applied shall be taken into account. 
Summary of conclusions: 
5.1 ENVIRONMENT 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
2-ethylhexyl acrylate represents, based on the present data configuration, no risk to the 
environment.  
There is therefore at present no need for further testing or gathering of exposure information. 
5.2 HUMAN HEALTH 
5.2.1.1 Consumers 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
5.2.1.2 Workers 
Conclusion (iii) There is a need for limiting the risks: risk reduction measures which are 
already being applied shall be taken into account. 
• The risk assessment reveals concern with regard to local effects after repeated inhalation for 
the formulation of preparations (Scenario 2). 
• Skin sensitisation gives rise to concern for all dermal exposure during production and 
polymerisation (Scenario 1), the formulation of preparations (Scenario 2) and the use of 
formulations containing monomeric 2-EHA in the building trade. 
5.2.1.3 Humans exposed via the environment 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
5.2.1.4 Risks to human health from physico-chemical properties 
Conclusion (ii) There is at present no need for further information and/or testing and for risk 
reduction measures beyond those which are being applied already. 
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Conclusion (ii) is reached because there are no risks from physico-chemical properties arising 
from the use of the substance. 
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ABBREVIATIONS 
ADI Acceptable Daily Intake 
AF Assessment Factor 
ASTM American Society for Testing and Materials 
ATP Adaptation to Technical Progress 
AUC Area Under The Curve 
B Bioaccumulation 
BBA Biologische Bundesanstalt für Land- und Forstwirtschaft 
BCF Bioconcentration Factor 
BMC Benchmark Concentration 
BMD Benchmark Dose 
BMF Biomagnification Factor 
BOD Biochemical Oxygen Demand 
bw  body weight / Bw, bw 
C Corrosive (Symbols and indications of danger for dangerous substances and preparations 
according to Annex II of Directive 67/548/EEC) 
CA Chromosome Aberration 
CA Competent Authority 
CAS Chemical Abstract Services 
CEC Commission of the European Communities 
CEN European Standards Organisation / European Committee for Normalisation 
CEPE European Committee for Paints and Inks 
CMR Carcinogenic, Mutagenic and toxic to Reproduction 
CNS Central Nervous System 
COD Chemical Oxygen Demand 
CSTEE Scientific Committee for Toxicity, Ecotoxicity and the Environment (DG SANCO) 
CT50 Clearance Time, elimination or depuration expressed as half-life 
d.wt dry weight / dw 
dfi daily food intake 
DG  Directorate General 
DIN Deutsche Industrie Norm (German norm) 
DNA DeoxyriboNucleic Acid  
DOC Dissolved Organic Carbon 
DT50 Degradation half-life or period required for 50 percent dissipation / degradation 
DT90 Period required for 90 percent dissipation / degradation 
E Explosive (Symbols and indications of danger for dangerous substances and preparations 
according to Annex II of Directive 67/548/EEC) 
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EASE Estimation and Assessment of Substance Exposure Physico-chemical properties [Model] 
EbC50 Effect Concentration measured as 50% reduction in biomass growth in algae tests 
EC European Communities 
EC10 Effect Concentration measured as 10% effect 
EC50 median Effect Concentration  
ECB  European Chemicals Bureau 
ECETOC  European Centre for Ecotoxicology and Toxicology of Chemicals 
ECVAM European Centre for the Validation of Alternative Methods 
EDC Endocrine Disrupting Chemical 
EEC European Economic Communities 
EINECS European Inventory of Existing Commercial Chemical Substances 
ELINCS European List of New Chemical Substances 
EN European Norm 
EPA Environmental Protection Agency (USA) 
ErC50 Effect Concentration measured as 50% reduction in growth rate in algae tests 
ESD Emission Scenario Document 
EU European Union 
EUSES European Union System for the Evaluation of Substances [software tool in support of 
the Technical Guidance Document on risk assessment] 
F(+) (Highly) flammable (Symbols and indications of danger for dangerous substances and 
preparations according to Annex II of Directive 67/548/EEC) 
FAO  Food and Agriculture Organisation of the United Nations 
FELS  Fish Early Life Stage  
foc Organic carbon factor (compartment depending) 
GLP Good Laboratory Practice 
HEDSET EC/OECD Harmonised Electronic Data Set (for data collection of existing substances) 
HELCOM Helsinki Commission -Baltic Marine Environment Protection Commission  
HPLC  High Pressure Liquid Chromatography 
HPVC High Production Volume Chemical (> 1000 tonnes/annum) 
IARC International Agency for Research on Cancer 
IC Industrial Category 
IC50 median Immobilisation Concentration or median Inhibitory Concentration 
ILO International Labour Organisation 
IPCS International Programme on Chemical Safety 
ISO International Organisation for Standardisation 
IUCLID International Uniform Chemical Information Database (existing substances) 
IUPAC International Union for Pure and Applied Chemistry 
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JEFCA Joint FAO/WHO Expert Committee on Food Additives 
JMPR Joint FAO/WHO Meeting on Pesticide Residues 
Koc organic carbon normalised distribution coefficient 
Kow octanol/water partition coefficient 
Kp solids-water partition coefficient 
L(E)C50 median Lethal (Effect) Concentration  
LAEL Lowest Adverse Effect Level 
LC50 median Lethal Concentration  
LD50 median Lethal Dose   
LEV Local Exhaust Ventilation 
LLNA Local Lymph Node Assay 
LOAEL Lowest Observed Adverse Effect Level 
LOEC Lowest Observed Effect Concentration 
LOED  Lowest Observed Effect Dose 
LOEL Lowest Observed Effect Level 
MAC Maximum Allowable Concentration 
MATC Maximum Acceptable Toxic Concentration 
MC Main Category  
MITI Ministry of International Trade and Industry, Japan 
MOE Margin of Exposure 
MOS Margin of Safety 
MW Molecular Weight 
N Dangerous for the environment (Symbols and indications of danger for dangerous 
substances and preparations according to Annex II of Directive 67/548/EEC 
NAEL  No Adverse Effect Level  
NOAEL No Observed Adverse Effect Level 
NOEL No Observed Effect Level 
NOEC  No Observed Effect Concentration 
NTP National Toxicology Program (USA) 
O Oxidising (Symbols and indications of danger for dangerous substances and preparations 
according to Annex II of Directive 67/548/EEC) 
OC Organic Carbon content 
OECD Organisation for Economic Cooperation and Development 
OEL Occupational Exposure Limit 
OJ Official Journal 
OSPAR  Oslo and Paris Convention for the protection of the marine environment of the Northeast 
Atlantic 
P Persistent 
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PBT  Persistent, Bioaccumulative and Toxic 
PBPK Physiologically Based PharmacoKinetic modelling 
PBTK Physiologically Based ToxicoKinetic modelling 
PEC Predicted Environmental Concentration 
pH logarithm (to the base 10) (of the hydrogen ion concentration {H+} 
pKa logarithm (to the base 10) of the acid dissociation constant 
pKb logarithm (to the base 10) of the base dissociation constant 
PNEC Predicted No Effect Concentration 
POP Persistent Organic Pollutant 
PPE Personal Protective Equipment 
QSAR (Quantitative) Structure-Activity Relationship 
R phrases Risk phrases according to Annex III of Directive 67/548/EEC 
RAR Risk Assessment Report 
RC Risk Characterisation 
RfC Reference Concentration 
RfD Reference Dose 
RNA RiboNucleic Acid 
RPE Respiratory Protective Equipment 
RWC Reasonable Worst-Case 
S phrases  Safety phrases according to Annex IV of Directive 67/548/EEC 
SAR Structure-Activity Relationships 
SBR Standardised birth ratio 
SCE Sister Chromatic Exchange 
SCHER Scientific Committee on Health and Environmental Risks 
SDS Safety Data Sheet 
SETAC  Society of Environmental Toxicology And Chemistry 
SNIF Summary Notification Interchange Format (new substances) 
SSD  Species Sensitivity Distribution 
STP  Sewage Treatment Plant 
T(+) (Very) Toxic (Symbols and indications of danger for dangerous substances and 
preparations according to Annex II of Directive 67/548/EEC) 
TDI Tolerable Daily Intake 
TG Test Guideline 
TGD Technical Guidance Document 
TNsG Technical Notes for Guidance (for Biocides) 
TNO The Netherlands Organisation for Applied Scientific Research 
ThOD Theoritical Oxygen Demand 
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UC Use Category 
UDS Unscheduled DNA Synthesis 
UN United Nations 
UNEP  United Nations Environment Programme  
US EPA Environmental Protection Agency, USA 
UV Ultraviolet Region of Spectrum 
UVCB Unknown or Variable composition, Complex reaction products of Biological material 
vB  very Bioaccumulative 
VOC Volatile Organic Compound 
vP  very Persistent  
vPvB  very Persistent and very Bioaccumulative 
v/v volume per volume ratio 
w/w weight per weight ratio 
WHO World Health Organisation 
WWTP Waste Water Treatment Plant 
Xn Harmful (Symbols and indications of danger for dangerous substances and preparations 
according to Annex II of Directive 67/548/EEC) 
Xi Irritant (Symbols and indications of danger for dangerous substances and preparations 
according to Annex II of Directive 67/548/EEC) 
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Appendix A        Distribution and Fate 
 
Distribution and Fate
Substance: 2 - (Ethylhexyl) acrylate
melting point:
vapour pressure:
water solubility:
part. coefficient octanol/water:
molecular weight:
gas constant:
temperature:
conc. of suspended matter
in the river:
density of the solid phase:
volume fraction water in susp. matter:
volume fraction solids in susp.matter:
volume fraction of water in sediment:
volume fraction of solids in sediment:
volume fraction of air in soil:
volume fraction of water in soil:
volume fraction of solids in soil:
aerobic fraction of the sediment comp.:
product of CONjunge and SURFair:
MP 183.15K.
VP 12 Pa.
SOL 9.6 mg. l 1.
LOGPOW 3.9
MOLW 0.184 kg. mol 1.
R 8.3143J. mol 1. K 1.
T 285 K.
SUSP water 15 mg. l 1.
RHOsolid 2500 kg. m 3.
Fwater susp 0.9
Fsolid susp 0.1
Fwater sed 0.8
Fsolid sed 0.2
Fair soil 0.2
Fwater soil 0.2
Fsolid soil 0.6
Faer sed 0.1
product 10 4 Pa.
distribution air/water: Henry-constant
HENRY VP MOLW
.
SOL HENRY 230 Pa m
3. mol 1.=
log HENRY
Pa m3. mol 1.
2.362=
K air_water
HENRY
R T. K air_water 0.0971=  
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solid/water-partition ceefficient Kp comp and total compartment/water-partition 
coefficient Kcomp_water
a 0.49 (a,b from TGD, p. 539 "ester")
b 1.05 K OC 10
a LOGP OW
. b
l. kg 1. K OC 914.113 l kg 1.=
Suspended matter
Kp susp 0.1 K OC. Kp susp 91.411 l kg 1.=
K susp_water Fwater susp Fsolid susp Kp susp. RHOsolid. K susp_water 23.753=
factor for the calculation of Clocalwater:
faktor 1 Kp susp SUSP water. faktor 1.0014=
Sediment
Kp sed 0.1 K OC. Kp sed 91.411 l kg 1.=
K sed_water Fwater sed Fsolid sed Kp sed. RHOsolid. K sed_water 46.506=
Soil
Kp soil 0.02 K OC. Kp soil 18.282 l kg 1.=
K soil_water Fair soil K air_water. Fwater soil Fsolid soil Kp soil. RHOsolid.
K soil_water 27.643=
Sludge (activated sludge)
K p_sludge 0.37 K OC. K p_sludge 338.222 l kg 1.=
Raw sewage
K p_sewage 0.30 K OC. K p_sewage 274.234 l kg 1.=  
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biodegradation in different compartments
surface water kbio water 0.047 d
1. (TGD, table 5)
soil DT50bio soil 30 d. (TGD, table 6)
kbio soil
ln 2( )
DT50bio soil
kbio soil 0.023 d
1=
sediment kbio sed
ln 2( )
DT50bio soil
Faer sed. kbio sed 2.31 10 3 d 1=
degradation in surface waters
khydr water 0 d
1. kphoto water 0 d 1.
kdeg water khydr water kphoto water kbio water
kdeg water 0.047 d
1=
Atmosphere
calculation of CONjunge * SURFaer for the OPS-model
VPL VP
exp 6.79 1 MP
285 K.
. VP wenn MP 285 K.> VPL, VP,( ) VP 12 Pa=
Fass aer
product
VP product
degradation in the atmosphere
Fass aer 8.333 10
6=
kdegair = 0,036 h-1  
Distribution in WWTP  acc. SimpleTreat 3.0 (debugged version, 7 Feb 97) :
k=1h-1
Summary of distribution
to air 29,8
to water 7,0
via primary sludge 7,2
via surplus sludge 0,3
degraded 55,8
total 100,0 %  
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Smiles O=C(OCC(CCCC)CC)C=C 
Chemical  Propenoic acid, 2-ethylhexyl ester 
CAS Number 000103-11-7 
Molecular Formula C11 H20 O2 
Molecular Weight 184.28 
 
EPI SUMMARY (v3.10) 
Physical Property Inputs 
Water Solubility (mg/L) 9.6 
Vapor Pressure (mm Hg) 0.090009 
Henry LC (atm-m3/mole) 0.0022705 
Log Kow (octanol-water) 3.90 
Boiling Point (deg C) 216.00 
Melting Point (deg C) -90.00 
 
Log Octanol-Water Partition Coef (SRC) 
Log Kow (KOWWIN v1.66 estimate) 4.09 
 
Boiling Pt, Melting Pt, Vapor Pressure Estimations (MPBPWIN v1.40) 
Boiling Pt (deg C) 216.92 Adapted Stein and Brown method) 
Melting Pt (deg C) -10.43 (Mean or Weighted MP) 
VP(mm Hg,25 deg C) 0.161 (Mean or Weighted MP) 
MP  (exp database) -90 deg C  
BP  (exp database) 213.5 deg C  
VP  (exp database) 1.78E-01 mm Hg at 25 deg C  
 
Water Solubility Estimate from Log Kow (WSKOW v1.40) 
Water Solubility at 25 deg C (mg/L) 43.24 
log Kow used 3.90 (user entered) 
melt pt used -90.00 deg C 
Water Sol (Exper. database match) 100 mg/L (25 deg C) 
Exper. Ref CHEM INSPECT TEST INST (1992) 
 
ECOSAR Class Program (ECOSAR v0.99g) 
Class(es) found: Acrylates 
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Henrys Law Constant  (25 deg C) [HENRYWIN v3.10] 
Bond Method 6.72E-004 atm-m3/mole 
Group Method 6.00E-004 atm-m3/mole 
Exper Database 4.32E-04 atm-m3/mole 
Henrys LC [VP/WSol estimate using EPI values] 2.273E-003 atm-m3/mole 
 
Probability of Rapid Biodegradation (BIOWIN v4.00) 
Linear Model 0.9424 
Non-Linear Model 0.9982 
Expert Survey Biodegradation Results  
Ultimate Survey Model 3.2305 (weeks) 
Primary Survey Model 4.0799 (days) 
Readily Biodegradable Probability (MITI Model)  
Linear Model 0.7234 
Non-Linear Model 0.8610 
 
Atmospheric Oxidation (25 deg C) [AopWin v1.90] Hydroxyl Radicals Reaction 
OVERALL OH Rate Constant 20.1115 E-12 cm3/molecule-sec 
Half-Life 0.798 Days (24-hr day; 0.5E6 OH/cm3) 
Half-Life 19.146 Hrs 
Ozone Reaction 
OVERALL Ozone Rate Constant 0.175000 E-17 cm3/molecule-sec 
Half-Life 6.549 Days (at 7E11 mol/cm3) 
 
Soil Adsorption Coefficient (PCKOCWIN v1.66) 
Koc 429 
Log Koc 2.632 
 
Aqueous Base/Acid-Catalyzed Hydrolysis (25 deg C) [HYDROWIN v1.67] 
Total Kb for pH > 8 at 25 deg C 1.330E-002  L/mol-sec 
Kb Half-Life at pH 8 1.651  years 
Kb Half-Life at pH 7 16.512  years 
 
BCF Estimate from Log Kow (BCFWIN v2.14) 
Log BCF 2.303  (BCF = 200.9) 
log Kow used 3.90 (user entered) 
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Volatilisation from Water 
Henry LC 0.00227 atm-m3/mole (entered by user) 
Half-Life from Model River 1.735 hours 
Half-Life from Model Lake 132.8  hours (5.532 days) 
 
Removal In Wastewater Treatment 
Total removal 57.97  percent 
Total biodegradation 0.19  percent 
Total sludge adsorption 20.62  percent 
Total to Air 37.17  percent 
 
Level III Fugacity Model 
 Mass Amount Half-Life Emissions 
 (percent) (hour) (kg/hour) 
Air 4.08 17.1 1,000 
Water 26.8 360 1,000 
Soil 67.8 360 1,000 
Sediment 1.42 1.44e+003 0 
Persistence Time 240 hours 
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Appendix B        Calculation of PEClocal for aquatic compartment during 
production and processing of chemicals at one site 
 
Calculation of PEClocal for aquatic compartment during production and 
processing of chemicals at one site
                                        status: TGD, ESD, IC-3/IC11, generic d 86400s.
a 365 d.
chemical: (2 - Ethylhexyl) acrylate
µg 10 9 kg.
Production volume:
Processing volume:
Emissionfactor for production (TGD, tab. A1.2):
Emissionfaktor for processing (TGD, tab. A3.10):
Duration of emission for production (TGD, tab. B1.6):
Duration of emission for processing (TGD, tab. B3.9):
Fraction of emission directed to water:
(SimpleTreat, k:1h-1; logH:2,36; logKow:3,9)
River flow rate  (TGD):
Factor (1 + K p * SUSPwater):
Regional concentration in surface water
T 1 70000tonne. a 1.
T 2 32000tonne. a 1.
f 1 0.3 %.
f 2 0.001 %.
Temission 1 300 d. a 1.
Temission 2 300 d. a 1.
Fstp water 7 %.
V 60 m3. s 1.
FACTOR 1.0014
PECregionalwater 0.0058µg. l 1.
Emission per day:
Elocal water
T 1 f 1.
Temission 1
T 2 f 2.
Temission 2
Elocal water 701.07 kg d
1.=
Concentration in surface water:
Clocal water
Elocal water Fstp water.
V FACTOR. Clocal water 9.45 µg l
1.=
PEClocalwater
PEClocalwater Clocal water PECregionalwater PEClocalwater 9.459 µg l
1.=
Release to wwtp:
RELEASEwwtp T 1 f 1. T 2 f 2. RELEASEwwtp 210.32 tonne a 1.=
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Release to surface water:
RELEASEsw T 1 f 1. T 2 f 2. Fstp water. RELEASEsw 14.722 tonne a 1.=
Annual average local PEC in surface water
Clocal water_ann Clocal water
Temission 1
365 d. a 1.
.
Clocal water_ann 7.77 µg l
1.=
PEClocalwater_ann Clocal water_ann PECregionalwater
PEClocalwater_ann 7.776 µg l
1.=  
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Appendix C        Calculation of PEClocal for aquatic durino processing of 
chemicals 
 
Calculation of PEClocal for aquatic compartment during processing of 
chemicals 
                                               status: TGD, ESD, IC-11, generic
d 86400s.
chemical: 2 - (Ethylhexyl) acrylate a 365 d.
µg 10 9 kg.
Processing volume:
Emissionfactor for processing (TGD, tab. A 3.10):
Duration of emission for processing (TGD, tab. B 3.9):
Fraction of emission directed to water:
(SimpleTreat, k:1 h-1; logH:2,36; logKow:3,9)
River flow rate  (TGD):
Factor (1 + K p * SUSPwater):
Regional cocncentration in surface water
T 10000tonne. a 1.
f 0.001 %.
Temission 300 d. a 1.
Fstp water 7 %.
V 60 m3. s 1.
FACTOR 1.0014
PECregional water 0.0058µg. l 1.
Emission per day:
Elocal water
T f.
Temission
Elocal water 0.33 kg d
1.=
Concentration in surface water:
Clocal water
Elocal water Fstp water.
V FACTOR. Clocal water 4.49 10
3 µg l 1.=
PEClocalwater
PEClocalwater Clocal water PECregionalwater PEClocalwater 0.01 µg l
1.=
Release to wwtp:
RELEASEwwtp T f. RELEASEwwtp 0.1 tonne a 1.=
Release to surface water:
RELEASEsw T f. Fstp water. RELEASEsw 7 10 3 tonne a 1.=
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Annual average local PEC in surface water
Clocal water_ann Clocal water
Temission
365 d. a 1.
.
Clocal water_ann 3.694 10
3 µg l 1.=
PEClocalwater_ann Clocal water_ann PECregionalwater
PEClocalwater_ann 9.494 10
3 µg l 1.=  
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Appendix D        Default exposure estimation of PEClocalwater (stage of life 
cycle: formulation of aqueous polymer dispersions, generic) 
 
 Default Exposure Estimation of PEClocalwater  
               status: TGD, table A and B, IC: 11, UC: 43 µg 10
9 kg.
chemical : 2 - (Ethylhexyl) acrylate d 86400s.
a 365 d.stage of life cycle: formulation of aqueous 
polymer dispersions, generic                               
 Total annual tonnage of chemical:
Product tonnage:
Release factor (A-table:2.1):
Fraction of main source (B-table:2.3/2.9):
Waste water flow of wwtp:
Duration of emission (B-table:2.3):
Fraction of emission directed to water:
(SimpleTreat; k:1h-1; logPow: 3,9; logH:2,36)
Dilution factor (TGD):
Factor (1+Kp * SUSPwater):
Regional concentration in surface water
TONNAGE 42 tonne. a 1.
PRODUCT 210000tonne. a 1.
f emission 0.3 %.
Fmainsource 0.4
EFFLUENTstp 2000 m
3. d 1.
Temission 300 d. a 1.
Fstp water 7 %.
DILUTION 10
FACTOR 1.0014
PECregionalwater 0.0058µg. l 1.
Emission per day:
Elocal water
TONNAGEFmainsource. f emission.
Temission
Elocal water 0.17 kg d
1.=
Influent concentration:
Clocal inf
Elocal water
EFFLUENTstp
Clocal inf 84 µg l
1.=
Effluent concentration:
Clocal eff Clocal inf Fstp water. Clocal eff 5.88 µg l 1.=
Concentration in surface water:
Clocal water
Clocal eff
FACTOR DILUTION. Clocal water 0.59 µg l
1.=
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PEClocalwater
PEClocalwater Clocal water PECregionalwater PEClocalwater 0.593 µg l
1.=
Release to wwtp
RELEASEwwtp TONNAGEf emission. RELEASEwwtp 0.126 tonne a 1.=
Release to surface water
RELEASEsw TONNAGEf emission. Fstp water.
RELEASEsw 8.82 10
3 tonne a 1.=
Annual average local PEC in surface water:
Clocal water_ann Clocal water
Temission
365 d. a 1.
.
Clocal water_ann 0.483 µg l
1.=
PEClocalwater_ann Clocal water_ann PECregionalwater
PEClocalwater_ann 0.488 µg l
1.=  
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Appendix E        Default exposure estimation of PEClocalwater (stage of life 
cycle: use (processing) of water based paints and adhesives) 
 
 Default Exposure Estimation of PEClocalwater  
                  status: TGD, table A and B, IC: 14, UC: 55/0 µg 10
9 kg.
chemical : 2 - (Ethylhexyl) acrylate d 86400s.
a 365 d.stage of life cycle: use (processing) of water 
based paints and adhesives                               
 Total annual tonnage of chemical:
Product tonnage:
Release factor (A-table:3.15/4.5):
Fraction of main source (B-table:3.13/4.5):
Waste water flow of wwtp:
Duration of emission (B-table:3.13/4.5):
Fraction of emission directed to water:
(SimpleTreat; k:1h-1; logPow: 3,9; logH:2,36)
Dilution factor (TGD):
Factor (1+Kp * SUSPwater):
Regional concentration in surface water
TONNAGE 35.7 tonne. a 1.
PRODUCT 178500tonne. a 1.
f emission 0.5 %.
Fmainsource 0.05
EFFLUENTstp 2000 m
3. d 1.
Temission 300 d. a 1.
Fstp water 7 %.
DILUTION 10
FACTOR 1.0014
PECregionalwater 0.0058µg. l 1.
Emission per day:
Elocal water
TONNAGEFmainsource. f emission.
Temission
Elocal water 0.0298 kg d
1.=
Influent concentration:
Clocal inf
Elocal water
EFFLUENTstp
Clocal inf 14.88 µg l
1.=
Effluent concentration:
Clocal eff Clocal inf Fstp water. Clocal eff 1.04 µg l 1.=
Concentration in surface water:
Clocal water
Clocal eff
FACTOR DILUTION. Clocal water 0.1 µg l
1.=
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PEClocalwater
PEClocalwater Clocal water PECregionalwater PEClocalwater 0.11 µg l
1.=
Total release for the regional model 
RELEASE TONNAGEf emission. Fstp water. RELEASE 0.012 tonne a 1.=
Annual average local PEC in surface water:
Clocal water_ann Clocal water
Temission
365 d. a 1.
.
Clocal water_ann 0.085 µg l
1.=
PEClocalwater_ann Clocal water_ann PECregionalwater
PEClocalwater_ann 0.091 µg l
1.=  
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Appendix F        Calculation of PEClocal for aquatice compartment durino 
paper recycling 
 
               Calculation of PEClocal for aquatic compartment during paper recycling
                                              status: TGD, ESD, IC-12 
chemical : 2- (Ethylhexyl) acrylate d 86400s.
a 365 d 1.Total annual consumption of substance for paper:
rate of paper recycling:
Deinking rate (tab. 7,8):
Rate by not adsorption (tab.7):
Number of working days per year:
Number of recycling sites:
Waste water flow of wwtp:
Fraction of emission directed to water:
(Simple-Treat, k:1h-1, logH:2,36; logPow:3,9)
Factor (1+Kp*SUSPwater):
Dilution factor (TGD):
Regional concentration in surface water
Ws 4200 kg. a 1.
µg 10 9 kg.
RR 50 %.
DR 90 %.
NA 20 %.
Nd 250 d. a 1.
Ns 10
EFFLUENTstp 2000 m
3. d 1.
Fstp water 7 %.
FACTOR 1.0014
DILUTION 10
PECregionalwater 0.0058µg. l 1.
Emission per day:
Elocal water
Ws RR. DR. NA.
Nd Ns. Elocal water 0.151 kg d
1.=
     
Influent concentration:   
Clocal inf
Elocal water
EFFLUENTstp
Clocal inf 75.6 µg l
1.=
Effluent concentration:  
        
Clocal eff Clocal inf Fstp water. Clocal eff 5.292 µg l 1.=
Concentration in surface water:  
Clocal water
Clocal eff
DILUTIONFACTOR. Clocal water 0.53 µg l
1.=
PEClocalwater
PEClocalwater Clocal water PECregionalwater PEClocalwater 0.534 µg l
1.=
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Release to hydrosphere
Release sw Elocal water Fstp water. Release sw 0.011 kg d 1.=
Annual average local PEC in surface water
Clocal water_ann Clocal water
Nd
365 d. a 1.
.
Clocal water_ann 0.362 µg l
1.=
PEClocalwater_ann Clocal water_ann PECregionalwater
PEClocalwater_ann 0.368 µg l
1.=  
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Appendix G.1    Atmosphere (OPS-model) – Calculation of Clocalair and 
PEClocalair, site specific 
 
Atmosphere (OPS-model)
a 365 Tag. d 24 h. mg 10 6 kg.
Calculation of Clocal air and PEC local air, site-specific
concentration in air at source
strength of 1kg/d
Cstd air 2.78 10
4. mg. m 3. kg 1. d.
Fraction of main source
Duration of emission
Fraction of emission
Local emission during emission episode
to air  
Fmainsource 1
Temission 300 d. a 1.
RELEASE 0.18 tonne. a 1.
Elocal air Fmainsource
RELEASE
Temission
.
Elocal air 0.6 kg d
1.=
Fraction of the emission to air from STP
Local emission rate to water during
emission episode
Local emission to air from STP during
emission episode
Fstp air 0.298
Elocal water 122 kg. d 1.
Estp air Fstp air Elocal water.
Estp air 36.356 kg d
1.=
Local concentration in air during emission
episode
Clocal air wenn Elocal air Estp air> Elocal air Cstd air., Estp air Cstd air.,
Clocal air 0.0101 mg m
3.=
Annual average concentration in air,
100m from point source Clocal air_ann Clocal air
Temission
365 d. a 1.
.
Clocal air_ann 8.307 10
3 mg m 3.=
Regional concentration in air
Annual average predicted environmental
concentration in air
PECregional air 7.88 10
7. mg. m 3.
PEClocalair_ann Clocal air_ann PECregional air
PEClocalair_ann 8.308 10
3 mg m 3.=
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Appendix G.2    Atmosphere (OPS – model) – Calculation of Clocalair and  
PEClocalair 
 
Atmosphere (OPS-model)
a 365 Tag. d 24 h. mg 10 6 kg.Calculation of Clocal air and PEC local air
2 - (Ethylhexyl) acrylate
concentration in air at source
strength of 1kg/d
Cstd air 2.78 10
4. mg. m 3. kg 1. d.
Fraction of main source
Duration of emission
Fraction of emission
Local emission during emission episode
to air  
Fmainsource 1
Temission 300 d. a 1.
RELEASE 10 tonne. a 1.
Elocal air Fmainsource
RELEASE
Temission
.
Elocal air 33.333 kg d
1.=
Fraction of the emission to air from STP
Local emission rate to water during
emission episode
Local emission to air from STP during
emission episode
Fstp air 0.298
Elocal water 0.33 kg. d 1.
Estp air Fstp air Elocal water.
Estp air 0.098 kg d
1.=
Local concentation in air during emission
episode
Clocal air wenn Elocal air Estp air> Elocal air Cstd air., Estp air Cstd air.,
Clocal air 9.267 10
3 mg m 3.=
Annual average concentration in air,
100m from point source Clocal air_ann Clocal air
Temission
365 d. a 1.
.
Clocal air_ann 7.616 10
3 mg m 3.=
Regional concentration in air
Annual average predicted environmental
concentration in air
PECregionalair 7.88 10
7. mg. m 3.
PEClocalair_ann Clocal air_ann PECregionalair
PEClocalair_ann 7.617 10
3 mg m 3.=
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Calculation of the deposition rate
DEPstd aer 1 10
2. mg. m 2. d 1. kg 1. d.
Fraction of the chemical bound to aerosol Fass aer 8.333 10
6.
Deposition flux ofgaseous compounds as a function
of Henry`s Law coefficient,at a source strength of 1kg/d
                  logH<-2            5E-4  mg * m -2 * d-1
                  -2<logH<2       4E-4  mg * m -2 * d-1
                  logH>2             3E-4  mg * m-2 * d-1  
DEPstd gas 3 10
4. mg. m 2. d 1. kg 1. d.
Total deposition flux during emission episode
DEPtotal Elocal air Estp air Fass aer DEPstd aer. 1 Fass aer DEPstd gas..
DEPtotal 0.01 mg m 2. d 1.=
DEPtotal ann DEPtotal
Temission
365 d. a 1.
.
Annual average total depostion flux
DEPtotal ann 8.246 10
3 mg m 2. d 1.=
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Appendix G.3    Atmosphere (OPS-model) 
 
Atmosphere (OPS-model)
a 365 Tag. d 24 h. mg 10 6 kg.
Calculation of Clocal air and PEC local air
2 - (Ethylhexyl) acrylate
stage of life cycle: formulation of aqueous polymer dispersions
generic, IC:11, UC: 43
Total annual tonnage of chemical:
Product tonnage:
Release factor (A-table:2.1, MC3 as default):
Fraction of main source (B-table:2.3/2.9):
TONNAGE 42 tonne. a 1.
PRODUCT 210000tonne. a 1.
f emission 0.005
Fmainsource 0.4
Duration of emission (B-table:2.3): Temission 300 d. a 1.
concentration in air at source
strength of 1kg/d
Cstd air 2.78 10
4. mg. m 3. kg 1. d.
Release
RELEASE TONNAGEf emission.
RELEASE 0.21 tonne a 1.=
Local emission during emission episode
to air  Elocal air Fmainsource
RELEASE
Temission
.
Elocal air 0.28 kg d
1.=
Fraction of the emission to air from STP
Local emission rate to water during
emission episode
Local emission to air from STP during
emission episode
Fstp air 0.298
Elocal water 1.12 kg. d 1.
Estp air Fstp air Elocal water.
Estp air 0.334 kg d
1.=
Local concentation in air during emission
episode
Clocal air wenn Elocal air Estp air> Elocal air Cstd air., Estp air Cstd air.,
Clocal air 9.279 10
5 mg m 3.=
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Annual average concentration in air,
100m from point source Clocal air_ann Clocal air
Temission
365 d. a 1.
.
Clocal air_ann 7.626 10
5 mg m 3.=
Regional concentration in air
Annual average predicted environmental
concentration in air
PECregionalair 7.88 10
7. mg. m 3.
PEClocalair_ann Clocal air_ann PECregional air
PEClocalair_ann 7.705 10
5 mg m 3.=
Calculation of the deposition rate
DEPstd aer 1 10
2. mg. m 2. d 1. kg 1. d.
Fraction of the chemical bound to aerosol Fass aer 8.333 10
6.
Deposition flux ofgaseous compounds as a function
of Henry`s Law coefficient,at a source strength of 1kg/d
                  logH<-2            5E-4  mg * m -2 * d-1
                  -2<logH<2       4E-4  mg * m-2 * d-1
                  logH>2             3E-4  mg * m -2 * d-1  
DEPstd gas 3 10
4. mg. m 2. d 1. kg 1. d.
Total deposition flux during emission episode
DEPtotal Elocal air Estp air Fass aer DEPstd aer. 1 Fass aer DEPstd gas..
DEPtotal 1.842 10 4 mg m 2. d 1.=
Annual average total depostion flux
DEPtotal ann DEPtotal
Temission
365 d. a 1.
.
DEPtotal ann 1.514 10
4 mg m 2. d 1.=  
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Appendix H.1    Exposure of Soil. Input: 2-(Ethylhexyl acrylate): site-specific, 
production and process 
 
Exposure of Soil d 86400s.
ppm mg kg 1. a 365 d.
Input: 2 - (Ethylhexyl) acrylate): site-specific, prod+proc
i 1 3..
annual average total deposition flux:
soil-water partitioning coefficient:
concentration in dry sewage sludge:
air-water partitioning coefficient:
rate constant for for removal from 
top soil:
PECregional: 
DEPtotal ann 0.009115mg. m 2. d 1.
K soil_water 27.64
C sludge 0 mg. kg 1.
K air_water 0.0971
kbio soil 0.023 d
1.
PECregionalnatural_soil 8.12 10
8. mg. kg 1.
Defaults:
mixing depth of soil:
bulk density of soil:
average time for exposure:
partial mass transfer coefficient at
air-side of the air-soil interface:
partial mass transfer coefficient at
soilair-side of the air-soil interface:
partial mass transfer coefficient at
soilwater-side of the air-soil interface:
fraction of rain water that infiltrates
into soil:
rate of wet precipitation:
DEPTHsoili
0.2 m.
0.2 m.
0.1 m.
RHOsoil 1700 kg. m 3.
Ti
30 d.
180 d.
180 d.
kasl air 120 m. d 1.
kasl soilair 0.48 m. d 1.
kasl soilwater 4.8 10
5. m. d 1.
Finf soil 0.25
RAINrate 1.92 10 3. m. d 1.
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dry sludge application rate: APPLsludgei
0.5 kg. m 2. a 1.
0.5 kg. m 2. a 1.
0.1 kg. m 2. a 1.
Calculation:
aerial deposition flux per kg of soil:
D airi
DEPtotal ann
DEPTHsoili RHOsoil
.
rate constant for valatilisation from soil:
k volati
1
kasl air K air_water.
1
kasl soilair K air_water. kasl soilwater
K soil_water. DEPTHsoili.
1
rate constant for leaching from soil layer:
k leachi
Finf soil RAINrate.
K soil_water DEPTHsoili
.
removal from top soil:
ki k volati
k leachi
kbio soil
concentration in soil
concentration in soil due to 10 years of continuous deposition:
Cdep soil_10i
D airi
ki
1 exp 365 d. 10. ki..
concentration just after the first year of sludge application:
Csludge soil_1i
C sludge APPLsludgei
. a.
DEPTHsoili RHOsoil
.
initial concentration in soil after 10 applications of sludge:
Csludge soil_10i
Csludge soil_1i
1
1
9
n
exp 365 d. ki. n
=
.
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sum of the concentrations due to both processes:
C soil_10i
Cdep soil_10i
Csludge soil_10i
average concentration in soil over T days:
Clocal soili
D airi
ki
1
ki Ti
. C soil_10i
D airi
ki
. 1 exp ki Ti..
PEClocalsoili
Clocal soili
PECregionalnatural_soil
Clocal soili
ppm
8.513 10 4.
8.513 10 4.
1.341 10 3.
PEClocalsoili
ppm
8.513 10 4.
8.513 10 4.
1.341 10 3.
Clocal soil            =
Clocal agr.soil      =
Clocal grassland  =
PEClocal soil            =
PEClocal agr.soil      =
PEClocal grassland  =
Indicating persistency of the substance in soil
initial concentration after 10 years:
C soil_10i
ppm
8.513 10 4.
8.513 10 4.
1.341 10 3.
initial concentration in steady-state situation:
Facci e
365 d. ki.
C soil_ss i
D airi
ki
Csludge soil_1i
1
1 Facci
.
C soil_ss i
ppm
8.513 10 4.
8.513 10 4.
1.341 10 3.
fraction of steady-state in soil achieved:
Fst_st i
C soil_10i
C soil_ss i
Fst_st i
1
1
1
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concentration in pore water
Clocal soil_porewi
Clocal soili
RHOsoil.
K soil_water
Clocal soil_porewi
mg l 1.
5.236 10 5.
5.236 10 5.
8.247 10 5.
Clocal soil_porew            =
Clocal agr.soil_porew      =
Clocal grassland_porew  =
PEClocalsoil_porewi
PEClocalsoili
RHOsoil.
K soil_water
PEClocalsoil_porewi
mg l 1.
5.236 10 5.
5.236 10 5.
8.248 10 5.
PEClocal soil_porew            =
PEClocal agr.soil_porew      =
PEClocal grassland_porew  =
concentration in ground water
PEClocalgrw = PEClocal agr_soil_porew
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Appendix H.2    Exposure of soil. Input: 2-(Ethylhexyl acrylate): process –  
worst case 
 
Exposure of Soil d 86400s.
ppm mg kg 1. a 365 d.
Input: 2 - (Ethylhexyl) acrylate): proc - worst case
i 1 3..
annual average total deposition flux:
soil-water partitioning coefficient:
concentration in dry sewage sludge:
air-water partitioning coefficient:
rate constant for for removal from 
top soil:
PECregional: 
DEPtotal ann 0.008246mg. m 2. d 1.
K soil_water 27.64
C sludge 0 mg. kg 1.
K air_water 0.0971
kbio soil 0.023 d
1.
PECregionalnatural_soil 8.12 10
8. mg. kg 1.
Defaults:
mixing depth of soil:
bulk density of soil:
average time for exposure:
partial mass transfer coefficient at
air-side of the air-soil interface:
partial mass transfer coefficient at
soilair-side of the air-soil interface:
partial mass transfer coefficient at
soilwater-side of the air-soil interface:
fraction of rain water that infiltrates
into soil:
rate of wet precipitation:
DEPTHsoili
0.2 m.
0.2 m.
0.1 m.
RHOsoil 1700 kg. m 3.
Ti
30 d.
180 d.
180 d.
kasl air 120 m. d 1.
kasl soilair 0.48 m. d 1.
kasl soilwater 4.8 10
5. m. d 1.
Finf soil 0.25
RAINrate 1.92 10 3. m. d 1.
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dry sludge application rate: APPLsludgei
0.5 kg. m 2. a 1.
0.5 kg. m 2. a 1.
0.1 kg. m 2. a 1.
Calculation:
aerial deposition flux per kg of soil:
D airi
DEPtotal ann
DEPTHsoili RHOsoil
.
rate constant for valatilisation from soil:
k volati
1
kasl air K air_water.
1
kasl soilair K air_water. kasl soilwater
K soil_water. DEPTHsoili.
1
rate constant for leaching from soil layer:
k leachi
Finf soil RAINrate.
K soil_water DEPTHsoili
.
removal from top soil:
ki k volati
k leachi
kbio soil
concentration in soil
concentration in soil due to 10 years of continuous deposition:
Cdep soil_10i
D airi
ki
1 exp 365 d. 10. ki..
concentration just after the first year of sludge application:
Csludge soil_1i
C sludge APPLsludgei
. a.
DEPTHsoili RHOsoil
.
initial concentration in soil after 10 applications of sludge:
Csludge soil_10i
Csludge soil_1i
1
1
9
n
exp 365 d. ki. n
=
.
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sum of the concentrations due to both processes:
C soil_10i
Cdep soil_10i
Csludge soil_10i
average concentration in soil over T days:
Clocal soili
D airi
ki
1
ki Ti
. C soil_10i
D airi
ki
. 1 exp ki Ti..
PEClocalsoili
Clocal soili
PECregionalnatural_soil
Clocal soili
ppm
7.701 10 4.
7.701 10 4.
1.213 10 3.
PEClocalsoili
ppm
7.702 10 4.
7.702 10 4.
1.213 10 3.
Clocal soil            =
Clocal agr.soil      =
Clocal grassland  =
PEClocal soil            =
PEClocal agr.soil      =
PEClocal grassland  =
Indicating persistency of the substance in soil
initial concentration after 10 years:
C soil_10i
ppm
7.701 10 4.
7.701 10 4.
1.213 10 3.
initial concentration in steady-state situation:
Facci e
365 d. ki.
C soil_ss i
D airi
ki
Csludge soil_1i
1
1 Facci
.
C soil_ss i
ppm
7.701 10 4.
7.701 10 4.
1.213 10 3.
fraction of steady-state in soil achieved:
Fst_st i
C soil_10i
C soil_ss i
Fst_st i
1
1
1
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concentration in pore water
Clocal soil_porewi
Clocal soili
RHOsoil.
K soil_water
Clocal soil_porewi
mg l 1.
4.737 10 5.
4.737 10 5.
7.461 10 5.
Clocal soil_porew            =
Clocal agr.soil_porew      =
Clocal grassland_porew  =
PEClocalsoil_porewi
PEClocalsoili
RHOsoil.
K soil_water
PEClocalsoil_porewi
mg l 1.
4.737 10 5.
4.737 10 5.
7.461 10 5.
PEClocal soil_porew            =
PEClocal agr.soil_porew      =
PEClocal grassland_porew  =
concentration in ground water
PEClocalgrw = PEClocal agr_soil_porew
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Appendix H.3    Exposure of soil. Input: 2-(Ethylhexyl acrylate): formulation 
aqueous polymer dispersions 
 
Exposure of Soil d 86400s.
ppm mg kg 1. a 365 d.
Input: 2 - (Ethylhexyl) acrylate): formualtion aqueous
polymer dispersions i 1 3..
annual average total deposition flux:
soil-water partitioning coefficient:
concentration in dry sewage sludge:
air-water partitioning coefficient:
rate constant for for removal from 
top soil:
PECregional: 
DEPtotal ann 0.0001514mg. m 2. d 1.
K soil_water 27.64
C sludge 0 mg. kg 1.
K air_water 0.0971
kbio soil 0.023 d
1.
PECregionalnatural_soil 8.12 10
8. mg. kg 1.
Defaults:
mixing depth of soil:
bulk density of soil:
average time for exposure:
partial mass transfer coefficient at
air-side of the air-soil interface:
partial mass transfer coefficient at
soilair-side of the air-soil interface:
partial mass transfer coefficient at
soilwater-side of the air-soil interface:
fraction of rain water that infiltrates
into soil:
rate of wet precipitation:
DEPTHsoili
0.2 m.
0.2 m.
0.1 m.
RHOsoil 1700 kg. m 3.
Ti
30 d.
180 d.
180 d.
kasl air 120 m. d 1.
kasl soilair 0.48 m. d 1.
kasl soilwater 4.8 10
5. m. d 1.
Finf soil 0.25
RAINrate 1.92 10 3. m. d 1.
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dry sludge application rate: APPLsludgei
0.5 kg. m 2. a 1.
0.5 kg. m 2. a 1.
0.1 kg. m 2. a 1.
Calculation:
aerial deposition flux per kg of soil:
D airi
DEPtotal ann
DEPTHsoili RHOsoil
.
rate constant for valatilisation from soil:
k volati
1
kasl air K air_water.
1
kasl soilair K air_water. kasl soilwater
K soil_water. DEPTHsoili.
1
rate constant for leaching from soil layer:
k leachi
Finf soil RAINrate.
K soil_water DEPTHsoili
.
removal from top soil:
ki k volati
k leachi
kbio soil
concentration in soil
concentration in soil due to 10 years of continuous deposition:
Cdep soil_10i
D airi
ki
1 exp 365 d. 10. ki..
concentration just after the first year of sludge application:
Csludge soil_1i
C sludge APPLsludgei
. a.
DEPTHsoili RHOsoil
.
initial concentration in soil after 10 applications of sludge:
Csludge soil_10i
Csludge soil_1i
1
1
9
n
exp 365 d. ki. n
=
.
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sum of the concentrations due to both processes:
C soil_10i
Cdep soil_10i
Csludge soil_10i
average concentration in soil over T days:
Clocal soili
D airi
ki
1
ki Ti
. C soil_10i
D airi
ki
. 1 exp ki Ti..
PEClocalsoili
Clocal soili
PECregionalnatural_soil
Clocal soili
ppm
1.414 10 5.
1.414 10 5.
2.227 10 5.
PEClocalsoili
ppm
1.422 10 5.
1.422 10 5.
2.235 10 5.
Clocal soil            =
Clocal agr.soil      =
Clocal grassland  =
PEClocal soil            =
PEClocal agr.soil      =
PEClocal grassland  =
Indicating persistency of the substance in soil
initial concentration after 10 years:
C soil_10i
ppm
1.414 10 5.
1.414 10 5.
2.227 10 5.
initial concentration in steady-state situation:
Facci e
365 d. ki.
C soil_ss i
D airi
ki
Csludge soil_1i
1
1 Facci
.
C soil_ss i
ppm
1.414 10 5.
1.414 10 5.
2.227 10 5.
fraction of steady-state in soil achieved:
Fst_st i
C soil_10i
C soil_ss i
Fst_st i
1
1
1
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concentration in pore water
Clocal soil_porewi
Clocal soili
RHOsoil.
K soil_water
Clocal soil_porewi
mg l 1.
8.696 10 7.
8.696 10 7.
1.37 10 6.
Clocal soil_porew            =
Clocal agr.soil_porew      =
Clocal grassland_porew  =
PEClocalsoil_porewi
PEClocalsoili
RHOsoil.
K soil_water
PEClocalsoil_porewi
mg l 1.
8.746 10 7.
8.746 10 7.
1.375 10 6.
PEClocal soil_porew            =
PEClocal agr.soil_porew      =
PEClocal grassland_porew  =
concentration in ground water
PEClocalgrw = PEClocal agr_soil_porew  
 
  133 
Appendix I         SimpleBox2.0a – Berechnung regionaler & kontinentaler 
PEC’s 
 
-Anpassung an TGD (1996) / EUSES 1.00: Michael Feibicke (06/98) 
Table I.1     INPUT – 2EHA 
Parameter names 
acc. SimpleBox20  
Unit Input Parameter names according Euses 
Physicochemical Properties 
Compound name [-] 2-EHA Substance 
Mol weight [g.mol-1] 184 Molecular weight 
Melting point [° C] -90 Melting point 
Vapor pressure (25) [Pa] 12 Vapour pressure at 25°C 
Log kow [log10] 3.9 Octanol-water partition coefficient 
Solubility (25) [mg.l-1] 9.6 Water solubility 
Distribution - Partition coefficients 
- Solids water partitioning (derived from Koc) 
Kp(soil) [l.kgd-1] 18.282 Solids-water partitioning in soil 
Kp(sed) [l.kgd-1] 91.411 Solids-water partitioning in sediment 
Kp(susp) [l.kgd-1] 91.411 Solids-water partitioning in sudpended matter 
- Biota-water 
BCF(fish) [l.kgw-1] 412 Biocentration factor for aquatic biota 
Degradation and Transfromation rates 
- Characterisation and STP 
PASSreadytest [y/n] y Characterization of biodegradability 
- Environmental Total Degradation 
kdeg(air) [d-1] 8.64E-01 Rate constant for degradation in air 
kdeg(water) [d-1] 4.70E-02 Rate constant for degradation in bulk surface 
water 
kdeg(soil) [d-1] 2.30E-02 Rate constant for degradation in bulk soil 
kdeg(sed) [d-1] 2.30E-03 Rate constant for degradation in bulk sediment 
Sewage treatment (e.g. calculated by SimpleTreat) 
- Continental 
FR(volatstp) [C] [-] 2.98E-01 Fraction of emission directed to air (STPcont) 
FR(effstp) [C] [-] 7.00E-02 Fraction of emission directed to water (STPcont) 
FR(sludgestp) [C] [-] 7.50E-02 Fraction of emission directed to sludge 
(STPcont) 
Table I.1 continued overleaf  
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Table I.1 continued  INPUT – 2EHA 
Parameter names 
acc. SimpleBox20  
Unit Input Parameter names according Euses 
- Regional 
FR(volatstp) [R] [-] 2.98E-01 Fraction of emission directed to air (STPreg) 
FR(effstp) [R] [-] 7.00E-02 Fraction of emission directed to water (STPreg) 
FR(sludgestp) [R] [-] 7.50E-02 Fraction of emission directed to sludge 
(STPreg) 
Release estimation 
- Continental 
Edirect(air) [C] [t.y-1] 51.78 Total continental emission to air 
STPload [C] [t.y-1] 13.71 Total continental emission to wastewater 
Edirect(water1) [C] [t.y-1] 5.67 Total continental emission to surface water 
Edirect(soil3) [C] [t.y-1] 0 Total continental emission to industrial soil 
Edirect(soil2) [C] [t.y-1] 0 Total continental emission to agricultural soil 
- Regional 
Edirect(air) [R] [t.y-1] 10.6 Total regional emission to air 
STPload [R] [t.y-1] 38.17 Total regional emission to wastewater 
Edirect(water1) [R] [t.y-1] 0.63 Total regional emission to surface water 
Edirect(soil3) [R] [t.y-1] 0 Total regional emission to industrial soil 
Edirect(soil2) [R] [t.y-1] 0 Total regional emission to agricultural soil 
Table I.2     OUTPUT – 2-EHA 
Zur Neuberechnung der Daten:  ->Extras ->Optionen ->Berechnen -> Datei_berechnen -> F9 drücken, 
sonst keine komplette Neuberechnung aller Bezüge!! 
Parameter names 
acc. SimpleBox20 
Unit Output Parameter names according Euses 
Physicochemical properties 
Compound name [-] 2-EHA Substance 
Output 
- Continental 
PECsurfacewater 
(total) 
[mg.l-1] 1.38E-07 Continental PEC in surface water (total) 
PECsurfacewater 
(dissolved) 
[mg.l-1] 1.38E-07 Continental PEC in surface water (dissolved) 
PECair [mg.m-3] 5.91E-08 Continental PEC in air (total) 
PECagr.soil [mg.kgwwt-1] 2.79E-07 Continental PEC in agricultural soil (total) 
PECporewater 
agr.soil 
[mg.l-1] 1.72E-08 Continental PEC in pore water of agricultural 
soils 
PECnat.soil [mg.kgwwt-1] 6.09E-09 Continental PEC in natural soil (total) 
Table I.2 continued overleaf 
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Table I.2 continued  OUTPUT – 2-EHA 
Parameter names 
acc. SimpleBox20 
Unit Output Parameter names according Euses 
Output 
- Continental 
PECind.soil [mg.kgwwt-1] 6.09E-09 Continental PEC in industrial soil (total) 
PECsediment [mg.kgwwt-1] 3.51E-06 Continental PEC in sediment (total) 
- Regional 
PECsurfacewater 
(total) 
[mg.l-1] 5.80E-06 Regional PEC in surface water (total) 
PECsurfacewater 
(dissolved) 
[mg.l-1] 5.79E-06 Regional PEC in surface water (dissolved) 
PECair [mg.m-3] 7.88E-07 Regional PEC in air (total) 
PECagr.soil [mg.kgwwt-1] 6.77E-05 Regional PEC in agricultural soil (total) 
PECporewater 
agr.soil 
[mg.l-1] 4.16E-06 Regional PEC in pore water of agricultural soils  
PECnat.soil [mg.kgwwt-1] 8.12E-08 Regional PEC in natural soil (total) 
PECind.soil [mg.kgwwt-1] 8.12E-08 Regional PEC in industrial soil (total) 
PECsediment [mg.kgwwt-1] 1.33E-04 Regional PEC in sediment (total) 
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Appendix J.1     Chemical properties and environmental concentrations 
(2-ethylhexyl acrylate :site specifice, production and process) 
 
Name:  2 - (Ethylhexyl) acrylate:
site-specific, prod + proc
CAS - No.: 103 - 11 - 7
________________________________________________________________________________
Input
chemical properties logK OW 3.9
octanol-water partitioning coefficient
[-] K OW 10
logK OW
Henry - partitioning coefficient
[Pa*m3*mol-1]
HENRY 230 Pa. m3. mol 1.
air-water partitioning coefficient
[-]
K air_water 0.0971
fraction of the chemical associated 
with aerosol particles
[-]
F ass_aer 8.333 10
6.
half-life for biodegration in surface water
[d]
DT 50_bio_water 14.748d.
environmental concentrations
annual average local PEC in surface water (dissolved)
[mgchem * lwater-1]
PEClocalwater_ann 0.000116mg. l 1.
annual average local PEC in air (total)
[mgchem * mair-3]
PEClocalair_ann 8.308 10
3. mg. m 3.
local PEC in grassland (total), averaged over 180 days
[mgchem * kgsoil -1]
PEClocalgrassland 1.341 10
3. mg. kg 1.
local PEC in porewater of agriculture soil
[mgchem * lporewater -1]
PEClocalagr_soil_porew 5.236 10
5. mg. l 1.
local PEC in porewater of grassland
[mgchem * lporewater -1]
PEClocalgrassland_porew 8.248 10
5. mg. l 1.
local PEC in groundwater under agriculture soil
[mgchem * lwater-1]
PEClocalgrw 5.236 10
5. mg. l 1.
regional PEC in surface water (dissolved)
[mgchem * lwater-1]
PECregionalwater 5.80 10
6. mg. l 1.
regional PEC in air (total)
[mgchem * mair-3]
PECregionalair 7.88 10
7. mg. m 3.
regional PEC in agriculture soil (total)
[mgchem*kgsoil-1
PECregionalagr_soil 6.77 10
5. mg. kg 1.
regional PEC in porewater of agriculture soils
[mgchem*lwater-1
PECregionalagr_soil_porew 4.16 10
6. mg. l 1.
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Results of calculation
DOSEtot local
1.99116 10 3 mg
kg bw d.
= DOSEtot regional 5.89920310
6 mg
kg bw d.
=
RDOSEdrwlocal
0.083225 %= RDOSEdrwregional 2.0148 %=
RDOSEairlocal
89.409475 %= RDOSEairregional 2.862372 %=
RDOSEstemlocal
5.406237 %= RDOSEstemregional 0.173339 %=
RDOSErootlocal
1.058184 %= RDOSErootregional 28.377083 %=
RDOSEmeatlocal
0.062128 %= RDOSEmeatregional 5.76514 10
3 %=
RDOSEmilklocal
0.036617 %= RDOSEmilkregional 3.39786610
3 %=
RDOSEfishlocal
3.944134 %= RDOSEfishregional 66.563243 %=
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Appendix J.2     Chemical properties and environmental concentrations 
(2-ethylhexyl acrylate : formulation aqueous polymer 
dispersions) 
 
Name:  2 - (Ethylhexyl) acrylate:
formulation aqueous polymer dispersions
CAS - No.: 103 - 11 - 7
________________________________________________________________________________
Input
chemical properties logK OW 3.9
octanol-water partitioning coefficient
[-] K OW 10
logK OW
Henry - partitioning coefficient
[Pa*m3*mol-1]
HENRY 230 Pa. m3. mol 1.
air-water partitioning coefficient
[-]
K air_water 0.0971
fraction of the chemical associated 
with aerosol particles
[-]
F ass_aer 8.333 10
6.
half-life for biodegration in surface water
[d]
DT 50_bio_water 14.748 d.
environmental concentrations
annual average local PEC in surface water (dissolved)
[mgchem * lwater-1]
PEClocalwater_ann 0.000488mg. l 1.
annual average local PEC in air (total)
[mgchem * mair -3]
PEClocalair_ann 7.705 10
5. mg. m 3.
local PEC in grassland (total), averaged over 180 days
[mgchem * kgsoil -1]
PEClocalgrassland 2.235 10
5. mg. kg 1.
local PEC in porewater of agriculture soil
[mgchem * lporewater -1]
PEClocalagr_soil_porew 8.746 10
7. mg. l 1.
local PEC in porewater of grassland
[mgchem * lporewater -1]
PEClocalgrassland_porew 1.375 10
6. mg. l 1.
local PEC in groundwater under agriculture soil
[mgchem * lwater-1]
PEClocalgrw 8.746 10
7. mg. l 1.
regional PEC in surface water  (dissolved)
[mgchem * lwater-1]
PECregional water 5.80 10
6. mg. l 1.
regional PEC in  air (total)
[mgchem * mair -3]
PECregional air 7.88 10
7. mg. m 3.
regional PEC in agriculture soil (total)
[mgchem*kgsoil-1
PECregional agr_soil 6.77 10
5. mg. kg 1.
regional PEC in porewater of agriculture soils
[mgchem*lwater-1
PECregional agr_soil_porew 4.16 10
6. mg. l 1.
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Results of calculation
DOSEtot local
3.55253410 4 mg
kg bw d.
= DOSEtot regional 5.89920310
6 mg
kg bw d.
=
RDOSEdrwlocal
1.962382 %= RDOSEdrwregional 2.0148 %=
RDOSEairlocal
4.647588 %= RDOSEairregional 2.862372 %=
RDOSEstemlocal
0.281022 %= RDOSEstemregional 0.173339 %=
RDOSErootlocal
0.099069 %= RDOSErootregional 28.377083 %=
RDOSEmeatlocal
6.46446710 3 %= RDOSEmeatregional 5.76514 10
3 %=
RDOSEmilklocal
3.81003610 3 %= RDOSEmilkregional 3.39786610
3 %=
RDOSEfishlocal
92.999665 %= RDOSEfishregional 66.563243 %=  
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